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1 ITRODUCTIO 
 
1.1 Membranes and Bacterial Lipid Homeostasis 
 
Biological membranes separate the cell from the environment and build compartments 
inside the cell to divide and protect important cellular processes. Membranes are part of 
the bacterial cell envelope which can be differentiated between Gram-negative and 
Gram-positive bacteria. The cell envelope of Gram-positive bacteria contains a 
cytoplasmic membrane, which is covered by a thick peptidoglycan layer. In contrast, 
Gram-negative bacteria possess a thin peptidoglycan layer and additionally an outer 
membrane. 
The semipermeable bacterial membrane functions as a natural barrier to the changing 
environment and sustains a wide variety of essential cellular processes. Therefore, 
continuous adaptation of a bacterium to changing environmental conditions requires a 
corresponding adjustment of the lipid composition. This especially is needed to cope 
with compounds that are potentially harmful for the integrity of the membrane. Cationic 
antimicrobial peptides (CAMP) can be found in many organisms exposed to bacterial 
attacks as part of the intrinsic defense system. These peptides have been shown to 
directly interact with the negatively charged bacterial membrane as an antibacterial 
target. A comparable mode of interaction was also suggested for various cationic 
antibiotics (Zasloff, 2002; Peschel and Sahl, 2006). 
Bacteria adjust their membrane lipid composition by modifying the types of fatty acids 
that are produced via various biosynthetic pathways or alternatively by altering the 
structures of pre-existing membrane lipids (Zhang and Rock, 2008). A major class of 
membrane lipids are the phospholipids which are glycerolipids that contain two fatty 
acid chains. These phospholipid acyl chains are mainly responsible for the fluidity of 
the membrane, which in turn influences many crucial membrane associated functions, 
such as the passive permeability for hydrophobic molecules, active solute transport and 
protein-protein membrane localized sterols contributes to membrane fluidity. Moreover, 
formation of cyclopropane fatty acids in the stationary growth phase renders the 
bacterial membrane more resistant to acidic stress (Chang and Cronan, 1999). 
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The polar head group composition of phospholipids in the membrane is tightly 
controlled. The relevance of this bacterial lipid homeostasis was clearly demonstrated 
by the analysis of phenotypes of bacterial mutants which are deficient in the related 
lipid biosynthesis genes. It was shown that the failure of membrane proteins to correctly 
fold in mutants with altered phospholipid composition gives rise to defects in solute 
transport, electron transport, the initiation of DNA replication and cell division (Tsatskis 
et al., 2005; Zhang et al., 2005; Xie et al., 2006). 
 
 
1.2 Structure and Function of Phospholipids 
 
Phospholipids contain a diacylglycerol and a phosphate group which can be modified 
with other polar groups, for instance ethanolamine or glycerol. The fatty acid residues 
of phospholipids are hydrophobic, whereas the head group is hydrophilic. This 
amphipathic character of phospholipids in combination with its almost linear structure is 
responsible for the formation of a lipid bilayer in an aqueous environment. The 
cytoplasmic membrane of all living organisms including all Gram-negative and      
Gram-positive bacteria is composed of this typical lipid bilayer. In contrast, the outer 
membrane of Gram-negative bacteria contains an asymmetric bilayer which is 
composed of various phospholipids in the inner leaflet whereas the outer leaflet contains 
lipopolysaccharides. 
The most abundant phospholipids of Escherichia coli and Pseudomonas aeruginosa are 
phosphatidylethanolamine (PE) (70 - 80 %), phosphatidylglycerol (PG) (10 - 25 %) and 
diphosphatidylglycerol (DPG) (5 %) (Hancock and Meadow, 1969; Huijbregts et al., 
2000) (Fig. 1). 
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Figure 1: Structures of phospholipids: phosphatidylethanolamine (A), phosphatidylglycerol (B) and 
diphosphatidylglycerol (C). 
The phosphate group, the glycerol backbone and the two fatty acid residues are the major constituents of 
phospholipids. Variations of the head group moiety are shown: A, phosphatidylethanolamine;                  
B, phosphatidylglycerol; C, diphosphatidylglycerol. R1 - R4: fatty acid side chains. 
 
Due to the protonated amino group and the presence of a phosphate group PE is a 
zwitter ionic molecule under physiological conditions. PG and DPG as negatively 
charged phospholipids are responsible for the overall net negative charge of the 
bacterial membrane (Huijbregts et al., 2000). 
The primary role of phospholipids is the formation of a semipermeable lipid bilayer. 
However, they are also involved in several other processes. PE was found essential for 
the proper folding of the membrane proteins lactose permease LacY, phenylalanine 
permease PheP and γ-aminobutyrate permease GabP from E. coli (Wang et al., 2002; 
Zhang et al., 2003; Zhang et al., 2005; Xie et al., 2006). In mutant strains lacking PE 
biosynthesis the cytosolic N-terminal half of LacY was shown to be exposed to the 
periplasmic site of the bacterial membrane. This change in membrane protein topology 
impedes the cellular import of lactose (Wang et al., 2002; Xie et al., 2006). Once proper 
folding of LacY was achieved, PE was dispensable for the active transport of lactose, 
indicating a functional role of PE as a so called “lipid chaperone” (Bogdanov and 
Dowhan, 1999; Xie et al., 2006). 
The translocation of outer membrane porins PhoE and OmpA and even the assembly of 
a functional photosynthetic apparatus in Synechocystis sp. PCC6803 failed in cells 
lacking PG (de Vrije et al., 1988; Kusters et al., 1991; Hagio et al., 2000; Sato et al., 
2000). Furthermore, PG and DPG are required for initiation of DNA replication by 
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recruitment of the peripheral membrane protein DnaA to the negative charge surface of 
the membrane by electrostatic interaction (Matsumoto, 2001). Membranes lacking DPG 
were found more sensitive to the DNA gyrase inhibitor novobiocin and to other 
antibiotics (Tropp et al., 1995; Suzuki et al., 2002). The three-fold methylated PE 
derivative phosphatidylcholine (PC), which is present in about 10 % of all bacteria, was 
shown to be essential in Legionella pneumophila for the attachment to macrophages, the 
formation of a type IV secretion system and for the transition into a state of higher 
virulence (Sohlenkamp et al., 2003; Conover et al., 2008). 
The functional role of phosphatidylinositol which is found in low abundance in bacteria 
is not clear. However, phosphatidylinositol formation was shown to be essential for the 
survival of Mycobacterium tuberculosis in macrophages (Jackson et al., 2000). 
It becomes clear, that phospholipids play an important role in diverse functions of the 
bacterial cell. 
 
 
1.3 Phospholipid Biosynthesis 
 
The biosynthesis of phospholipids proceeds via a common biosynthetic pathway. Most 
of the required enzymes can be found conserved in prokaryotes as well as in eukaryotes. 
Phospholipid synthesis is located at the inner leaflet of the cytoplasmic membrane 
(Huijbregts et al., 2000; Cronan, 2003). (Geiger et al., 2010) 
In all organisms glycerol-3-phosphate is the common precursor of phospholipid 
biosynthesis (Fig. 2). Glycerol-3-phosphate is either directly synthesized by the 
phosphorylation of glycerol by glycerol kinase or by glycerol-3-phosphate 
dehydrogenase via the NADH-dependent reduction of dihydroxyacetone phosphate. In a 
next step the glycerol-3-phosphate acyltransferase PlsB catalyzes the formation of         
1-acyl-glycerol-3-phosphate via transfer of the acyl group from acyl-CoA or acyl-ACP 
(acyl carrier protein). Alternatively, 1-acyl-glycerol-3-phosphate is synthesized by 
conversion of acyl-ACP to acyl-phosphate which is then used for acylation of glycerol-
3-phosphate by the glycerol-3-phosphate acyltransferase PlsY (Lu et al., 2006). The 
second acyl group is added by the 1-acyl-glycerol-3-phosphate acyltransferase to 
synthesize phosphatidic acid (Frentzen et al., 1983). Acyl-ACP is synthesized in                  
the    fatty    acid    biosynthesis    pathway    by    condensation    of    acetyl-ACP    and 
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Figure 2: Overview of the biosynthesis of phospholipids according to Geiger et al. (2010). 
All phospholipids are synthesized based on glycerol-3-phosphate. CDP-diacylglycerol is the branching 
point for the synthesis of the anionic phospholipids PG and DPG and for the zwitter ionic phospholipids 
PE and PC. Enzymes are shown in blue. R1 – R4: fatty acid side chains. ACP = acyl carrier protein. CMP 
= cytidine monophosphate. CDP = cytidine diophosphate. CTP = cytidine triphosphate. Pi = inorganic 
phosphate, PPi = inorganic pyrophosphate. SAM = S-adenosyl-L-methionine. SAH =                               
S-adenosylhomocysteine. 
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malonyl-ACP and the repeated cycle of reactions involving reduction, dehydration and 
reduction of carbon-carbon bonds and again the condensation with malonyl-ACP (Rock 
and Cronan, 1996). 
Subsequently, phosphatidic acid is converted to the central phospholipid intermediate 
cytidine diphosphate diacylglycerol (CDP-diacylglycerol) by the reaction of the      
CDP-diglyceride synthase (Raetz, 1978). CDP-diacylglycerol is the precursor for 
formation of PG, DPG, PE, PC and other phospholipids like phosphatidylinositol. 
For synthesis of PE and PC, first CDP-diacylglycerol is condensed with serine to form 
phosphatidylserine. This reaction is catalyzed by the phosphatidylserine synthase. In a 
second step, catalyzed by the phosphatidylserine decarboxylase, phosphatidylserine is 
decarboxylated to yield PE. Subsequently, PE can be converted into PC in the 
“methylation pathway” by the phospholipid-N-methyltransferase via three                     
S-adenosyl-L-methionine dependent methylation steps or alternatively, by the PC 
synthase in the “nucleotide pathway” by condensation of choline and                        
CDP-diacylglycerol (Sohlenkamp et al., 2003). 
The phosphatidylglycerol phosphate synthase catalyzes the transfer of                
glycerol-3-phosphate to CDP-diacylglycerol producing phosphatidylglycerol phosphate. 
Thereby cytidine monophosphate (CMP) is released. Phosphatidylglycerol phosphate is 
further converted to PG by the phosphatidylglycerol phosphate phosphatase (Chang and 
Kennedy, 1967). Finally, two molecules of PG can be condensed in a transesterification 
reaction of the cardiolipin synthase to yield DPG (De Siervo and Salton, 1971). 
A small number of bacteria, for example M. tuberculosis contain phosphatidylinositol. 
This sugar containing phospholipid is synthesized by the condensation of myo-inositol 
to CDP-diacylglycerol catalyzed by the phosphatidylinositol synthase (Jackson et al., 
2000). 
 
 
 
 
 
 
 
   Introduction 
 
7 
 
1.4 Aminoacylated Derivatives of Phosphatidylglycerol  
 
Early investigations of the lipid composition of some bacteria revealed the occurrence 
of aminoacylated phosphatidylglycerol derivatives. The formation of                        
lysyl-phosphatidylglycerol (L-PG) under low pH conditions in Staphylococcus aureus 
and Enterococcus faecalis (formerly known as Streptococcus faecalis) was already 
described in the 60s (Houtsmuller and van Deenen, 1965). Furthermore, in 1962 
MacFarlane first described the existence of alanyl-phosphatidylglycerol (A-PG) in 
Clostridium welchii (today known as C. perfringens) (MacFarlane, 1962). In E. faecalis 
A-PG and L-PG were found simultaneously, whereas the presence of solely A-PG was 
described for Bifidobacterium liberorum (dos Santos Mota et al., 1970; Exterkate et al., 
1971). The formation of L-PG by P. aeruginosa strain NCTC 6750 was observed by 
Kenward et al. (1979). Moreover, aminoacylation of PG with arginine, glycine and 
ornithine, respectively, has been described (Houtsmuller and van Deenen, 1963; Gould 
and Lennarz, 1967; Kocun, 1970). Interestingly, in addition to L-PG formation in the 
Gram-positive Listeria monocytogenes also the modification of DPG with lysine was 
observed (Fischer and Leopold, 1999). The most abundant aminoacylated PG 
derivatives L-PG and A-PG are illustrated in Figure 3. 
 
 
 
Figure 3: Structures of lysyl-phosphatidylglycerol (A) and alanyl-phosphatidylglycerol (B). 
Lysyl-phosphatidylglycerol and alanyl-phosphatidylglycerol are derivatives of PG. The aminoacyl 
residues of the two molecules are highlighted in grey. R1 and R2: fatty acid side chains. 
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Aminoacyl-PGs are either zwitter ionic phospholipids or alternatively they possess a 
positive net charge, dependent on the utilized amino acid residue (MacFarlane, 1962; 
Houtsmuller and van Deenen, 1963; Fischer and Leopold, 1999; Sohlenkamp et al., 
2007; Roy and Ibba, 2008b). Therefore, aminoacylation of PG is a process by which the 
negative net charge of the bacterial membrane is reduced. However, to date it is not 
clear whether lysinylation of PG, alanylation of PG but also the modification with other 
amino acids have a comparable effect on the physiology of the organism. 
 
 
1.4.1 Aminoacyl-Phosphatidylglycerol Synthase MprF from Staphylococcus 
aureus 
 
In transposon mutagenesis studies with Gram-positive Staphylococcus xylosus, a mutant 
with an increased sensitivity to the lantibiotic gallidermin was observed. The insertion 
of the transposon had inactivated an open reading frame (ORF) of 2’525 bp. The 
corresponding gene of the opportunistic pathogenic Gram-positive bacterium S. aureus 
encodes a putative membrane protein of 841 amino acids which showed no similarities 
to known proteins. The mutant strain of S. aureus was found incapable of L-PG 
synthesis and was thereby rendered sensitive to cationic defensins when compared with 
the wild type strain. Due to the increased sensitivity to a variety of CAMPs this enzyme 
was named MprF (multiple peptide resistance factor) (Peschel et al., 2001). It was 
concluded that the biosynthesis of L-PG is an important determinant for the 
pathogenicity of S. aureus since the reduction of the overall net anionic charge of the 
bacterial membrane led to reduced binding to the membrane and cellular permeability 
for defensins. A repulsion of cationic antimicrobial compounds as a ‘defense 
mechanism’ was proposed (Peschel et al., 2001) (Fig. 4). 
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Figure 4: Putative mode of action of the resistance mechanism to antimicrobial peptides of 
S. aureus (Peschel et al., 2001). 
The cell wall and membrane of S. aureus are shown. The hydrophobic and positively charged portions of 
CAMPs are indicated in grey and white, respectively. In wild type bacteria a high amount of PG is 
esterified with lysine residues. Positively charged L-PG results in a reduced binding capacity of the cell 
envelope for CAMPs. In the mprF mutant cell lacking L-PG CAMPs accumulate in the membrane 
composed mainly of negatively charged lipids (Peschel et al., 2001). 
 
The positively charged L-PG results into a reduced binding capacity of the cell envelope 
for CAMPs, whereas in the mprF mutant cell lacking L-PG CAMPs accumulate in the 
membrane composed mainly of negatively charged lipids (Peschel et al., 2001). The 
accumulation of CAMPs in the membrane was proposed to result in the leakage of 
intracellular content and subsequently to cell death (Zasloff, 2002). 
 
 
1.4.2 Orthologous MprF Proteins 
 
Proteins homologous to MprF from S. aureus were found conserved in many pathogenic 
as well as in non-pathogenic bacteria. They are distributed over almost all phyla of 
bacteria and were also observed in archaea of the genus Methanosarcina. 
During the last decade, enzymes responsible for L-PG synthesis were also discovered 
and investigated for Bacillus subtilis (YfiW-YfiX), Sinorhizobium medicae WSM419 
(LpiA), Listeria monocytogenes (Lmo1695), Rhizobium tropici CIAT899 (LpiA), 
Mycobacterium tuberculosis (LysX), Agrobacterium tumefaciens (NP_355467) and 
Bacillus anthracis (Ba1486) (Staubitz and Peschel, 2002; Reeve et al., 2006; Thedieck 
et al., 2006; Sohlenkamp et al., 2007; Maloney et al., 2009; Roy and Ibba, 2009; 
Samant et al., 2009). 
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Studies with the orthologous mprF genes from L. monocytogenes, R. tropici, 
M. tuberculosis and B. anthracis revealed an analogous resistance mechanism to 
CAMPs as described for S. aureus (Thedieck et al., 2006; Sohlenkamp et al., 2007; 
Maloney et al., 2009; Samant et al., 2009). Furthermore, a S. medicae mutant which 
lacks the mprF homolog gene lpiA (low-pH inducible gene A) was compromised in its 
ability to survive under acidic conditions (Reeve et al., 2006). 
Most organisms only contain a single gene encoding an MprF homologous protein. 
However, in the Gram-positive bacterium C. perfringens SM101 two homologous genes 
were identified, one coding for a lysyl-phosphatidylglycerol synthase (L-PGS) and an 
additional one coding for an alanyl-phosphatidylglycerol synthase (A-PGS) (Roy and 
Ibba, 2008b). Formation of A-PG and L-PG in C. perfringens was speculated as a 
mechanism for fine-tuning of the biophysical properties of the bacterial membrane (Roy 
and Ibba, 2008b). 
Based on computational analysis for characterized L-PG and A-PG synthesizing 
enzymes a two domain architecture consisting of an N-terminal transmembrane domain 
and an additional C-terminal domain was proposed. The N-terminal domains of these 
enzymes from various organisms are highly variable in size and share only an amino 
acid sequence identity of approximately 15 %. In C. perfringens A-PGS, this domain 
consists of 228 amino acid residues, whereas the N-terminal domain of L-PGS from 
B. anthracis contains 527 amino acid residues. In contrast to this the C-terminal 
domains of aminoacyl-phosphatidylglycerol synthases (aa-PGS) were found highly 
conserved with an amino acid sequence identity of approximately 30 %. 
Interestingly, M. tuberculosis lysX encodes an L-PGS as a fusion to a lysyl-tRNA 
synthetase which is indispensable for L-PG synthesis (Maloney et al., 2009). 
From these theoretical findings it was concluded, that the C-terminal domain might be 
essential for synthesis of aminoacyl-PG (aa-PG). 
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1.4.3 Mechanism of aa-PG Synthesis 
 
The enzymatic reaction mechanism of the synthesis of aa-PG is so far unknown. Based 
on the high degree of amino acid sequence conservation for the C-terminal domain it 
was concluded, that this part of the molecule carries the key amino acid residues 
responsible for A-PG or L-PG catalysis. 
After treatment of S. aureus infections with daptomycin several daptomycin-resistant 
clinical isolates with several mutations in the mprF gene were observed. Daptomycin is 
a cyclic lipoprotein antibiotic which acts as CAMP in combination with Ca2+ (Straus 
and Hancock, 2006; Baltz, 2009). The resistant strains carried mprF genes encoding the 
following amino acid exchanges: E44A, S295L, P314L, T345A, T345I, I420N, I420S, 
I420T, I506M, and L826F (S. aureus numbering). These amino acid residues are not 
conserved in other MprF homolog proteins and most prominently located in the            
N-terminal transmembrane domain (Friedman et al., 2006; Julian et al., 2007; 
Kosowska-Shick et al., 2009). 
Several conserved amino acid residues of the C-terminal domain (proposed to contain 
the active site) of S. aureus MprF were exchanged (D546A, K547A, K621A, E624A, 
E685A, D731A, R734A, K806; S. aureus numbering) (Ernst et al., 2009). Amino acid 
exchanges K547A, K621A, E624A, D731A, R734A, and K806A lead to completely 
abrogate L-PG synthesis under in vivo conditions (Ernst et al., 2009). However, these 
analyses did not provide further insights into the related enzymatic mechanism. 
 
 
1.4.4 Substrate Recognition 
 
The most prominent role of tRNAs is the transfer of an activated amino acid residue to 
the ribosome during mRNA translation in protein synthesis. However, other processes 
than protein synthesis in which aminoacylated tRNAs serve as amino acid donor are 
known. These processes include peptidoglycan crosslinking, synthesis of antibiotics and 
tetrapyrrole biosynthesis (Matsuhashi et al., 1965; Yamato et al., 1986; Smith et al., 
1992). Initial evidence for a tRNA-dependent transfer of the aminoacyl-moiety to PG 
was obtained in early studies of Gould et al. (1968) and Nesbitt et al. (1968). It was 
shown that MprF from S. aureus uses tRNALys from different bacteria. Furthermore, 
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tRNALys aminoacylated with the lysine analog S-β-aminoethylcysteine was employed as 
substrate by MprF and resulted in the synthesis of S-β-aminoethylcysteinyl-PG. In 
contrast, S-β-aminoethylcysteinyl-tRNACys did not serve as substrate, indicating that the 
aa-PGS enzymes might possess a high degree of specificity for their cognate tRNAs 
(Nesbitt and Lennarz, 1968). In addition, Gould and co-workers tested several modified 
Ala-tRNA derivatives as substrate for A-PGS from the Gram-positive bacterium 
C. perfringens. All substrate analogs containing modified amino acid moieties           
(N-acetylalanyl-tRNAAla, lactyl-tRNAAla and phenylalanyl-tRNAAla) did not sustain any 
A-PGS activity which clearly indicates that this part of the aminoacylated tRNA 
substrate is recognized with a high degree of specificity. Furthermore, it was shown, 
that also the tRNAAla part of the molecule is relevant for substrate recognition, since 
Ala-tRNACys was not tolerated as an A-PGS substrate (Gould et al., 1968). Roy and 
Ibba (2008) were able to show that the overall integrity of tRNAAla is not a prerequisite 
for C. perfringens A-PGS catalysis (Roy and Ibba, 2008b). 
Only recently, it was shown that some aa-PG enzymes contain expanded amino acid 
specificities. Under in vitro conditions for the Enterococcus faecium aa-PGS a broad 
specificity for lysine, arginine and alanine was shown, whereas for the orthologous       
B. subtilis protein a primary specificity for lysine, in parallel with a relaxed specificity 
allowing for A-PG synthesis was observed (Roy and Ibba, 2009). However, for the     
A-PGS from C. perfringens and the L-PGS from A. tumefaciens strict amino acid 
specificity for alanine and lysine, respectively, was demonstrated. 
Concerning the polar head group of PG it was shown that only a 2’deoxy-glycerol 
instead of a glycerol head group was tolerated as substrate (Lennarz et al., 1967). 
Specific recognition of this part of the molecule was concluded. 
These analyses revealed first insights in the recognition of the tRNA and the PG 
substrate of aa-PGS enzymes.  
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1.4.5 Truncated MprF Homologs with Catalytic Activity 
 
Ernst et al. (2009) described the analysis of a truncated MprF variant under in vivo 
conditions. Deletion of 8 of the initial transmembrane helices out of the postulated       
14 transmembrane helices comprising the N-terminal transmembrane domain still 
resulted in L-PGS activity for the enzyme from S. aureus (Ernst et al., 2009). 
Nonetheless, the S. aureus strain producing this truncated MprF variant was shown to 
be susceptible to daptomycin analogous as the mprF mutant strain. Based on this 
observation it was speculated that the deleted N-terminal transmembrane helices are 
required for the efficient translocation of L-PG to the outer leaflet of the cytoplasmic 
membrane. A putative flippase activity in the 8 N-terminal transmembrane helices was 
proposed (Ernst et al., 2009). Based on these results in combination with the          
tRNA-dependent reaction mechanism (chapter 1.4.4) the following model was proposed     
(Fig. 5). 
 
Figure 5: Proposed model of L-PG synthesis by MprF from S. aureus and mode of MprF-mediated 
bacterial CAMP resistance (Ernst et al., 2009). 
The staphylococcal cell wall and membrane are shown. L-PG is synthesized by the transfer of a         
lysyl-moiety from Lys-tRNALys to PG. This reaction is catalyzed by the “synthase domain” of MprF.     
L-PG is then translocated from the inner leaflet of the cytoplasmic membrane to the outer leaflet by the 
putative flippase activity located in the 8 N-terminal transmembrane helices. L-PG formation results in a 
reduction of the overall net negative charge of the membrane surface (Ernst et al., 2009). 
 
In in vitro experiments with B. subtilis L-PGS and the C. perfringens A-PGS it was 
shown that a mutant protein with a truncation of the complete hydrophobic N-terminal 
domain still allows for enzymatic activity (Roy and Ibba, 2009). However, these mutant 
proteins did not sustain detectable lipid modification under in vivo conditions (Roy and 
cell wall 
membrane 
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Ibba, 2009). These results indicate that most of the N-terminal domain or in the case of 
B. subtilis and C. perfringens the complete N-terminal domain is dispensable for 
aminoacylation of PG. From these experiments one might conclude that the key amino 
acid residues responsible for catalysis are located in the C-terminal domain. 
 
 
1.5 The MprF Homolog Protein of Pseudomonas aeruginosa 
 
1.5.1 Pseudomonas aeruginosa: a Brief Introduction 
 
Pseudomonas aeruginosa is a metabolically versatile Gram-negative bacterium which is 
well known for its successful adaptation to several environmental niches (Stover et al., 
2000). P. aeruginosa is also an opportunistic pathogen responsible for a variety of 
nosocomial infections and burn-related sepsis (van Delden and Iglewski, 1998). It is the 
dominant pathogen of cystic fibrosis infections after antibiotics treatment (van Delden 
and Iglewski, 1998; Koch and Hoiby, 2000; Lyczak et al., 2002). During various 
infectious and non-infectious states, P. aeruginosa faces changing environmental 
conditions including highly variable pH values. Natural aquatic and terrestic habitats of 
P. aeruginosa span a pH range from 4.5 to 9.5. Moreover, under conditions of cystic 
fibrosis the airway surface liquid of the lung was found acidified to pH < 6.5 due to 
defective bicarbonate ion transport (Coakley et al., 2003). This pH alteration was 
proposed to contribute to cystic fibrosis pathogenesis. Moreover, a typical inflammatory 
response includes an acidification of the corresponding site by the production of acids 
(Simmen et al., 1994). 
Little is known about the alteration of membrane charge and membrane composition in 
Gram-negative bacteria including P. aeruginosa in response to changing environmental 
conditions. In earlier studies modification of the overall phospholipid composition of 
P. aeruginosa was described as a result of the stationary phase and starvation (Hancock 
and Meadow, 1969; Kenward et al., 1979). Conrad and Gilleland (1981) have observed 
the specific reduction of the phospholipid content of PG and PE for a polymyxin 
resistant P. aeruginosa strain. Furthermore, formation of L-PG by P. aeruginosa strain 
NCTC 6750 was observed under glucose and magnesium depletion by Kenward et al. 
(1979). In P. aeruginosa isolates from cystic fibrosis patients modification of LPS 
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component lipid A by addition of aminoarabinose as well as palmiate and retention of 
3-hydroxydecanoate resulted into increased resistance to CAMPs and β-lactam 
antibiotics (Ernst et al., 2007). (Conrad and Gilleland, 1981) 
P. aeruginosa exhibits high resistance rates to several antimicrobial agents which make 
it exceedingly difficult to treat infections. This general resistance was ascribed to a 
combination of different factors. P. aeruginosa is intrinsically resistant to many 
structurally unrelated antimicrobial agents as a result of the low permeability of the 
outer membrane and due to the presence of highly efficient efflux pump systems 
(Livermore, 1984; Poole, 2001; Mesaros et al., 2007). Furthermore, P. aeruginosa 
possesses several resistance genes against antibiotics and the formation of 
P. aeruginosa biofilms creates an additional barrier hampering antibiotic treatment 
(Stewart and Costerton, 2001; Lambert, 2002). 
The understanding of underlying resistance mechanisms is of prime importance to find 
new targets for the efficient treatment of P. aeruginosa infections. 
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1.5.2 ORF PA0920 from Pseudomonas aeruginosa Encodes an MprF Homolog 
Protein  
 
The gene product of ORF PA0920 from P. aeruginosa PAO1 shares 22 % sequence 
identity with the MprF protein from S. aureus. Based on this theoretical analysis a 
similar function was proposed. The overproduction of ORF PA0920 in E. coli resulted 
in the synthesis of a new lipid (Fig. 6) (Lorenzo, 2006; Klein, 2007). 
 
 
Figure 6: Detection of membrane lipids of A-PGS overproducing E. coli (Klein, 2007). 
An analysis of lipid composition of E. coli cultivated in LB medium by two-dimensional thin layer 
chromatography (2D-TLC) and spraying with 5 % (w/v) molybdatophosphoric acid is shown. E. coli 
TOP10 cells expressing ORF PA0920 from P. aeruginosa (A) results in the synthesis of a new lipid 
(indicated by an arrow) which is absent from E. coli control strain (B). PE = phosphatidylethanolamine, 
PG = phosphatidylglycerol, DPG = diphosphatidylglycerol. 
 
This new lipid was stained positive with molybdenum blue and ninhydrin indicating an 
amino group containing phospholipid (Lorenzo, 2006; Klein, 2007). In mass 
spectrometry analysis this lipid was clearly identified as A-PG (Piekarski, 2007). 
Therefore, the PA0920 protein was termed to A-PGS. The overproduction of A-PGS in 
E. coli TOP10 resulted in the accumulation of approximately 5 % A-PG when 
compared to the total lipid content. Furthermore, recombinantly overproduced A-PGS 
was found localized in the membrane fraction of E. coli and was solubilized using 
Triton X-100 (Klein, 2007). Subsequently, solubilized A-PGS was subjected to an in 
vitro assay resulting in A-PG formation. RNase pre-treatment of such experiments 
abolished A-PG formation which might also indicate a tRNA-dependent catalysis of    
A-PGS from P. aeruginosa. 
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1.6 Aim of this Study 
 
Aminoacyl-phosphatidylglycerol synthases (aa-PGS) catalyze the tRNA-dependent 
modification of the phospholipid phosphatidylglycerol (PG) to aminoacyl-PG and 
render bacteria resistant to CAMPs. Consequently, the inhibition of this class of 
enzymes is a promising strategy to render pathogenic bacteria more susceptible to 
antibacterial agents. To find a rationale for the development of efficient inhibitor 
molecules the understanding of the physiological relevance of aa-PGS catalysis and the 
underlying enzymatic mechanism is of prime importance. 
The first objective of this work was to investigate conditions under which the        
alanyl-phosphatidylglycerol synthase (A-PGS) from Pseudomonas aeruginosa is 
upregulated in the natural host. Furthermore, it was intended to identify physiological 
conditions under which A-PG synthesis is beneficial for P. aeruginosa. For this 
purpose, phenotypical differences between the P. aeruginosa wild type and a deletion 
mutant strain lacking the A-PGS encoding ORF PA0920 had to be determined by using 
standard microbiological methods and also by using a phenotype microarray analysis 
system. 
A second objective was to establish a minimal A-PGS catalytic fragment. Once 
identified, the truncated A-PGS variant should be recombinantly produced, purified and 
biochemically characterized. For analysis of A-PGS activity in vivo and in vitro assays 
had to be developed. 
Finally, the catalytic reaction mechanism was of central interest. For its elucidation 
several mutant variants of A-PGS had to be produced by site directed mutagenesis and 
subsequently biochemically characterized. Chemical modification experiments should 
complete the picture. Determinants of the PG and the tRNA substrate important for 
recognition and catalysis had to be elucidated. Besides this, the topology of the            
C-terminus of the membrane protein had to be analyzed. 
Obtained data should be integrated to a biochemical model of A-PGS function and 
regulation for the design of future inhibition strategies. 
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2 MATERIALS AD METHODS 
 
2.1 Instruments, Chemicals and Materials 
 
2.1.1  Instruments 
 
agarose gel electrophoresis Agagel Biometra 
agarose gel documentation GelDoc BioRad 
autoclave LVSA 50/70 Zirbus 
blotting equipment Semidry-Blot Trans-Blot®SD BioRad 
centrifuges Centrifuge 5804 Eppendorf 
 Minispin Eppendorf 
 RC 5B Plus Sorvall 
 L7-65 Ultracentrifuge Beckman 
DNA sequencing ABI Prism™ 310 Genetic 
Analyzer 
Applied Biosystems 
FPLC ÄKTApurifier™ GE Healthcare 
French®  Press French® Pressure Cell SLM Aminco 
 French® Pressure Cell Press Polytec 
luminescence (fluorescence)  
     spectrometer 
LS50B Perkin Elmer 
lyophilization Lyovac GT2 Amsco/Finn-Aqua 
mass spectrometer QTOF 2 mass spectrometer  Micromass  
pH determination pH-Meter CG 842 Schott 
photometer Ultrospec 2000 Amersham Pharmacia 
power supply electrophorese PowerPac 300 Biorad 
scales SBA 52 Scaltec 
 BP61S Sartorius 
scintillation counting TriCarb 2900 TR Perkin Elmer 
SDS-PAGE Mini Protean III BioRad 
shaker 305/3020 GFL 
 TR-150 Infors AG 
 Bench Top Shaker, TR  Infors AG HT 
sonication UW 2070 Bandelin 
 Sonotrode MS73 Bandelin 
Speed vac® SPD101B Savant 
thermocycler Tpersonal Biometra 
 Tgradient Biometra 
thermomixer Thermomixer 5436 Eppendorf 
vortex Vortex-Genie 2 Scientific Industries 
water purification Milli-Q System Millipore 
X-ray developer Optimax® Protec® 
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2.1.2  Chemicals and Materials 
antibodies anti-His (murine) GE Healthcare 
 anti-mouse HRP-conjugate 
     (Fc-specific) 
Pierce 
 anti-myc-antibody (murine) Invitrogen 
blotting materials Gel Blotting Papers Roth 
 Roti-PVDF-membrane Roth 
chemicals Bradford reagent Sigma-Aldrich 
 GelStar® Nucleic Acid Gel Stain Cambrex 
 Molybdatophosphoric acid  Merck 
 phosphatidylglycerol (L-α- 
     phosphatidyl-DL-glycerol sodium 
     salt from egg yolk lecithin) 
Sigma-Aldrich 
 diphosphatidylglycerol (cardiolipin 
     from bovine heart) 
Sigma-Aldrich 
enzymes creatin phosphokinase Sigma-Aldrich 
 Phusion™ polymerase Finnzymes 
 PreScission Protease GE Healthcare 
 restriction enzymes  New England Biolabs 
 Ribonuclease A Sigma-Aldrich 
 T4 DNA Ligase New England Biolabs  
 Taq DNA polymerase Biotherm 
kits QIAquick Gel Extraction Kit Qiagen 
 QIAquick PCR Purification Kit Qiagen 
 QuikChange® Site-Directed  
     Mutagenesis Kit 
Agilent Technologies 
 SuperSignal® West Pico  
     Chemiluminescence Kit 
Pierce 
molecular weight standards GeneRuler™ DNA Ladder Mix Fermentas 
 Protein Molecular Weight Marker Fermentas 
 PageRuler™ Prestained Protein  
     Ladder 
Fermentas 
 molecular weight marker Kit Sigma-Aldrich 
PCR materials nucleotides (dNTPs, rNTPs) Fermentas 
 oligonucleotides Biomers, MWG Biotech, 
Integrated DNA  
Technologies 
radioactively labeled molecules [U-14C]-L-alanine, 162 mCi mmol-1 Moravek Biochemicals 
 [1-14C]-L-alanine, 51 mCi mmol-1 Moravek Biochemicals 
 [2,3-3H]-L-alanine, 52 mCi mmol-1 GE Healthcare 
 [U-14C]-L-histidine, 322 mCi mmol-1 GE Healthcare 
 [U-14C]-L-lysine, 312 mCi mmol-1 Moravek Biochemicals 
scintillation solution OptiPhase HighSafe 2 Perkin Elmer 
thin layer chromatography DC-plates Alugram® SIL G/UV254  Macherey-Nagel 
other materials Chelating Sepharose FF GE Healthcare 
 Glutathione Sepharose 4FF GE Healthcare 
 gravity flow column “Poly-Prep”, 
     0.8 x 4 cm 
BioRad 
 Microcon® Centrifugal Filter Unit Millipore 
 Slide-A-Lyzer® MINI dialysis units Pierce 
 sterile filter  Millipore, Sartorius 
 Superdex 75 HR 10/30 GE Healthcare 
 MonoQ 5/50 GL Pharmacia Biotech  
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Chemicals and reagents not specifically listed here were purchased from the following 
manufacturers: Fluka, GE Healthcare, Macherey-Nagel, Merck, Riedel-de Haën, Roche, 
Roth, and Sigma-Aldrich. 
 
 
2.2  Bacterial Strains, Plasmids and Primers 
 
2.2.1 Bacterial Strains 
 
All bacterial strains used in this work are listed in Table 1. 
 
Table 1: P. aeruginosa and E. coli strains used in this study. 
Bacterial strain  Genotype or phenotype Reference 
P. aeruginosa   
 
PAO1 Wild type 
(Dunn and Holloway, 
1971) 
 ADD1976 
 
PAO1 derivative containing lacUV5/lacIq-
regulated T7 RNA polymerase gene 
(Brunschwig and Darzins, 
1992) 
 KS11 PAO1 attB::(mini-CTX-lacZ) (Schreiber et al., 2006) 
 PAO-MW20 PAO1 rpoS::aacC, Gmr (Whiteley et al., 2000) 
 NB170 PAO1 ∆relA ∆spoT (Boes et al., 2008) 
 ∆PA0920 P. aeruginosa ∆PA0920 deletion mutant (Lorenzo, 2006) 
 PPA0920-lacZ 
 
P. aeruginosa carrying a PPA0920-lacZ reporter 
gene fusion integrated at the attB site 
(Spier, 2007) 
 ∆PA0920compl 
 
 
 
 
∆PA0920 attB::(mini-CTX2-PA0920), 
complementation of ∆PA0920 via integration 
of the region ranging from 187 bp downstream 
to 90 bp upstream of the PA0920 region into 
the attB site 
This work 
 PAO-SK01 ∆PA0920 attB::(mini-CTX2) This work 
 PAO-SK02 PAO1 attB::(mini-CTX2) This work 
 PAO-SK03 
 
PAO-MW20 carrying a PPA0920-lacZ reporter 
gene fusion integrated at the attB site 
This work 
 PAO-SK04 
 
NB170 carrying a PPA0920-lacZ reporter gene 
fusion integrated at the attB site 
This work 
E. coli   
 DH10B F
- mcrA ∆(mrr-hsdRMS-mcrBC) 
Φ80dlacZ∆M15 ∆lacX74 deoR recA1 endA1 
araD139 ∆(ara, leu) 7697 galU galK λ- rpsL 
nupG 
Invitrogen, Darmstadt, 
Germany 
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Bacterial strain  Genotype or phenotype Reference 
 TOP10 F
- mcrA ∆(mrr-hsdRMS-mcrBC) 
Φ80lacZ∆M15 ∆lacX74 recA1 ara∆139 
∆(ara-leu)7697 galU galK rpsL (Strr) endA1 
nupG 
(Grant et al., 1990) 
 BL21 (λDE3) F
– ompT gal dcm lon hsdSB(rB
- mB
-) λ(DE3 
[lacI lacUV5-T7 gene 1 ind1 sam7 nin5]) 
(Studier et al., 1990) 
 BL21 (DE3)-RIL 
CodonPlus™ 
F– ompT hsdS(rB
- mB
-) dcm+ Tetr gal λ(DE3) 
endA Hte[argU ileY leuW], Camr 
Stratagene, Santa Clara, 
CA, USA 
 Rosetta (DE3) pLysS F
– ompT hsdSB(rB
– mB
–) gal dcm (DE3) 
pLysSRARE, Camr 
Novagen, Darmstadt, 
Germany 
 Rosetta 2 (DE3) F
– ompT hsdSB(rB
– mB
–) gal dcm (DE3) 
pRARE2, Camr 
Novagen, Darmstadt, 
Germany 
 K-12, strain AG1, 
clone JW2667 
recA1 endA1 gyrA96 thi-1 hsdR17(rK– mK+) 
supE44 relA1, carrying plasmid pCA24N 
which encodes for alanyl-tRNA synthetase 
from E. coli, Camr 
(Kitagawa et al., 2005) 
 K-12, strain AG1, 
clone JW2498 
recA1 endA1 gyrA96 thi-1 hsdR17(rK– mK+) 
supE44 relA1, carrying plasmid pCA24N 
which encodes for histidyl-tRNA synthetase 
from E. coli, Camr 
(Kitagawa et al., 2005) 
 ST18 S17 λ-pir ∆hemA (Thoma and Schobert, 
2009) 
 
 
2.2.2 Plasmids 
 
All plasmids used in this work are listed in Table 2. 
 
Table 2: Plasmids used in this work. 
 Plasmid Description Reference 
 mini-CTX-lacZ chromosomal integration vector for 
P. aeruginosa carrying a promoterless lacZ 
gene, Tcr 
(Becher and Schweizer, 
2000) 
 
mini-CTX-PPA0920-lacZ 
 
mini-CTX-lacZ containing a 469 bp fragment 
of the upstream region of the PA0920 gene 
cloned into XhoI and EcoRI sites 
(Spier, 2007) 
 mini-CTX2 chromosomal integration vector for 
P. aeruginosa, Tcr 
(Hoang et al., 2000) 
 pFLP2 source of FLP recombinase, Apr (Hoang et al., 1998) 
 pUCP20T shuttle vector E. coli-P. aeruginosa, Cbr (West et al., 1994) 
 pET22b(+) expression vector for E. coli, PT7, oripBR322, 
lacI, C-terminal His6-tag, Ap
r 
Novagen, Darmstadt, 
Germany 
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 Plasmid Description Reference 
 pET28b(+) expression vector for E. coli, PT7, oripBR322, 
lacI, N-terminal His6-tag, Kan
r 
Novagen, Darmstadt, 
Germany 
 pBAD-His-A expression vector for E. coli, ParaBAD, oripBR322, 
N-terminal His6-tag, Ap
r 
Invitrogen, Darmstadt, 
Germany 
 pBADmyc-His-A expression vector for E. coli, ParaBAD, oripBR322, 
C-terminal His6-tag and myc epitope, Ap
r 
Invitrogen, Darmstadt, 
Germany 
 pGEX-6P-1 E. coli expression vector for N-terminal 
protein fusion with GST-tag, specific cleavage 
site for PreScission Protease, Ptac, oripBR322, 
Apr 
GE Healthcare, Munich, 
Germany 
 pUC18 expression vector for E. coli, Plac, oripBR322, 5’-
terminal part of the lacZ gene encoding the N-
terminal fragment of β-galactosidase, Apr 
(Yanisch-Perron et al., 
1985) 
 pUC119 expression vector for E. coli, Plac, oripBR322,5’-
terminal part of the lacZ gene encoding the N-
terminal fragment of β-galactosidase, 
containing the intergenic region of M13 for 
production of ssDNA, Apr 
(Vieira and Messing, 
1987) 
 pET15bLysS expression vector for lysyl-tRNA synthetase 
from Borrelia burgdorferi, PT7, oripBR322, N-
terminal His6-tag, Ap
r 
(Ibba et al., 1997) 
 pT7-911 expression vector for E. coli encoding the T7 
RNA polymerase, IPTG inducible promoter, 
N-terminal His6-tag, Ap
r 
 
Kindly provided by 
Thomas E. Shrader, Albert 
Einstein College of 
Medicine, New York 
 pGEX-6P-1/PA0920 
∆AS1-542 
pGEX-6P-1 carrying base pairs 1627-2643 of 
the ORF PA0920 from P. aeruginosa in 
BamHI-XhoI restriction sites, encoding amino 
acid residues 543-881 of A-PGS as GST-
fusion protein, Apr 
(Tiefenau, 2007) 
 pGEX-6P-1/mprF 
∆AS1-514 
pGEX-6P-1 carrying base pairs 1543-2520 of 
the mprF gene from Staphylococcus aureus in 
BamHI-XhoI restriction sites, encoding amino 
acid residues 515-840 of MprF as GST-fusion 
protein, Apr 
(Tiefenau, 2007) 
 pGEX-6P-1/lin1803 
∆AS1-511 
pGEX-6P-1 carrying base pairs 1534-2595 of 
the Listeria innocua ORF lin1803 in BamHI-
XhoI restriction sites, encoding amino acid 
residues 512-865 of Lin1803 as GST-fusion 
protein, Apr 
(Tiefenau, 2007) 
 pGEX-6P-1/lmo1695 
∆AS1-510 
pGEX-6P-1 carrying base pairs 1531-2595 of 
the Listeria monocytogenes ORF lmo1695 in 
BamHI-XhoI restriction sites, encoding amino 
acid residues 511-865 of Lmo1695 as GST-
fusion protein, Apr 
(Tiefenau, 2007) 
 pGEX-6P-1/PA0920 
∆AS1-542 D579A 
pGEX-6P-1/PA0920∆AS1-542 derivative, 
amino acid exchange aspartate 579 to alanine 
(Arendt, 2009) 
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 Plasmid Description Reference 
 pGEX-6P-1/PA0920 
∆AS1-542 D579N 
pGEX-6P-1/PA0920∆AS1-542 derivative, 
amino acid exchange aspartate 579 to 
asparagine 
(Arendt, 2009) 
 pGEX-6P-1/PA0920 
∆AS1-542 E657D 
pGEX-6P-1/PA0920∆AS1-542 derivative, 
amino acid exchange glutamate 657 to 
aspartate 
(Arendt, 2009) 
 pGEX-6P-1/PA0920 
∆AS1-542 E657Q 
pGEX-6P-1/PA0920∆AS1-542 derivative, 
amino acid exchange glutamate 657 to 
glutamine 
(Arendt, 2009) 
 pGEX-6P-1/PA0920 
∆AS1-542 E658D 
pGEX-6P-1/PA0920∆AS1-542 derivative, 
amino acid exchange glutamate 658 to 
aspartate 
(Arendt, 2009) 
 pGEX-6P-1/PA0920 
∆AS1-542 E658Q 
pGEX-6P-1/PA0920∆AS1-542 derivative, 
amino acid exchange glutamate 658 to 
glutamine 
(Arendt, 2009) 
 pGEX-6P-1/PA0920 
∆AS1-542 S709A 
pGEX-6P-1/PA0920∆AS1-542 derivative, 
amino acid exchange serine 709 to alanine 
(Arendt, 2009) 
 pGEX-6P-1/PA0920 
∆AS1-542 S709N 
pGEX-6P-1/PA0920∆AS1-542 derivative, 
amino acid exchange serine 709 to asparagine 
(Arendt, 2009) 
 pGEX-6P-1/PA0920 
∆AS1-542 D710A 
pGEX-6P-1/PA0920∆AS1-542 derivative, 
amino acid exchange aspartate 710 to alanine 
(Arendt, 2009) 
 pGEX-6P-1/PA0920 
∆AS1-542 D710N 
pGEX-6P-1/PA0920∆AS1-542 derivative, 
amino acid exchange aspartate 710 to 
asparagine 
(Arendt, 2009) 
 pGEX-6P-1/PA0920 
∆AS1-542 E720Q 
pGEX-6P-1/PA0920∆AS1-542 derivative, 
amino acid exchange glutamate 720 to 
glutamine 
(Arendt, 2009) 
 pGEX-6P-1/PA0920 
∆AS1-542 S724A 
pGEX-6P-1/PA0920∆AS1-542 derivative, 
amino acid exchange serine 724 to alanine 
(Arendt, 2009) 
 pGEX-6P-1/PA0920 
∆AS1-542 S724N 
pGEX-6P-1/PA0920∆AS1-542 derivative, 
amino acid exchange serine 724 to asparagine 
(Arendt, 2009) 
 pGEX-6P-1/PA0920 
∆AS1-542 S763A 
pGEX-6P-1/PA0920∆AS1-542 derivative, 
amino acid exchange serine 763 to alanine 
(Arendt, 2009) 
 pGEX-6P-1/PA0920 
∆AS1-542 S763N 
pGEX-6P-1/PA0920∆AS1-542 derivative, 
amino acid exchange serine 763 to asparagine 
(Arendt, 2009) 
 pBAD-His-A/PA0920 pBAD-His-A containing the PA0920 gene 
fused to the sequence for N-terminal His6-tag 
cloned into XhoI and HindIII sites 
(Klein, 2007) 
 pBADmyc-His-A/ 
PA0920 
pBADmyc-His-A containing PA0920 gene 
fused to the sequence for C-terminal His6-tag 
cloned into HindIII and ?coI sites 
(Lorenzo, 2006) 
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 Plasmid Description Reference 
 pET22b(+)PA0920 
 
pET22b(+) carrying PA0920 gene in ?deI and 
HindIII sites, encoding a C-terminal His6-tag 
(Piekarski, 2007) 
 mini-CTX2-PA0920 chromosomal integration vector containing 
187 bp of PA0920 upstream region, the 
PA0920 gene and 90 bp of downstream region 
into SacI and HindIII sites 
This work 
 pUCP20T-T7-PA0920-
His6 
pUCP20T carrying the PA0920 gene fused to 
the sequence for C-terminal His6-tag, under 
PT7 into BamHI and KpnI sites 
This work 
 pET28b(+)alaRS pET28b(+) carrying the P. aeruginosa ORF 
PA0903 encoding the alanyl-tRNA synthetase 
in ?deI-BamHI sites 
This work 
 pUC18tRNA
Ala1 pUC18 containing ORF PA4280.3 (coding for 
tRNAAla1) from P. aeruginosa cloned into 
EcoRI and BamHI sites under control of PT7, 
3’ BstNI restriction site 
This work 
 pUC119tRNA
Ala2 pUC119 containing ORF PA3133.2 (coding 
for tRNAAla2) from P. aeruginosa cloned into 
EcoRI and BamHI restriction sites under 
control of PT7, 3’ BstNI restriction site 
This work 
 pGEX-6P-1/ 
A-PGS543-855N 
pGEX-6P-1/PA0920∆AS1-542 derivative, 
amino acid exchange alanine 856 to 
asparagine and deletion of amino acid residues 
857-881  
This work 
 pBAD-His-A/ 
PA09201-855N 
pBAD-His-A/PA0920-derivative, amino acid 
exchange alanine 856 to asparagine and 
deletion of amino acid residues 857-881 
This work 
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2.2.3 Oligonucleotides 
 
DNA and RNA oligonucleotides used in this work are listed in Table 3 and 4, 
respectively. Oligonucleotides were purchased from MWG Biotech AG (Ebersberg, 
Germany), Biomers (Ulm, Germany) or Integrated DNA Technologies (Coralville, IA, 
USA). Synthetic RNA oligonucleotides were used for mimicking of the acceptor stem 
of tRNAAla and tRNAHis. 
 
Table 3: DA oligonucleotides used in this work. 
Restriction sites are shown in italics. Exchanged nucleotides for mutagenesis of P. aeruginosa A-PGS or 
introduced stop-codons are highlighted in bold font and BstNI restriction sites are underlined. 
Oligonucleotide name Sequence (5’-3’) 
 1PA0920SacIF GTAATGAGCTCGCTGAACCATCGCTGAAC 
 2PA0920HindIIIR GATTATTAAGCTTGGTCGGCTCCAGAGCAG 
 3pET22b+BamHf GATGGATCCGTCGGCGATATAGGC 
 4pET22b+KpnIr GATATGGTACCGCAGCAGCCAACTC 
 27alasSNdeIfw ATAGCCATATGAAAAGCGCTGAAATCCG 
 28alsSBclIrv ATAGCTGATCATCAGAGCCCTTGCTCGAC 
 alatRNA1fw AATTCTAATACGACTCACTATAGGGGCCATAGCTCAGCTGGGAG
AGCGCCTGCTTTGCACGCAGGAGGTCAGGAGTTCGATCCTCCTT
GGCTCCACCAG 
 alatRNA1rv GATCCTGGTGGAGCCAAGGAGGATCGAACTCCTGACCTCCTGCG
TGCAAAGCAGGCGCTCTCCCAGCTGAGCTATGGCCCCTATAGTG
AGTCGTATTAG 
 alatRNA2fw AATTCTAATACGACTCACTATAGGGGCTATAGCTCAGCTGGGAG
AGCGCTTGCATGGCATGCAAGAGGTCGACGGTTCGATCCCGTCT
AGCTCCACCAG 
 alatRNA2rv GATCCTGGTGGAGCTAGACGGGATCGAACCGTCGACCTCTTGCA
TGCCATGCAAGCGCTCTCCCAGCTGAGCTATAGCCCCTATAGTG
AGTCGTATTAG 
 QCP856NSTOPfw CTACCTGGCCGTGCCAAACTAGGGCTCGACCCGCTGGTG 
 QCP856NSTOPrv CACCAGCGGGTCGAGCCCTAGTTTGGCACGGCCAGGTAG 
 
 
Table 4: RA oligonucleotides used in this work. 
The tetraloops of microhelices are shown in italics. The CCA 3’ ends are highlighted in bold font. 
Oligonucleotide name Sequence (5’-3’) 
 microhelix A GGGGCUCUUCGGAGCUCCACCA 
 microhelix B GGGGACGUUCGCGUCUCCACCA 
 microhelix C ACGGCUCUUCGGAGCUGUGCCA 
 microhelix D ACGGACGUUCGCGUCUGUACCA 
 microhelix E GUGGCUCUGCGGAGCUACACCA 
 microhelix F GGUGGCUCUGCGGAGCCACCCCA 
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2.3 Growth Media and Media Additives 
 
2.3.1 Media 
 
2.3.1.1  LB medium 
As a standard medium for growth of all bacterial strains, Luria Bertani (LB) medium 
(Sambrook and Russell, 2001) was used unless indicated otherwise. For solid media, 
1.5 % (w/v) agar-agar was added before sterilization. 
 
LB medium tryptone 10.0 g/l 
 NaCl 5.0 g/l 
 yeast extract 5.0 g/l 
 
To generate acidic growth conditions (pH 5.5) LB medium was supplemented with 
250 mM 2-(?-morpholino)ethanesulfonic acid. 
 
For protein production of HisRS and AlaRS in E. coli strains AG1 clone JW2498 and 
JW2667 LB medium with self inducing reagents for T7 promoters were added to avoid 
the need for IPTG addition according to Studier (2005).(Studier, 2005). 
 
LB medium with self inducing  LB medium 930 ml 
reagents 1 M MgCl2 1 ml 
 50x 5052 20 ml 
 20x NPS 50 ml 
 
50x 5052 glycerol 250 g/l 
 glucose 25 g/l 
 α-lactose 100 g/l 
 
20x NPS, pH 6.7 (NH4)2SO4  500 mM 
 Na2HPO4 x 7 H2O  1 M 
 KH2PO4  1 M 
 
20x NPS was autoclaved, whereas 50x 5052 was sterilized using a sterile filter unit 
(pore width 0.2 µm). 
 
 
2.3.1.2  AB medium 
For the cultivation of P. aeruginosa AB medium (Heydorn et al., 2000) and also a 
modified AB medium was used. For solid AB media, 1.5 % (w/v) agar-agar in water 
was prepared and autoclaved. After cooling, the other compounds of the medium were 
added. 
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AB medium standard A10  100 ml/l 
 1 M glucose  20 ml/l 
 50 mM FeSO4 x 7 H2O 500 µl/l 
 trace elements 1 ml/l 
 1 M MgCl2  1 ml/l 
 1 M CaCl2  100 µl/l 
 
All compounds were prepared as stock solutions. Standard A10, magnesium chloride, 
and calcium chloride were autoclaved, whereas glucose, ferrous (II) sulphate and trace 
elements were sterilized using a sterile filter unit (pore width 0.2 µm). 
 
standard A10  (NH4)2SO4 20 g/l 
 Na2HPO4 x 7 H2O 90 g/l 
 KH2PO4  30 g/l 
 
trace elements  CaSO4 x 2 H2O 200 mg/l 
 FeSO4 x 7 H2O 200 mg/l 
 MnSO4 x H2O 20 mg/l 
 CuSO4 x 5 H2O 20 mg/l 
 ZnSO4 x 5 H2O 20 mg/l 
 NaMoO4 x H2O 10 mg/l 
 H3BO3 5 mg/l 
 
For cultivation of P. aeruginosa under acidic and neutral growth conditions a modified 
AB medium was used. In this medium the pH value was adjusted by using a modified 
standard A10 buffer system (Table 5) containing 20 g/l ammonium sulphate. For 
cultivation under alkaline conditions (pH 9.5) 1 M of N-tris(hydroxymethyl)methyl-3-
aminopropanesulfonic acid was added to the standard A10, subsequently the pH value 
was precisely titrated with NaOH. In all cases the pH value of the individual media was 
verified at the beginning and at the end of the cultivation. 
 
Table 5: pH-modified A10. 
A10 with different pH values were adjusted by the phosphate buffer system. 
pH value A10 a2HPO4 x 7 H2O KH2PO4 pH value of AB media 
4  1.00 mM 449.00 mM 4.3 
4.5  2.00 mM 448.00 mM 4.8 
5  20.00 mM 430.00 mM 5.3 
5.5  50.00 mM 400.00 mM 5.8 
6  62.50 mM 387.50 mM 6.3 
6.5  152.00 mM 313.00 mM 6.8 
7  300.00 mM 150.00 mM 7.3 
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2.3.2 Additives 
 
Antibiotics and other additives were prepared as concentrated stock solutions, sterilized 
by filtration (pore width 0.2 µm) and were added to the medium after autoclaving. The 
following concentrations were used: 
 
Substance Solvent Concentration of 
stock solution 
Final concentration 
   cultivation of  
E. coli 
cultivation of 
P. aeruginosa 
ampicillin dH2O 100 mg/ml 100 µg/ml - 
carbenicillin  dH2O 100 mg/ml  100 µg/ml 250 µg/ml 
chloramphenicol ethanol 100 % (v/v) 34 mg/ml 34 µg/ml - 
kanamycin dH2O 30 mg/ml 30 µg/ml - 
tetracycline ethanol 70 % (v/v) 10 mg/ml 12.5 µg/ml 80 µg/ml 
IPTG dH2O 100 mM 50 – 400 µM 2 mM 
L-arabinose dH2O 20 % (w/v) 0.002 – 2 % - 
 
 
2.4 Microbiological Techniques 
 
2.4.1 Sterilization 
 
All media were vapour sterilized at 121 °C and 1 bar positive pressure for 20 min. Other 
substances and solutions were either vapour sterilized or if temperature sensitive 
sterilized by filtration (pore width 0.2 µm). 
 
 
2.4.2 Cultivation of E. coli and P. aeruginosa 
 
E. coli cells for recombinant protein production were grown under vigorous aeration. 
Pre-cultures were inoculated from glycerol stocks or single colonies from a plate culture 
in 100 ml of LB medium containing the respective antibiotics and grown overnight at 
37 °C and 200 rpm in baffled flasks. After inoculation with pre-culture (1:100), 500 ml 
cultures were grown at 37 °C until induction of protein production with indicated 
amounts of IPTG or L-arabinose. Cultures were then incubated at 17 °C, 30 °C or 37 °C 
for 3 - 5 h. 
P. aeruginosa pre-cultures were inoculated from single colonies from a plate culture in 
100 ml of LB or AB media containing the respective antibiotics and grown overnight at 
37 °C and 200 rpm in baffled flasks. After inoculation with pre-culture (1:100), 500 ml 
cultures were grown at 37 °C. Protein production was induced with indicated amounts 
of IPTG. Cultures were further incubated at 37 °C for 4, 6 or 24 h. 
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Agar plates were either utilized for plating 50 - 100 µl of a bacterial cell suspension 
with a Drigalski spatula or for streaking cells with an inoculating loop with liquid 
culture or with a single colony. Plates were incubated aerobically at 37 °C overnight. 
 
 
2.4.3 Determination of Cell Density 
 
The cell density of liquid cultures was determined by measuring the optical density 
(OD) at a wave length of 578 nm. For cell densities with an OD578 ≥ 0.6 dilutions with 
the respective cultivation medium were prepared before measurement. An OD578 of 1 
corresponds to approximately 1 x 109 cells/ml. 
 
 
2.4.4 Storage of Bacteria 
 
Strains were kept on agar plates at 4 °C for up to four weeks. For long term storage 
glycerol stocks were prepared. Therefore, an overnight culture was mixed with glycerol 
to yield a final concentration of 20 % (w/v) and kept at -80 °C. 
 
 
2.4.5 Immunogold-Labeling 
 
E. coli TOP10 pBADmyc-His-A/PA0920 was induced at an OD578 of 0.5 with           
0.75 % (w/v) L-arabinose and cultivated for 4 h at 37 °C. Bacteria were fixed with 1 % 
(v/v) formaldehyde in the growth medium at 4 °C. After washing with cacodylate buffer 
containing 10 mM glycine samples were dehydrated with a graded series of acetone (10, 
30, 50, 70, 90, 100 % (v/v)) and embedded in London Resin White (LRW) resin. 
Ultrathin sections were cut with a diamond knife and collected onto butvar coated 
nickel grids (300 mesh). Sections were incubated with anti-myc epitope mouse 
monoclonal IgG1 (1:50 dilution of the stock solution containing 1 mg/ml IgG1 
antibodies) for 16 h at 4 °C. After washing with 1x PBS bound antibody was made 
visible by using goat anti-mouse IgG antibodies coupled to 10 nm gold-nanoparticles 
(1:200 dilution of the stock solution, incubation for 1 h at RT). After washing with       
1x PBS containing 1 % (v/v) Tween 20, additional washing steps with 1x PBS and with 
distilled water were performed. Then air-dried sections were counterstained with            
4 % (w/v) aqueous uranyl acetate for 3 min before examination in a Zeiss transmission 
electron microscope EM910 at an acceleration voltage of 80 kV and calibrated 
magnifications. Images were recorded digitally with a Slow-Scan CCD-Camera 
(ProScan, 1024x1024, Scheuring, Germany) with ITEM-Software (Olympus Soft 
Imaging Solutions, Münster, Germany). Images were corrected for brightness and 
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contrast applying Adobe photoshop CS 3. This work was kindly done by Dr. Manfred 
Rohde and Ina Schleicher at the HZI, Braunschweig. 
 
cacodylate buffer, pH 6.9 cacodylate 100 mM 
 CaCl2 10 mM 
 MgCl2 10 mM 
 sucrose 90 mM 
   
1x PBS, pH 7.4 NaCl 137 mM 
 KCl 2.7 mM 
 Na2HPO4 x 7 H2O 10 mM 
 KH2PO4 2 mM 
 
 
2.5 Molecular Biological Techniques 
 
2.5.1 Preparation of Plasmid DA (Miniprep) 
 
Cells from a 2 ml overnight culture were harvested by centrifugation (11’000 * g; 
5 min). The sedimented cells were suspended in 150 µl of GTE solution and incubated 
for 5 min at room temperature (RT). For cell lysis, 300 µl of NaOH/SDS were added. 
The sample was carefully mixed by inverting the tube and incubated at RT for 2 min. 
225 µl of NaAc were added and the sample was carefully mixed again. After 
centrifugation (11’000 * g; 25 min) the supernatant was mixed with 600 µl of 
isopropanol in a fresh tube and centrifuged (11’000 * g; 10 min). The sedimented DNA 
was suspended in 200 µl of TES solution containing 3 µl of RNase A and incubated for 
1 h at 37 °C. Following an extraction with 200 µl CPI and vigorous shaking, the DNA 
was centrifuged (11’000 * g; 3 min). The DNA in the upper phase was precipitated 
again by addition of 400 µl of 100 % ethanol and centrifugation (11’000 * g; 20 min). 
Finally, the DNA precipitate was dried and solubilized in 50 µl dH2O. 
 
GTE solution Tris-HCl, pH 8.0 25 mM 
 ethylenediaminetetraacetic        
acid (EDTA) 
10 mM 
 glucose 50 mM 
   
NaOH/SDS NaOH 200 mM 
 SDS 1 % (w/v) 
   
NaAc sodium acetate, pH 4.8 3 M 
   
TES solution Tris-HCl, pH 8.0 50 mM 
 EDTA 10 mM 
 NaCl 150 mM 
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CPI phenol 50 % (v/v) 
 chloroform 49 % (v/v) 
 isoamyl alcohol 1 % (v/v) 
   
RNase A Ribonuclease A in 50 % (w/v)   
glycerol 
 
 
10 g/l 
2.5.2 Determination of DA Concentration 
 
The concentration and purity of a DNA solution was determined by measuring the 
absorbance at 260 nm and additionally at 280 nm to account for protein impurities. For 
a pure DNA solution, an A260nm of 1 corresponds to a concentration of 50 µg/ml 
dsDNA. The quality of the DNA solution is deduced from the ratio of A260nm to A280nm. 
With A260nm/A280nm = 1.8 - 2.0, the DNA can be considered as pure. 
 
 
2.5.3 Agarose Gel Electrophoresis 
 
For the analytical separation of DNA-fragments agarose gels (1 % (w/v) agarose in 
TAE-buffer) were prepared. DNA samples were mixed with DNA loading dye to 
facilitate loading and to indicate the progress of the samples in the gel. GeneRuler™ 
DNA Ladder Mix (MBI Fermentas, St. Leon-Roth, Germany) was used as DNA 
standard according to the manufacturer’s instructions. Depending on the size of the gel, 
a voltage of 80 - 100 V was applied. The DNA fragments migrate towards the anode 
with a velocity that is proportional to the negative logarithm of their length. After 
electrophoresis, gels were incubated in an ethidium bromide solution for 30 min. The 
DNA was detected via its fluorescence under UV light (λ = 312 nm). 
 
TAE buffer, pH 8.0 Tris-acetate 40 mM 
 EDTA 1 mM 
   
DNA loading dye bromophenol blue 350 µM 
 xylene cyanol FF 450 µM 
 glycerol 50 % (w/v) 
   
ethidium bromide solution ethidium bromide 0.1 % (w/v) 
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2.5.4 Cloning of DA 
 
For the characterization of A-PGS1-855N and A-PGS543-855N proteins plasmids            
pBAD-His-A/PA0920 (Klein, 2007) and pGEX-6P-1/PA0920∆AS1-542 (Tiefenau, 
2007) were mutagenized by site-directed mutagenesis. 
Furthermore, the alanyl-tRNA synthetase (AlaRS) encoding ORF PA0903 from           
P. aeruginosa was cloned into the pET28b(+) vector (Novagen, Darmstadt, Germany) 
to facilitate recombinant protein production in E. coli. The two isoacceptor tRNAAla 
genes (PA4280.3, PA3133.2) from P. aeruginosa were cloned into pUC18 or pUC119 
vectors that allowed for in vitro T7 RNA polymerase run-off transcription after plasmid 
cleavage with BstNI (Sampson and Uhlenbeck, 1988). To study the overproduction of 
A-PGS in P. aeruginosa, a C-terminal His6-tagged A-PGS construct was cloned into the 
E. coli-P. aeruginosa shuttle vector pUCP20T (West et al., 1994). Furthermore, a mini-
CTX2 based vector (Hoang et al., 2000) for the chromosomal complementation of the 
P. aeruginosa deletion mutant ∆PA0920 was constructed. 
 
 
2.5.4.1  Amplification of DA by Polymerase Chain Reaction (PCR) 
For amplification of DNA by PCR, oligonucleotide primers were designed carrying 
appropriate recognition sequences for restriction endonucleases. Oligonucleotides used 
in this study are listed in Table 3. 
PCR was performed in a total volume of 20 µl. After an initial DNA denaturation step 
(95 or 98 °C), a cycle consisting of denaturation, primer annealing (55 - 75 °C), and 
primer elongation (72 °C) was completed 30 times. PCR reactions were terminated by a 
final elongation period. The elongation step was adjusted according to the length of the 
DNA template and the employed DNA polymerase. 
 
Standard thermocycler program for PhusionTM polymerase (Finnzymes, Espoo, 
Finland): 
 
 
 
 
 
Standard thermocycler program for Taq DNA polymerase (Biotherm, Cologne, 
Germany): 
 
 
 
 
 
 
5 min 98 °C  
30 sec 98 °C  
30 sec  X °C         30x 
30 sec/kb 72 °C  
5 min 72 °C  
5 min 95 °C  
30 sec 95 °C  
30 sec  X °C        30x 
60 sec/kb 72 °C  
5 min 72 °C  
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2.5.4.2  Restriction of DA 
Restriction of DNA (vectors and PCR products) was carried out using restriction 
endonucleases purchased from New England BioLabs (Ipswich, MA, USA). Reaction 
buffers, concentrations of enzymes, DNA concentrations as well as incubation 
temperatures were chosen according to manufacturer’s instructions. The restriction 
proceeded for 1 - 3 h according to the employed enzymes. 
 
 
2.5.4.3  Purification of PCR Products and Vectors 
After amplification of DNA by PCR, the resulting PCR products were purified using the 
“QIAquick PCR Purification Kit” (QIAgen, Hilden, Germany) according to the 
manufacturer’s instructions. 
Restriction enzymes were removed by agarose gel electrophoresis. DNA was visualized 
using the GelStar® Nucleic Acid Gel Stain (Biozym, Hessisch Oldendorf, Germany) on 
a blue light detector (Biozym, Hessisch Oldendorf, Germany) using a yellow filter. 
DNA fragments were then excised from the gel and purified using the "QIAquick Gel 
Extraction Kit" (QIAgen, Hilden, Germany) according to manufacturer’s instructions. 
 
 
2.5.4.4  Ligation of DA 
Ligation of DNA was carried out using the T4 DNA ligase (MBI Fermentas, St. Leon-
Roth, Germany) according to the manufacturer’s instructions. An amount of 25 - 50 ng 
vector DNA was mixed with insert DNA (insert to vector ratio with regard to molar 
concentrations ≈ 5:1) in a final volume of 20 µl. Moreover, control reactions in the 
absence of insert or ligase were carried out. All reactions were incubated at RT for 2 h 
or at 17 °C overnight. 
 
 
2.5.4.5  Site-directed Mutagenesis (QuikChange) 
Single amino acids or even multiple amino acid residues of a protein of interest can be 
exchanged by inserting site-specific mutations into the DNA sequence of the 
corresponding gene. The QuikChange® Site-directed Mutagenesis Kit (Agilent 
Technologies, Santa Clara, CA, USA) was employed in this work for mutational 
analysis of truncated A-PGS variants (A-PGS1-855N and A-PGS543-855N) from 
P. aeruginosa. 
The method utilizes a dsDNA plasmid carrying the gene of interest and two synthetic 
oligonucleotide primers. The primers contain the desired mutation and are 
complementary to opposite strands of the vector. During PCR with the PfuTurbo DNA 
polymerase a mutated plasmid is generated. The PCR product is treated with DpnI, an 
endonuclease specifically digesting partially methylated DNA, here the parental 
template DNA. This allows isolation of the newly in vitro synthesized unmethylated 
Materials and Methods   
  
34 
 
DNA of the mutated plasmid with which a suitable E. coli strain is subsequently 
transformed. The DNA is then ligated by the DNA ligase of E. coli. 
PCR reactions with the QuikChange® Site-directed Mutagenesis Kit were carried out 
according to the manufacturer’s instructions. However, the volume of the PCR reaction 
was reduced to 25 µl. Competent E. coli DH10B cells were transformed with the 
mutated plasmids. Primers used for site-directed mutagenesis are listed in Table 3. 
 
 
2.5.4.6  Construction of Vectors 
 
Complementation of the ∆PA0920 deletion mutant 
For the complementation of the chromosomal ∆PA0920 deletion mutant (Lorenzo, 
2006), a 2’947 bp PCR product covering 187 bp of the PA0920 upstream region, the 
PA0920 gene and 90 bp of PA0920 downstream region was amplified with the 
PhusionTM polymerase using primers 1PA0920SacIF and 2PA0920HindIIIR (primer 
annealing 75 °C). The PCR product was digested with SacI and HindIII and ligated into 
vector mini-CTX2 (Hoang et al., 2000) to generate mini-CTX2-PA0920. 
 
Construction of P. aeruginosa overexpression vectors for PA0920  
By using primers 3pET22b+BamHf and 4pET22b+KpnIr the PA0920 sequence flanked 
by the vector encoded T7 promoter region and a C-terminal His6-tag region was 
amplified from plasmid pET22b(+)PA0920 (Piekarski, 2007) using the Taq DNA 
polymerase (annealing temperature 70 °C). The BamHI/KpnI-digested PCR fragment 
was cloned into the shuttle vector pUCP20T (West et al., 1994) to yield plasmid 
pUCP20T-T7-PA0920-His6. 
 
Construction of a P. aeruginosa alanyl-tRA synthetase overexpression vector 
ORF PA0903 encoding the AlaRS from P. aeruginosa was amplified from genomic 
DNA using the PhusionTM polymerase with primers 27alaSNdeIfw and 28alaSBclIrv 
(annealing temperature 75 °C). The PCR fragment was digested with ?deI and BclI and 
cloned into the ?deI/BamHI site of pET28b(+) to yield pET28b(+)alaRS. 
 
Construction of vectors for the in vitro transcription of tRA
Ala
 from P. aeruginosa 
The two isoacceptor tRNAAla genes (PA4280.3, PA3133.2) from P. aeruginosa were 
cloned using a hybridization method of oligonucleotides. Therefore, two 
complementary oligonucleotides were designed containing a 5’ EcoRI site, the             
T7 promoter sequence, the respective tRNAAla gene sequence, a 3’ BstNI and BamHI 
site. One nmol of each oligonucleotide was phosphorylated using 20 units of                
T4 polynucleotide kinase (New England BioLabs, Ipswich, MA, USA) in T4 DNA 
Ligase Buffer (New England BioLabs, Ipswich, MA, USA) at 37 °C for 1 h. 
Stochiometric amounts of phosphorylated oligonucleotides alatRNA1fw and 
alatRNA1rv, or alatRNA2fw and alatRNA2rv were hybridized by incubation at 100 °C 
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for 5 min followed by a cooling step to 25 °C for 30 min. The resulting DNA fragments 
(containing sticky ends compatible of EcoRI and BamHI restriction sites) were cloned 
into the EcoRI-BamHI site of pUC18 or pUC119. 
 
Construction of vectors for production of truncated A-PGS variants from 
P. aeruginosa 
Vectors pGEX-6P-1/A-PGS543-855N and pBAD-His-A/PA09201-855N were constructed by 
site-directed mutagenesis with the QuikChange® Site-directed Mutagenesis Kit (Agilent 
Technologies, Santa Clara, CA, USA) according to the manufacturer’s instruction using 
pGEX-6P-1/PA0920∆AS1-542 and pBAD-His-A/PA0920, respectively, as templates. 
The mutation of alanine residue 856 to asparagine and also the incorporation of a stop 
codon were facilitated by using primers QCP856NSTOPfw and QCP856NSTOPrv. 
 
 
2.5.5 Preparation of Competent E. coli cells 
 
2.5.5.1  The CaCl2 Method 
An overnight culture of E. coli cells was inoculated in a ratio of 1 : 100 and grown in 
100 ml LB medium under aerobic conditions. The bacteria were incubated at 37 °C and 
200 rpm in baffled flasks until the culture reached an OD578 of 0.6. Then, cells were 
harvested by centrifugation (2’900 * g; 10 min; 4 °C) and after washing with 10 ml of 
ice-cold CaCl2 solution, cells were suspended in 1 ml CaCl2 solution and stored at           
-80 °C. 
 
 
 
2.5.5.2  The RbCl Method 
E. coli cells were grown aerobically in 500 ml of LB medium containing the required 
additives. When the culture reached an OD578 of 0.6 cells were harvested by 
centrifugation (2’900 * g; 10 min; 4 °C), suspended in 100 ml TFB1 and incubated on 
ice for 5 min. After subsequent centrifugation (2’900 * g; 10 min; 4 °C) cells were 
suspended in 2 volumes of TFB2 (referring to the volume of the cell sediment) and 
incubated on ice for 60 min. These cells were either immediately used for 
transformation or stored at -80 °C. 
 
 
 
 
CaCl2 solution CaCl2 100 mM 
 glycerol 10 % (w/v) 
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2.5.6 Transformation of Competent E. coli cells 
 
The CaCl2 and RbCl competent E. coli cells were transformed by heat shock. For this 
purpose, 1 – 10 µl of plasmid DNA (50 µg/ml) was mixed with 100 µl of competent 
E. coli cells and incubated on ice for 10 min. After heating the cells for 45 sec to 42 °C, 
cells were incubated for 2 min on ice. To regenerate the transformed cells, they were 
incubated in 500 µl of LB medium at 37 °C for 1 h. The transformation volume was 
plated on LB medium agar plates with appropriate antibiotics and incubated overnight 
at 37 °C. 
 
 
2.5.7 Diparental Mating with P. aeruginosa 
 
Transfer of mini-CTX derived plasmids into P. aeruginosa cells was carried out by 
diparental mating using E. coli ST18 (Thoma and Schobert, 2009) as donor. The CTX 
integrase of mini-CTX promoted the integration of the vector into the attB site of the 
P. aeruginosa genome. In the resulting strain parts of the mini-CTX vector containing 
the tetracycline resistance cassette were deleted using a FLP recombinase encoded on 
the pFLP2 plasmid (Hoang et al., 1998) to yield markerless P. aeruginosa strains. 
CaCl2 competent E. coli ST18 cells were transformed with an E. coli-P. aeruginosa 
shuttle vector. One ml of an overnight culture of E. coli ST18 carrying the 
corresponding plasmid was sedimented (11’000 * g; 2 min; RT), suspended in 50 µl of 
an overnight culture of P. aeruginosa, and cultivated on a LB agar plate for 6 h at 
37 °C. Bacteria were suspended in 400 µl of LB medium and selected on LB agar plates 
containing tetracycline. Subsequently, the tetracycline cassette was discarded from the 
P. aeruginosa genome. Therefore, in a second diparental mating the plasmid pFLP2 
using E. coli ST18 was transferred into P. aeruginosa. Positive clones were selected by 
using carbenicillin LB agar plates. The pFLP2 encoded Flp recombinase enables the 
excision of the mini-CTX derived DNA sequences located in between two FRT 
TFB1 potassium acetate 30 mM 
 CaCl2 10 mM 
 MnCl2 50 mM 
 RbCl 100 mM 
 glycerol 15 % (v/v) 
 pH 5.8, adjusted with acetic acid  
   
TFB2 piperazine-N,N’-bis(2-ethane  
     sulfonic acid)-KOH, pH 6.5 
10 mM 
 CaCl2 75 mM 
 RbCl 10 mM 
 glycerol 15 % (v/v) 
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(Flippase Recognition Target) sites. To remove plasmid pFLP2 from P. aeruginosa 
cells were plated on LB agar plates containing 5 % (w/v) sucrose. Due to toxic 
accumulation of levan by the pFLP2 encoded levansucrase (sacB), cells without pFLP2 
are selected. Colony PCR was performed to verify the correct insertion into the 
P. aeruginosa genome. 
 
 
2.5.8 Sequencing 
 
The successful modification of DNA (cloning as well as site-directed mutagenesis) was 
confirmed by sequence determination of the respective DNA region based on the Sanger 
method (Sanger et al., 1977). The sequencing reactions were conducted with an ABI 
PRISMTM 310 Genetic Analyzer (Applied Biosystems, Darmstadt, Germany). The 
required PCR in the presence of fluorescence-labeled ddNTPs and the purification of 
the PCR product were carried out as described by the manufacturer. The analysis of all 
sequencing results was done using DNASTAR software package (GATC Biotech, 
Konstanz, Germany). 
 
 
2.6 Protein Biochemical Methods 
 
2.6.1 Recombinant Protein Production 
 
2.6.1.1  Production of A-PGS from P. aeruginosa 
For recombinant production of the membrane protein A-PGS from P. aeruginosa in 
E. coli, 500 ml LB medium supplemented with ampicillin were inoculated (ratio 1:100) 
with an overnight culture of E. coli TOP10 carrying pBADmyc-His-A/PA0920 or 
pBAD-His-A/PA0920, respectively. The pBAD/His and pBAD/myc-His derived 
expression constructs allow for the tight regulated, dose-dependent recombinant protein 
production and purification. The employed araBAD promoter (ParaBAD) from E. coli 
allows for the tuning of protein production levels to obtain the recombinant peptide as a 
soluble protein. By varying the concentration of L-arabinose, protein production levels 
can be optimized. In addition, the tight regulation of ParaBAD by AraC is important for 
the expression of potentially toxic genes (Guzman et al., 1992). 
Cultures were grown aerobically in LB medium supplemented with ampicillin at 37 °C 
and 180 rpm to an OD578 of 0.5. Recombinant production of A-PGS was induced by the 
addition of L-arabinose to a final concentration of 0.02 % (w/v) for production of     
His6-A-PGS or 0.75 % (w/v) for production of A-PGS-myc-His6, respectively. Cells 
were cultivated for 4 h and subsequently harvested by centrifugation (2’900 * g;          
10 min; 4 °C). Cell sediments were stored at -20 °C. 
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2.6.1.2 Recombinant Production of Truncated A-PGS, L-PGS and Mutant 
Proteins 
The truncated P. aeruginosa A-PGS variant A-PGS543-881 and the corresponding mutant 
proteins (containing single amino acid exchanges), were produced as soluble           
GST-fusion proteins in E. coli BL21 (λDE3). Cultures were grown aerobically in LB 
medium supplemented with ampicillin at 37 °C and 180 rpm to an OD578 of 0.5. 
Recombinant production of truncated variants and mutant proteins was induced by the 
addition of 50 µM IPTG. Protein production was performed at 37 °C for 3 h. Cells were 
harvested by centrifugation (2’900 * g; 10 min; 4 °C) and stored at -20 °C. 
Analogously, truncated versions of L-PGS from S. aureus (MprF515-840), L. innocua 
(Lin1803512-865) and L. monocytogenes (Lmo1695512-865) and P. aeruginosa                  
A-PGS543-855N were produced by cultivation for 5 h at 17 °C after IPTG induction        
(50 µM). 
 
 
2.6.1.3  Production of lysyl-tRA Synthetase from B. burgdorferi and alanyl-
tRA Synthetase from P. aeruginosa 
For the establishment of an in vitro aa-PGS activity assay it was mandatory to produce 
und purify the corresponding aminoacyl-tRNA synthetases. Therefore, the lysyl-tRNA 
synthetase (LysRS) from B. burgdorferi was produced in E. coli Rosetta 2 (DE3) cells 
carrying vector pET15bLysS (Ibba et al., 1997). The AlaRS from P. aeruginosa was 
produced in E. coli Rosetta (DE3) pLysS cells carrying plasmid pET28b(+)alaRS. 
Cultures were grown aerobically at 37 °C and 180 rpm to an OD578 of 0.5. Recombinant 
production of lysyl-tRNA synthetase or alanyl-tRNA synthetase was induced by the 
addition of 200 µM IPTG after a temperature shift to 30 °C. After 5 h, cells were 
harvested by centrifugation (2’900 * g; 10 min; 4 °C). Cell sediments were stored at      
-20 °C. 
 
 
2.6.1.4  Production of histidyl-tRA Synthetase and alanyl-tRA Synthetase 
from E. coli 
His6-tagged E. coli AlaRS and HisRS were overproduced using the E. coli ASKA 
library clones JW2667 and JW2498 (Kitagawa et al., 2005), respectively. Cultures were 
grown in LB medium with self inducing reagents (Studier, 2005) supplemented with 
chloramphenicol at 37 °C overnight. Cells were harvested by centrifugation (2’900 * g; 
10 min; 4 °C). 
 
 
2.6.1.5  Production of A-PGS in P. aeruginosa ADD1976 
ADD1976 (Brunschwig and Darzins, 1992) is a P. aeruginosa PAO1 derivative, which 
carries a chromosomal integrated T7 RNA polymerase gene under control of an 
inducible lacUV5 promoter. P. aeruginosa ADD1976 harboring pUCP20T-T7-PA0920-
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His6 for production of A-PGS-His6 was cultivated at 37 °C in 500 ml of LB medium 
supplemented with carbenicillin to an OD578 of 0.8. Protein production was induced by 
addition of 2 mM IPTG. Cells were further incubated for 4 h and harvested by 
centrifugation (2’900 * g; 10 min; 4 °C). Cell sediments were stored at -20 °C. 
 
 
2.6.2 Disruption of Cells  
 
For characterization of the A-PGS enzyme overproduced in E. coli or in P. aeruginosa, 
sedimented cells were suspended in lysis buffer 1 and disrupted by a double passage 
through a French® Press (Thermo Fisher Scientific, Waltham, Ma, USA) at            
19’200 p.s.i.. 
 
lysis buffer 1 Hepes-NaOH, pH 7.8  50 mM 
 
For analysis of the truncated aa-PGS variants sedimented cells were suspended in lysis 
buffer 2 or optional in lysis buffer 2 without 1,4-dithio-D,L-threitol (DTT) (chemical 
modification experiments) and disrupted by French® Press. 
 
 
1x PBS, pH 7.4 NaCl 137 mM 
 KCl 2.7 mM 
 Na2HPO4 x 7 H2O 10 mM 
 KH2PO4 2 mM 
 
E. coli BL21 CodonPlusTM (DE3)-RIL overproducing T7 RNA polymerase were 
suspended in lysis buffer 3 and disrupted by French® Press. 
 
 
 
 
 
 
 
 
 
 
lysis buffer 2 DTT  2 mM  
 in 1x PBS, pH 7.4  
lysis buffer 3 Tris-HCl, pH 8.0 50 mM 
 NaCl 100 mM 
 β-mercaptoethanol 5 mM 
 glycerol 5 % (w/v) 
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E. coli Rosetta (DE3) pLysS overproducing the AlaRS from P. aeruginosa and Rosetta 
2 (DE3) pLysS overproducing the LysRS from B. burgdorferi were suspended in lysis 
buffer 4 and 5, respectively. Cells were disrupted by French® Press. 
 
 
 
For purification of HisRS and AlaRS from E. coli, cells were suspended in lysis buffer 6 
and broken by sonication (3x 1 min; 0.5 sec interval; amplitude 70 %; sonotrode MS73 
(Bandelin, Berlin, Germany). 
 
2.6.3 Isolation of Membrane Proteins 
 
To determine the enzymatic activity of the full length A-PGS from P. aeruginosa it was 
mandatory to solubilize this membrane protein from the bacterial membrane. Therefore, 
a Triton X-100 based solubilization method was employed. Outer membrane proteins 
were separated from cytoplasmic membrane proteins by treatment with sarcosyl, a 
detergent which has been shown to selectively solubilize the cytoplasmic membrane 
proteins. 
 
 
2.6.3.1  Triton X-100 Solubilization 
The full length A-PGS from P. aeruginosa was solubilized by Triton X-100. Therefore, 
after cell disruption the membrane fraction of E. coli TOP10 pBAD-His-A/PA0920 was 
sedimented by ultracentrifugation (110’000 * g; 1 h; 4 °C). To purify the membrane 
fraction from soluble proteins a discontinuous sucrose gradient centrifugation was 
performed. For this purpose, the membrane fraction was suspended in 2 ml of a 
20 % (w/v) sucrose solution and was layered onto a three-step gradient consisting of a 
60 %, 40 % and 20 % (w/v) sucrose solution (3 ml each). After centrifugation for 2 h at 
145’000 * g and 4 °C in a swing-out-rotor (SW 40 Ti), the membrane fraction was 
enriched on the boundary layer of the 40 % (w/v) and 60 % (w/v) sucrose solution. The 
obtained membrane fraction was harvested and diluted in the same volume of               
lysis buffer 4  Tris-HCl, pH 7.2  50 mM 
 NaCl  300 mM 
 MgCl2 40 mM 
 glycerol  10 % (w/v) 
lysis buffer 5  Tris-HCl, pH 8.0  35 mM 
 NaCl  300 mM 
 glycerol  10 % (w/v) 
lysis buffer 6 Tris-HCl, pH 7.0 50 mM 
 NaCl 200 mM 
 MgCl2 20 mM 
 β-mercaptoethanol 1 mM 
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2x solubilization buffer. This suspension was stirred overnight and subsequently 
centrifuged (110’000 * g; 1 h; 4 °C). The supernatant contains solubilized membrane 
proteins. 
 
 
 
 
2.6.3.2  Sarcosyl Solubilization 
Alternatively, the full length A-PGS from P. aeruginosa was solubilized by sarcosyl 
(sodium lauryl sarcosinate). Sarcosyl was found to disrupt selectively the cytoplasmic 
membrane of bacteria (Filip et al., 1973). The preparation of the outer membrane 
fractions was performed according to Bölin et al. (1982). Therefore, L-PGS 
overproducing E. coli cells were suspended in 20 ml of TEM buffer and disrupted by 
French® Press. After ultracentrifugation (110’000 * g; 1 h; 4 °C) the sediment was 
suspended in 20 ml of SM buffer, stirred at 4 °C overnight and subsequently centrifuged 
(110’000 * g; 1 h; 4 °C). The evolving supernatant contained solubilized cytoplasmic 
membrane proteins. The outer membrane proteins containing sediment was suspended 
in 1x sample buffer. 
(Bölin et al., 1982) 
 
 
 
 
 
 
 
sucrose solution sucrose 20/40/60 % (w/v) 
 Tris-HCl, pH 8.0 10 mM 
 MgCl2 100 mM 
2x solubilization buffer Tris-HCl, pH 8.0 100 mM 
 MgCl2 40 mM 
 Triton X-100 18 M 
 
TEM buffer 
 
Tris-HCl, pH 8.0 
 
10 mM 
 EDTA 5 mM 
 β-mercaptoethanol 1 mM 
   
SM buffer sarcosyl 0.5 % (w/v) 
 β-mercaptoethanol 1 mM 
   
4x sample buffer  Tris-HCl, pH 6.8 62.5 mM 
 SDS 1 % (w/v) 
 β-mercaptoethanol 0.5 % (v/v) 
 glycerol 10 % (v/v) 
Materials and Methods   
  
42 
 
2.6.4 Affinity Chromatography of Cytosolic and Solubilized Membrane Proteins 
 
For the affinity chromatography of cytosolic proteins, the cellular extract after cell 
disruption was centrifuged at 110’000 * g and 4 °C for 1 h. The resulting supernatant 
was loaded onto a gravity-flow column equilibrated with the appropriate lysis buffer. 
For affinity chromatography of membrane proteins, the supernatant of the protein 
solubilization procedure was used. 
 
 
2.6.4.1  Affinity Chromatography of GST-tagged Proteins 
For purification of GST-tagged proteins, a Poly-Prep chromatography column (BioRad, 
Munich, Germany) containing 1 ml of glutathione-Sepharose 4FF (GE Healthcare, 
Munich, Germany) was used. After applying the protein sample, the column was 
washed with 10 column volumes (Cv) of lysis buffer 2 (compare chapter 2.6.2) and      
10 Cv of Tris buffer. Alternatively, the column was washed with 20 Cv of 1x PBS 
(2.4.5). The resin was incubated for 30 min with elution buffer A containing 10 mM 
glutathione, subsequently proteins were eluted using 4x 1 ml elution buffer A. 
 
Tris buffer Tris-HCl, pH 8.0 50 mM 
 DTT 2 mM 
 
elution buffer A glutathione 10 mM 
 in Tris buffer or 1x PBS  
 
 
2.6.4.2  Affinity Chromatography of His6-tagged Proteins 
For the purification of His6-tagged proteins Chelating Sepharose FF (GE Healthcare, 
Munich, Germany) was used. The material was first loaded with 2 Cv of 100 mM of 
NiSO4 and washed with 5 Cv of H2O. The cytosolic extract or Triton X-100-solubilized 
membrane fractions after ultracentrifugation were applied onto nickel-loaded Chelating 
Sepharose FF. After extensive washing (10 Cv of washing buffer) and an optional      
pre-elution step (lysis buffer containing 5 mM of imidazole), proteins were eluted in 
lysis buffer containing 500 mM or alternatively 1 M of imidazole. 
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Purification of His6-tagged Alanyl-tRA Synthetase from P. aeruginosa 
 
 
 
Purification of His6-tagged Alanyl-tRA Synthetase and Histidyl-tRA Synthetase 
from E. coli 
 
 
Purification of His6-tagged T7 RA polymerase 
 
 
 
Purification of His6-tagged A-PGS from Membrane Solubilized Fractions 
washing buffer F 2x solubilization buffer (2.6.3.1) 50 % (v/v) 
 imidazole 5 mM 
 
elution buffer F 2x solubilization buffer 50 % (v/v) 
 imidazole 500 mM 
 
 
 
 
washing buffer B Tris-HCl, pH 7.2  50 mM 
 NaCl  300 mM 
 MgCl2 40 mM 
 glycerol  10 % (w/v) 
 
pre-elution buffer B 
 
imidazole  
 
5 mM 
 in washing buffer B  
elution buffer B imidazole  500 mM 
 in washing buffer B  
   
washing buffer C Tris-HCl, pH 7.0 50 mM 
 NaCl 200 mM 
 MgCl2 20 mM 
 β-mercaptoethanol 1 mM 
elution buffer C 
 
imidazole 
in washing buffer C 
1 M 
washing buffer E Tris-HCl, pH 8.0 50 mM 
 NaCl 100 mM 
 β-mercaptoethanol 5 mM 
 glycerol 5 % (w/v) 
pre-elution buffer E imidazole  5 mM 
 in washing buffer E  
elution buffer E imidazole  500 mM 
 in washing buffer E  
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2.6.5 Dialysis 
 
Buffer exchange was performed at 4 °C using dialysis membranes with a molecular 
weight cut off of 14’000. Elution fractions were dialyzed three times against 500 -    
1000 ml of the respective buffer without imidazole (14 h, 2 h, 2 h). T7 RNA polymerase 
containing elution fractions were dialyzed by dialysis membrane against storage buffer 
and stored at -80 °C. 
 
 
2.6.6 Protease Digestion for Removal of GST-Tag 
 
GST-fusion tags of the purified recombinant proteins were proteolytically cleaved using 
the PreScission Protease site. Therefore, proteins bound to the resin were incubated 
overnight with the corresponding protease (10 units mg-1) in 2 ml Tris buffer (chapter 
2.6.4.1) or 1x PBS (chapter 2.4.5) at 4 °C. 
 
 
2.7 Protein Characterization 
 
2.7.1 Determination of Protein Concentration 
 
Concentrations of purified proteins were determined using the Bradford reagent (Sigma-
Aldrich, St Louis, MO, USA) according to the manufacturer’s instructions. The assay is 
based on the colorimetric method developed by Bradford (1976). Bovine serum albumin 
was used as a standard. (Bradford, 1976) 
 
 
2.7.2 Discontinuous SDS Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
 
Proteins were analyzed by SDS-PAGE as described by Laemmli (1970) with 
modifications by Righetti et al. (1990) for discontinuous SDS-PAGE. 
Protein samples containing soluble proteins were supplemented with 2x SDS loading 
dye and incubated at 95 °C for 10 min. For the analysis of membrane proteins, samples 
were incubated at 40 °C for 30 min in 2x SDS loading dye. This variation was 
mandatory to avoid irreversible aggregation of membrane proteins. 
Samples were loaded onto gels which were run at 45 mA until the band of bromophenol 
blue dye reached the lower end of the gel. During electrophoresis, proteins were first 
storage buffer Hepes-KOH, pH 8.0 20 mM 
 NaCl 100 mM 
 EDTA 1 mM 
 DTT 3 mM 
 glycerol 50 % (w/v) 
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focussed in the stacking gel and subsequently separated according to their relative 
molecular mass in the running gel. The size standard employed was the Protein 
Molecular Weight Marker (MBI Fermentas, St. Leon-Roth, Germany). For 
immunochemical detection of proteins, the protein standard PageRulerTM Prestained 
Protein Ladder (MBI Fermentas, St. Leon-Roth, Germany) was used. Subsequently, 
gels were stained with Coomassie Brilliant Blue G-250 and destained until distinct 
protein bands were visible. For documentation, gels were scanned and then dried 
between two cellophane foils for storage. 
(Laemmli, 1970; Righetti et al., 1990).    
acrylamide stock solution acrylamide 30 % (w/v) 
(Roth) N,N’-methylen bisacrylamide 0.8 % (w/v) 
   
running gel, 12 % (w/v) acrylamide stock solution 2 ml 
 1.5 M Tris-HCl, pH 8.8 with 
0.4 % (w/v) SDS 
1.25 ml 
 dH2O 1.75 ml 
 10 % (w/v) ammonium  
peroxodisulphate (APS) 
50 µl 
 N,N,N',N',-tetramethyl ethylen 
diamine (TEMED) 
5 µl  
   
running gel, 9 % (w/v) acrylamide stock solution 1.5 ml 
 1.5 M Tris-HCl, pH 8.8 with 
0.4 % (w/v) SDS 
1.25 ml 
 dH2O 2.25 ml 
 10 % (w/v) APS 50 µl 
 TEMED 5 µl  
 
stacking gel, 6 % (w/v) 
 
acrylamide stock solution 
 
0.5 ml 
 0.5 M Tris-HCl, pH 6.8 with 
0.4 % (w/v) SDS 
625 µl 
 dH2O 1.375 ml 
 10 % (w/v) APS 25 µl 
 TEMED 2.5 µl  
   
electrophoresis buffer Tris-HCl, pH 8.4 50 mM 
 glycine 380 mM 
 SDS 0.1 % (w/v) 
   
2x SDS loading dye Tris-HCl, pH 6.8 50 mM 
 glycerol 10 % (v/v) 
 β-mercaptoethanol 2 mM 
 SDS 2 % (w/v) 
 bromophenol blue 0.1 % (w/v) 
   
staining solution acetic acid 10 % (v/v) 
 ethanol 30 % (v/v) 
 Coomassie Brilliant Blue  0.25 % (w/v) 
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destaining solution acetic acid 10 % (v/v) 
 ethanol 30 % (v/v) 
   
   
2.7.3 Immunochemical Detection of Proteins by Western Blot 
 
For the immunochemical detection, electrophoretically separated proteins were 
transferred onto a polyvinylidene difluoride (PVDF - pore width 0.45 µm) membrane 
using a Trans Blot apparatus (semi dry transfer cell; BioRad, Munich, Germany). 
Therefore, the PVDF-membrane was activated in methanol for 15 min and then 
equilibrated in Towbin buffer. After SDS-PAGE, the unstained gel and two pieces of 
Whatman paper were equilibrated in Towbin buffer for 15 min. The proteins were 
blotted onto the membrane for 1 h at 10 V per gel using the semi dry method according 
to the manufacturer’s instructions. 
For detection of His6-tagged or myc epitope containing A-PGS proteins, the membrane 
was blocked overnight in blocking buffer, and incubated for 1 h with murine anti-His 
antibody (GE Healthcare, Munich, Germany) or with murine anti-myc-antibody 
(Invitrogen, Darmstadt, Germany) which was previously diluted 1:5’000. After washing 
three times for 10 min in wash buffer, the membrane was incubated with the secondary 
anti-mouse antibody (1:10’000) conjugated with horse-radish peroxidase (Pierce, Bonn, 
Germany) for 45 min. Subsequently, the membrane was washed four times in           
PBS-Tween for 10 min and the chemiluminescence reaction was performed using the 
SuperSignal® West Pico Chemiluminescence Kit (Pierce, Bonn, Germany) according to 
manufacturer’s instruction. 
 
Towbin buffer Tris-HCl, pH 9.5 25 mM 
 glycine 192 mM 
   
PBS-Tween Tween 20 0.1 % (v/v) 
 in 1x PBS (2.4.5)  
   
blocking buffer skim milk powder 5 % (w/v) 
 in PBS-Tween  
   
wash buffer skim milk powder 0.5 % (w/v) 
 in PBS-Tween  
 
 
2.7.4 Determination of ative Molecular Mass 
 
Analytical gel permeation chromatography was performed using a Superdex 75 HR 
10/30 column (GE Healthcare, Munich, Germany) equilibrated with Tris buffer (chapter 
2.6.4.1) supplemented with 250 mM NaCl. This column was calibrated using the 
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following marker proteins: carbonic anhydrase (Mr ~ 29’000) and bovine serum albumin 
(Mr ~ 66’000) (Molecular weight marker Kit, Sigma-Aldrich, St Louis, MO, USA). 
Then, 250 µl of the purified protein (3 - 5 mg ml-1) was run under identical conditions at 
a flow rate of 0.5 ml min-1. Protein elution was monitored by measuring the absorbance 
at 280 nm. 
 
 
2.7.5 UV/Visible Light Absorption and Fluorescence Spectroscopy 
 
For detection of possible cofactors of A-PGS UV-visible light spectra of purified 
recombinant A-PGS543-881 were recorded from 260 - 900 nm using a V-550 
spectrometer (Jasco, Groß Umstadt, Germany). Fluorescence spectra using the LS50B-
luminescence spectrometer (Perkin Elmer, Boston, MA, USA) were monitored to detect 
possible fluorescent cofactors. Therefore, purified A-PGS543-881 was excited from 250 - 
450 nm. Fluorescence emission maxima were detected from 250 - 800 nm. 
 
 
2.7.6 Inductively Coupled Plasma - Mass Spectrometry (ICP-MS) 
 
To determine protein-bound metal ions (Cu2+, Fe2+, Mg2+, Mn2+, Ni2+, Zn2+) commercial 
inductively coupled plasma - mass spectrometry (ICP-MS) was performed 
(CURRENTA Bayer-Analytics, Leverkusen, Germany). For this purpose, the affinity 
purification of GST-A-PGS543-881 was performed in the absence of DTT. 
 
 
2.7.7 Testing of promoter–lacZ Reporter Gene Fusion 
 
For determination of β-galactosidase activities P. aeruginosa strains PAO1-PPA0920-lacZ 
(Spier, 2007), PAO-SK03 and PAO-SK04 and control strains KS11 (Schreiber et al., 
2006), PAO-SK01 and PAO-SK02 were cultivated in pH-adjusted AB minimal media 
or additional in LB media over a time period of 24 h. Aerobic growth conditions were 
achieved by vigorous shaking (200 rpm) of 60 ml cultures in 300 ml baffled flasks at    
37 °C. Samples at different time points were centrifuged (11’000 * g; 5 min; RT) and 
suspended in 800 µl of Z buffer. Cells were disrupted by adding one drop of                
0.1 % (w/v) SDS and one drop of chloroform, respectively, and incubation for 5 min at 
30 °C. The β-galactosidase assay was initiated by addition of 200 µl of                                     
o-nitrophenyl-β-D-galactopyranoside (4 mg ml-1) at 30 °C. The reaction was stopped 
using 500 µl of 1 M Na2CO3 when a yellow coloring of the assay was observed. The 
required time for this enzymatic reaction was determined. After centrifugation       
(11’000 * g; 5 min; RT), the supernatant was photometrically analyzed at 420 nm.  
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β-galactosidase activity was expressed in Miller units (MU) (Miller, 1992) using the 
following equation: 
 
 
E420:   extinction at a wavelength of 420 nm 
OD578:  optical density of the employed cell culture 
V [ml]:  volume of the employed cell culture 
t [min]:  time of enzymatic reaction 
 
Obtained values of β-galactosidase activity are the averages of at least three 
independent experiments. 
 
 
2.8 Lipid Analysis 
 
2.8.1 Extraction and Analysis of Polar Membrane Lipids by two-dimensional 
Thin Layer Chromatography and Liquid Scintillation Counting 
 
Whole bacterial cells or alternatively membrane fractions from an A-PGS activity assay 
were harvested by centrifugation for 5 and 30 min at 11’000 * g, respectively. The 
sediment was used for a modified extraction method of polar membrane lipids 
according to Bligh and Dyer (1959). Hence, the sediment was suspended in 100 µl of 
dH2O, 375 µl of methanol/chloroform (2:1, by volume) was added, mixed vigorously 
and incubated for 5 min at RT. After centrifugation (11’000 * g; 3 min; RT) the 
supernatant was mixed with 200 µl of chloroform/dH2O (1:1, by volume), centrifuged 
(11’000 * g; 3 min; RT) and the lower chloroform phase was harvested and dried at 
40 °C. The obtained lipids were suspended in methanol/chloroform (1:1, by volume) 
and subjected to two-dimensional thin layer chromatography (2D-TLC) or used for 
scintillation analysis. 
For 2D-TLC, silica thin-layer plates “DC-plates Alugram® SIL G/UV254” (Macherey-
Nagel, Düren, Germany) were loaded with appropriate amounts of lipid extracts and run 
in the first dimension with chloroform/methanol/water (60:25:4, by volume), and in the 
second dimension with chloroform/methanol/acetic acid/water (80:12:15:4, by volume) 
(Tindall, 1990). Total polar lipids were detected by spraying with 5 % (w/v) 
molybdatophosphoric acid (Merck, Darmstadt, Germany) and subsequently by 
carbonization at 120 °C for 5 min. Free amino groups were detected using 0.3 % (w/v) 
Z buffer Na2HPO4 60 mM 
 NaH2PO4 40 mM 
 KCl 10 mM 
 MgSO4 1 mM 
 β-mercaptoethanol 50 mM 
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ninhydrin solution (Merck, Darmstadt, Germany) and carbonization at 110 °C for 5 min. 
Phospholipids were identified by spraying the plate previously used for the detection of 
free amino groups with 1.3 % (w/v) Molybdenum Blue Spray reagent (Sigma-Aldrich, 
St. Louis, MO, USA). 
Radioactively labeled phospholipids were analyzed by autoradiography of 2D-TLC or 
by scintillation counting. Therefore, the lipid fraction was added to 4 ml of OptiPhase 
HighSafe 2 (Perkin Elmer, Boston, MA, USA) and counts per minute were detected 
using a TriCarb 2900 TR scintillation counter (Perkin Elmer, Boston, MA, USA). 
(Bligh and Dyer, 1959) 
 
2.8.2 Biophysical Lipid Analyses 
 
2D-TLC-isolated polar lipids were dissolved in methanol/chloroform/water (6:3:1, by 
volume) prior positive and negative ion electrospray mass spectrometric analysis      
(ESI-MS). A voltage of approximately 1’000 V was applied to the nanospray capillary, 
and ions were subjected to ESI-MS on a QTOF 2 mass spectrometer (Micromass, 
Manchester, UK). For tandem mass spectrometry (MS/MS) analysis, parent ions were 
selected by the quadrupole mass filter and subjected to collision-induced dissociation. 
The resulting daughter ions were separated by the TOF analyzer. A 1H nuclear magnetic 
resonance (NMR) spectrum of the sample used for MS analysis was recorded on a 
Bruker AVANCEIII 600 NMR spectrometer (Bruker, Karlsruhe, Germany) with a 
cyroprobehead locked to the major deuterium signal of the CD3OD solvent. Chemical 
shifts were referenced to the residual 1H signal of the solvent at 3.35 p.p.m.. 
Additionally, the residue linked to the second glycerol moiety was determined by gas 
chromatography coupled with mass spectrometry (GC/MS) analysis after hydrolysis and 
derivatization with isopropanol followed by pentafluoropropionic acid anhydride using 
a Chirasilval column (50 m) connected to a GCQ ion trap mass spectrometer (Thermo 
Electron Corporation, Erlangen, Germany). The fatty acid composition of the isolated 
lipid was confirmed by GC/MS of the fatty acid methyl esters. These were released after 
acid catalyzed methanolysis of the intact lipid. This work was kindly done by              
Dr. Manfred Nimtz and Prof. Dr. Victor Wray at the HZI, Braunschweig. 
 
 
2.9 tRA Methods 
 
For A-PGS activity assays, the tRNA substrate was purchased (tRNA Mix from E. coli) 
or produced by in vitro transcription. These tRNAs were either subjected directly to 
coupled AlaRS/A-PGS activity assays or were aminoacylated with radioactively labeled 
amino acids and subsequently subjected to an activity assay. 
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2.9.1 In vitro Transcription and Purification of tRA 
 
For in vitro transcription of tRNAAla, template DNA was prepared by BstNI digestion of 
500 µg of the respective plasmid in NEB Buffer 2 (New England BioLabs, Ipswich, 
MA, USA), 1x BSA and with 150 units of BstNI in a total volume of 250 µl. After 
incubation at 60 °C for 3 h, the reaction mixture was precipitated using 100 µl 3 M 
sodium acetate (pH 4.8) and 625 µl ethanol at -20 °C overnight. The precipitated 
plasmid DNA was used for in vitro transcription in a reaction volume of 250 µl 
containing 40 mM Hepes-KOH (pH 7.8), 22 mM MgCl2, 1 mM spermidine, 5 mM 
DTT, 3 mM of each ribonucleotide triphosphate (rNTP), and 200 nM purified T7 RNA 
polymerase at 37 °C overnight. Efficient in vitro transcription was clearly indicated by 
the visible precipitation of PPi. 
For purification of tRNA transcripts MonoQ anion exchange chromatography (MonoQ 
5/50 GL (Pharmacia Biotech, Munich, Germany)) with a flow rate of 0.5 ml min-1 and a 
20 ml gradient (0 - 750 mM NaCl) of MonoQ-buffer A and B was used according to 
Jahn et al. (1991). Subsequently, 500 µl tRNA fractions were precipitated by 1.25 ml 
ethanol and 200 µl of 3 M sodium acetate (pH 5.2) and centrifugation (2’900 * g; 1 h;     
4 °C). Alternatively, tRNA transcripts were purified via 12 % polyacrylamide gel 
electrophoresis in the presence of 8 M urea according to Pande et al. (1991). Therefore, 
tRNA in vitro transcription reactions were supplemented with 2x tRNA loading dye and 
loaded onto a polyacrylamide gel and allowed to run at 18 watt overnight. tRNA bands 
were excised after visualization by UV detection with a portable UV lamp. Gel 
extraction was performed by the addition of 1 M sodium acetate (pH 5.0) and shaking at 
4 °C. Subsequently, the tRNA was precipitated by addition of one volume isopropanol 
to the liquid phase and centrifugation (6’000 * g; 1 h; 4 °C). Precipitated tRNA was 
dissolved in dH2O. (Pande et al., 1991)  (Jahn et al., 1991) 
 
MonoQ-buffer A MOPS-KOH, pH 6.2 20 mM 
   
MonoQ-buffer B MOPS-KOH, pH 6.2 20 mM 
 NaCl 1.5 M 
   
acrylamide stock solution acrylamide 38 % (w/v) 
(Roth) 40 % (w/v) N,N’-methylen bisacrylamide 2 % (w/v) 
   
polyacrylamide gel (12 %)  acrylamide stock solution 40 
% (w/v) 
300 ml 
 urea 500 g 
 10x TBE buffer 100 ml 
 10 % (w/v) APS 3 ml 
 TEMED 300 µl 
  dH2O added to volume of 
1000 ml 
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2.9.2 Denaturating Polyacrylamide Gel Electrophoresis of tRAs 
 
tRNAs were analyzed by denaturating polyacrylamide gel electrophoresis. Therefore, 
samples were supplemented with 2x tRNA loading dye. The included urea inhibits the 
formation of secondary and tertiary structures. Samples were loaded onto 10 % (w/v) 
polyacrylamide gels which were run at 30 watt until the band of bromophenol blue dye 
dropped out of the lower end of the gel. As size standard the tRNA Mix from E. coli 
(Sigma-Aldrich, St. Louis, MO, USA) was employed. Subsequently, gels were stained 
with toluidine blue (tRNA staining solution) for 5 min and destained with water until 
distinct tRNA bands were visible. For documentation, gels were scanned and dried 
between two cellophane foils for storage. 
 
2.9.3 Aminoacylation of tRA and tRA Microhelices 
(Swairjo et al., 2004) 
Purified, synthetic tRNA microhelices were purchased from Integrated DNA 
Technologies (Coralville, IA, USA). tRNA in vitro transcripts and microhelices were 
denatured at 80 °C for 2 min and subsequently incubated at 60 °C for 2 min, followed 
by addition of 10 mM MgCl2 and immediate cooling on ice to facilitate RNA folding. 
AlaRS aminoacylation reactions were performed at RT according to Swairjo et al. 
(2004) in aminoacylation buffer A using 4.75 µM of [2,3-3H]-L-alanine (52 µCi µmol-1, 
GE Healthcare, Munich, Germany) and 20 µM of [1-14C]-L-alanine (51 µCi µmol-1, 
Moravek Biochemicals, Brea, CA), respectively, 10 µM of tRNA [tRNA Mix from 
 
 
10x TBE buffer Tris Tris  1 M 
 Boric acid   850 mM 
 EDTA  100 mM 
   
2x tRNA loading dye urea 8 M 
 bromophenol blue  250 µg/ml 
 xylene cyanol  250 µg/ml 
 sucrose 20 % (w/v) 
 
 
  
polyacrylamide gel, 10 % (w/v) acrylamide stock solution 40 % (w/v) 2.5 ml 
 urea 4.8 g 
 10x TBE buffer 1 ml 
 10 % (w/v) APS 60 µl 
 TEMED 10 µl 
 dH2O added to volume of 10 ml  
   
tRNA staining solution acetic acid 1 % (v/v) 
 methanol 40 % (v/v) 
 toluidine blue 2.5 mM 
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E. coli strain W (Sigma-Aldrich, St. Louis, MO, USA) or in vitro transcribed tRNAAla] 
or microhelices and 1 µM of purified AlaRS. At different time points samples were 
spotted onto Whatman filters (Whatman, Munich, Germany) and the tRNA was 
precipitated by incubation of the filters in 5 % (w/v) trichloroacetic acid for 10 min. 
Subsequently filters were subjected to 4 ml scintillation liquid OptiPhase High Safe 2 
(Perkin Elmer, Boston, MA, USA) and counts per minute were detected using a TriCarb 
2900 TR scintillation counter (Perkin Elmer, Boston, MA, USA). 
 
 
HisRS aminoacylation reaction was carried out in aminoacylation buffer B at 37 °C 
according to Connolly et al. (2004) containing 21.7 µM of [U-14C]-L-histidine 
(322 µCi µmol-1, GE Healthcare, Munich, Germany), 10 µM of microhelix F and 1 µM 
of purified HisRS. 
 
(Connolly et al., 2004) 
2.9.4 Purification of Aminoacylated tRAs and tRA Microhelices 
 
Aminoacylated tRNAs were purified by a phenol/chloroform extraction. To inhibit 
hydrolysis of the aminoacyl-bond acidic phenol (pH 4.5 - 5.0) was used. Furthermore, 
purification steps were performed as quickly as possible with cold solutions. 
For purification of aminoacylated tRNAs, the aminoacylation reaction (1 ml) was 
supplemented with 4 ml 375 mM sodium acetate (pH 5.2), mixed and subsequently 
supplemented with 5 ml PCI solution, mixed again vigorously and centrifuged 
(11’000 * g; 1 min; 4 °C). To the upper phase 5 ml chloroform were added, mixed again 
and centrifuged. Aminoacylated tRNA was precipitated by addition of 15 ml ethanol to 
the upper phase and centrifugation (11’000 * g; 25 min; 4 °C). The tRNA sediment was 
dried by vacuum centrifugation, suspended in 100 µl of 30 mM sodium acetate (pH 4.9) 
and stored at -20 °C. 
aminoacylation buffer A Hepes-NaOH, pH 7.5 50 mM 
 KCl 20 mM 
 MgCl2 10 mM 
 BSA 0.1 mg/ml 
 β-mercaptoethanol 20 mM 
 ATP 4 mM 
aminoacylation buffer B Hepes-NaOH, pH 7.5 50 mM 
 MgCl2 10 mM 
 BSA 100 µg/ml 
 DTT 5 mM 
 ATP 2 mM 
PCI solution phenol 25 ml 
 chloroform 24 ml 
 isoamyl alcohol 1 ml 
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2.10 aa-PGS Activity Assays 
 
For determination of activity of the recombinantly produced aa-PGS variants, in vivo 
and in vitro activity assays were established. The product of aa-PGS catalysis - 
aminoacylated PG - was isolated by lipid extraction and either detected by 2D-TLC or 
by liquid scintillation analysis. In all cases, assays were completed by control 
experiments in which the enzyme or the tRNA substrate was omitted. Alternatively, the 
assay mixture was pre-treated with 100 µg ml-1 of RNase A. 
 
 
2.10.1  Determination of in vivo aa-PGS Activity 
 
For determination of the in vivo aa-PGS activity 5 ml of E. coli cells overproducing aa-
PGS proteins or P. aeruginosa cells were harvested by centrifugation. Alternatively, 
cells were disrupted by French® Press and incubated with 2.8 mM - 44 mM of            
[U-14C]-L-alanine or [1-14C]-L-alanine (Moravek Biochemicals, Brea, CA, USA) and 
2.8 mM [U-14C]-L-lysine (Moravek Biochemicals, Brea, CA, USA), respectively, in the 
presence of an ATP-regenerating system (containing 2 mM of ATP, 18 mM of creatin 
phosphate and 35 U ml-1 creatin phosphokinase) for 1 h at 37 °C and 1’000 rpm. Then 
lipids were extracted and separated by 2D-TLC. Radioactively labeled phospholipids 
were visualized by autoradiography. 
 
 
2.10.2  Determination of in vitro aa-PGS Activity Using E. coli Extracts To 
Provide PG and aa-tRA 
 
For the in vitro activity assay using E. coli extracts an E. coli crude cellular extract was 
employed to provide the substrate molecules PG and aa-tRNA. Therefore, 500 µl of a 
crude cellular extract overproducing AlaRS or LysRS E. coli cells (compare chapter 
2.6.1.4) were supplemented with 2 - 20 µM of purified GST-A-PGS543-881 (or             
GST-A-PGS543-855N, GST-Sa-L-PGS515-840, GST-Lm-L-PGS511-865,                            
GST-Li-L-PGS512-865), 2 mM of ATP, an ATP-regenerating system (consisting of        
18 mM of creatine phosphate and 35 U ml-1 of creatine phosphokinase) and 20 µM of 
[1-14C]-L-alanine (Moravek Biochemicals, Brea, CA, USA) and [U-14C]-L-lysine 
(Moravek Biochemicals, Brea, CA, USA), respectively, in a total volume of 700 µl at 
37 °C under vigorous shaking (1’000 rpm). Samples of 100 µl volume were heat 
inactivated (5 min at 60 °C) and subjected to lipid extraction. 
All assays for the determination of A-PGS543-881 mutant activities were standardized by 
analyzing the individual proteins at a concentration of 10 µM for 1 h at 37 °C. The 
activities for wild type GST-A-PGS543-881 obtained were set as 100 %. All other values 
of mutant GST-A-PGS543-881 were related to this. Experiments were performed in 
triplicate and were completed by control experiments in which GST-A-PGS543-881 was 
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omitted or in which the crude cellular extract was pre-treated with 100 µg ml-1 of 
RNase A for 25 min. 
To determine the specific activity of full length His6-A-PGS the purified and solubilized 
protein was incubated with membrane fragments of a crude cellular extract of E. coli 
Rosetta (DE3) pLysS overproducing the AlaRS from P. aeruginosa. 
 
 
2.10.3  Determination of in vitro A-PGS Activity 
 
The in vitro A-PGS activity was determined by using purified aminoacylated tRNA or 
alternatively in a coupled AlaRS/A-PGS assay. For the in vitro A-PGS assay with 
aminoacylated tRNA, 0.2 - 5 µM of purified GST-A-PGS543-881 and 2 - 20 nM of 
aminoacylated tRNA were added to a commercially available PG fraction [2 mg ml-1 
PG from egg yolk lecithin (Sigma-Aldrich, St Louis, MO, USA)] supplemented with 
1.76 mg ml-1 Triton X-100 in 50 mM Tris-HCl, pH 8.0. For the coupled AlaRS/A-PGS 
in vitro assay the crude cellular extract of the above mentioned in vitro activity assay 
using E. coli extracts was substituted with 5 µM of purified AlaRS, 10 - 15 µM of 
tRNA, and 2.7 mM of PG in aminoacylation buffer A (chapter 2.9.3) according to 
Swairjo et al. (2004). Samples of 100 µl volume were inactivated by the addition of   
375 µl of MeOH/chloroform (2:1, v/v) and subsequently subjected to lipid extraction. 
Radioactively labeled phospholipids were detected by autoradiography. 
 
 
2.10.4  Analysis of A-PGS Substrate Recognition by using Artificial PG 
Derivatives 
 
Artificial lipids were employed to identify essential determinants of the PG substrate. 
For this purpose the coupled AlaRS/A-PGS in vitro assay was performed in the 
presence of PG derivatives (Avanti Polar Lipids, Inc., Alabaster, Al, USA) at a 
concentration of 2 mg ml-1. 
 
 
2.10.5  Analysis of A-PGS Substrate Recognition by using Artificial tRA 
Substrates 
 
To determine the tRNA identity elements of A-PGS catalysis P. aeruginosa wild type in 
vitro transcribed tRNAAla1 and tRNA microhelices were aminoacylated and subjected to 
an in vitro assay containing 5 µM of GST-A-PGS543-881 in a total volume of 575 µl. The 
obtained A-PGS activity using in vitro transcribed tRNAAla1 was set as 100 %. 
Experiments were performed in triplicate. Standard deviations were ± 10 %. 
Microhelices which were inefficiently aminoacylated by AlaRS were tested as substrate 
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for A-PGS catalysis in a coupled AlaRS/A-PGS in vitro assay. Therefore, microhelices 
(20 µM) were pre-incubated at 37 °C for 30 min in the standard AlaRS aminoacylation 
buffer A (500 µl) (chapter 2.9.3). A-PGS catalysis was then initiated by the addition of 
500 µl of aminoacylation buffer A containing 5.4 mM of PG (supplemented with       
1.76 mg ml-1 Triton X-100) and 10 µM GST-A-PGS543-881. Experiments were performed 
in duplicate. This work was done in cooperation with Dr. Ilka Heinemann at the Yale 
University, New Haven. 
 
 
2.10.6 Chemical Modification of A-PGS543-881 
 
To characterize potential amino acid residues with relevance for the A-PGS reaction 
mechanism, 10 pmol of A-PGS543-881 were chemically modified with reagents showing 
a high degree of specificity for individual amino acids. For this purpose, the affinity 
purification of GST-A-PGS543-881 was performed in the absence of DTT. After extensive 
washing of the column with 1x PBS (20 Cv) the target protein was liberated from the 
column by PreScission Protease treatment. The obtained eluate fraction (~ 60 µM) was 
incubated in the presence of phenylmethylsulfonyl fluoride (PMSF) (0.1, 1 mM), 
diisopropyl fluorophosphate (DIPFP) (0.1, 1 mM) and iodacetamide (1, 10 mM) at 4 °C 
for 45 min, or alternatively in the presence of citraconic anhydride (2, 10 mM) and       
p-hydroxyphenylglyoxal (HPG) (0.5, 1, 5, 10 mM) at 20 °C in the dark for 45 min. 
These protein fractions were excessively dialyzed against 1x PBS using Slide-A-Lyzer® 
MINI dialysis units (Pierce, Bonn, Germany) and subjected to in vitro activity assays 
using E. coli extracts in the presence of 10 mM ATP (ATP-regenerating system 
omitted) or to in vitro assays using aminoacylated tRNAAla. To study the influence of 
metal chelating agents the in vitro activity assays using E. coli extracts and in vitro 
assay was incubated in the presence of EDTA (3, 10, 20 mM) or 1,10-phenanthroline 
(1, 3, 5, 10, 20 mM), respectively. 
 
 
2.11 Phenotypic Determination 
 
The P. aeruginosa ∆PA0920 deletion mutant was tested for biofilm formation, motility 
or for the ability of excretion of extracellular proteins. Furthermore, a commercial 
available test system with over thousand culture conditions was employed. 
 
 
2.11.1  Standard Phenotype Assays 
 
Swimming and swarming motility were assayed on AB minimal medium agar plates 
containing 0.3 % and 0.5 % (w/v) agar according to O’Toole & Kolter (1998). The 
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plates were inoculated with a single colony using a toothpick. After incubation of the 
swimming plates for 24 h and swarming plates for 48 h at 37 °C the motility zone 
diameter was measured. Twitching motility was tested using thin LB agar plates, which 
were inoculated with a single colony by a toothpick down to the agar-plastic interface, 
and measuring the twitch zone diameter after 24 h of incubation at 37 °C and 48 h at RT 
as described (Köhler et al., 2000). For static microtitre biofilms a 24 h LB overnight 
culture was diluted with fresh LB medium to yield 106 cells per ml, and 200 µl was 
inoculated into wells of a 96-well polystyrene round-bottom microtitre plate (Nunc, 
Roskilde, Denmark). Plates were then incubated at 37 °C without shaking for 24 h. 
Medium and planktonic cells were discarded. Surface-attached bacteria were stained 
with 0.1 % (w/v) crystal violet for 15 min, followed by washing and ethanol 
solubilization of crystal violet-stained cells for quantification of A600 (O'Toole and 
Kolter, 1998). The screening for extracellular enzymes was performed by spotting cells 
onto Difco™ DNase Test Agar with Methyl Green (Difco Laboratories, Detroit, MI) for 
DNase activity or onto agar plates containing 0.1 % (w/v) Elastin (Sigma-Aldrich, St. 
Louis, MO, USA) for elastase activity, 5 % (w/v) sheep red blood for haemolysin 
activity, 1 % (w/v) egg yolk (Fluka, Buchs, Switzerland) for phospholipase A and C 
activity and 5 % (w/v) skim milk powder (Roth, Karlsruhe, Germany) for protease 
activity, respectively, and incubation at 37 °C for 24 h. (O'Toole and Kolter, 1998) 
 
 
2.11.2  Phenotyping of P. aeruginosa ∆PA0920 using Biolog Microarray 
 
P. aeruginosa wild type and the corresponding ∆PA0920 deletion mutant strain were 
tested for phenotypic changes in MicroPlatesTM PM9 – PM20 of the Phenotype 
Microarray system from Biolog using IF-10 medium (Biolog, Hayward, CA, USA) as 
described by Zhou et al. (2003) according to manufacturer’s instruction. The employed 
test system is based on the reduction of a tetrazolium dye. Plates PM9 - PM20 measure 
sensitivities to salt and pH stresses and to a wide variety of antibiotics, antimetabolites 
and other inhibitors. The phenotypic changes were monitored visual by color change 
based on the reduction of a tetrazolium dye. Conditions showing significant alterations 
in the phenotypic behavior for the mutant strain were subjected to a second independent 
experiment. For this purpose, relevant conditions were reproduced. P. aeruginosa wild 
type, ∆PA0920 deletion mutant and the complemented ∆PA0920 deletion mutant (strain 
∆PA0920compl) were mixed with CrCl3 (Riedel-de-Haën, Selze, Germany) (3, 3.5 and 
4 mM), cefsulodin (Sigma-Aldrich, St. Louis, MO, USA) (17.5, 20 and 25 mM), 
protamine sulphate (Roth, Karlsruhe, Germany) (4.2, 5.6 and 8.3 mM) and sodium 
lactate (Fluka, Buchs, Switzerland) (535, 625 and 714 mM) in a volume of 240 µl of    
IF-10 medium (Biolog, Hayward, CA, USA) containing tetrazolium dye and incubated 
in 96-well plates at 37 °C. At different time points, the A600 was measured using a 
FusionTM plate reader (Perkin Elmer, Boston, MA, USA).(Zhou et al., 2003) 
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3 RESULTS AD DISCUSSIO 
 
In this thesis the biological function of open reading frame (ORF) PA0920 from 
Pseudomonas aeruginosa and the biochemistry of its encoded protein were 
characterized. For this purpose, the transcriptional regulation of ORF PA0920 was 
investigated. This was followed by a phenotypic comparison of P. aeruginosa wild type 
and a ∆PA0920 deletion strain. The biochemical reaction mechanism of the encoded 
enzyme responsible for alanyl-phosphatidylglycerol synthesis was studied. Finally, the 
subcellular localization was determined. 
 
 
3.1 Bioinformatical Analyses of Alanyl-Phosphatidylglycerol 
Synthase from Pseudomonas aeruginosa 
 
Aminoacyl-phosphatidylglycerol synthases (aa-PGS) are enzymes catalyzing the 
modification of the phospholipid phosphatidylglycerol with an aminoacyl-moiety. 
Basic Local Alignment Search Tool (BLAST) analysis (Altschul et al., 1990) using the 
Staphylococcus aureus MprF amino acid sequence as query identified ORF PA0920 
potenially encoding an aa-PGS protein in the genome of P. aeruginosa. After 
overproduction of the ORF PA0920 gene product in E. coli TOP10 a new amino group 
containing phospholipid was observed in the membrane of the E. coli host (Lorenzo, 
2006; Klein, 2007). This lipid was identified in MS/MS analysis as                         
alanyl-phosphatidylglycerol (A-PG) (Piekarski, 2007). So, the PA0920 protein was 
renamed to alanyl-phosphatidylglycerol synthase (A-PGS). 
The A-PGS protein from P. aeruginosa shares 22 % amino acid sequence identity with 
MprF from S. aureus. In the C-terminal protein region a high conservation (35 % 
identity, 52 % homology) of amino acid residues was observed, whereas the N-terminal 
region was less conserved. A complete sequence alignment can be found in the 
appendix. 
Using the program PSORTb v 2.0 the subcellular localization of the ORF PA0920 gene 
product was predicted in the cytoplasmic membrane with the highest possible score. 
Furthermore, no cleavable N-terminal signal peptide was proposed (Gardy et al., 2005). 
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Prediction of protein domains of A-PGS by the program TMPred (Hofmann and Stoffel, 
1993) revealed a two domain protein architecture (Fig. 7). 
 
 
 
Figure 7: Protein architecture of A-PGS from P. aeruginosa predicted by TMPred. 
The A-PGS protein sequence was subjected to TMPred prediction (Hofmann and Stoffel, 1993). Based on 
the prediction the pointed domain model was designed. Numbers specify the amino acid residues. 
 
The A-PGS protein from P. aeruginosa was proposed to possess an N-terminal 
transmembrane domain consisting of 14 transmembrane helices (amino acid residues    
1 - 542) followed by a C-terminal more hydrophilic domain containing an additional 
putative transmembrane helix (residues 543-881) (Fig. 7). According to this theoretical 
analysis, the N-terminus of the protein is located at the cytoplasmic site of the 
membrane, whereas the C-terminus is located in the periplasm. Furthermore, 
comparison of A-PGS with protein families using `Pfam protein families database` 
revealed similarities to an uncharacterized protein family (UPF0104) and an 
uncharacterized conserved protein (DUF2156) (Finn et al., 2010). 
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3.2 A-PG Synthesis in Pseudomonas aeruginosa 
 
3.2.1 A-PG Formation in Pseudomonas aeruginosa 
 
Overproduction of A-PGS from P. aeruginosa in E. coli resulted in the synthesis of an 
amino group containing phospholipid (Lorenzo, 2006; Klein, 2007). However, the lipid 
composition of wild type P. aeruginosa cells cultivated in LB medium, in AB minimal 
medium or in magnesium/glucose depleted medium (Kenward et al., 1979) revealed no 
detectable A-PG synthesis in lipid analysis via 2D-TLC and molybdatophosphoric acid 
staining (Piekarski, 2007). Therefore, formation of A-PG in P. aeruginosa was 
elucidated using radioactively labeled L-alanine. For this purpose, P. aeruginosa wild 
type and P. aeruginosa ∆PA0920 deletion mutant were cultivated in LB medium to an 
OD578 of 1.6 and disrupted by a passage through a French
® Press. This crude cellular 
extract was combined in an in vivo activity assay with 2 mM ATP, an ATP-regenerating 
system and 44 µM [U-14C]-L-alanine and incubated for 1 h at 37 °C. Subsequently, 
extracted lipids were separated by 2D-TLC and radioactively labeled phospholipids 
were detected by autoradiography. Figure 8 A shows the autoradiography analysis of the 
lipid composition of P. aeruginosa wild type extract. In Figure 8 B and C a cellular 
extract of the P. aeruginosa ∆PA0920 deletion mutant or alternatively the 
P. aeruginosa wild type extract pre-treated with RNase A was employed. 
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Figure 8: Synthesis of A-PG by P. aeruginosa wild type and ∆PA0920 deletion mutant. 
P. aeruginosa wild type and P. aeruginosa ∆PA0920 deletion mutant were cultivated in LB medium to 
an OD578 of 1.6. Cells were harvested, suspended in lysis buffer 1 (chapter 2.6.2) and disrupted by a 
passage through a French® Press. Obtained crude cellular extracts were subjected to an in vivo assays with 
[U-14C]-L-alanine as described in “Materials and Methods”. After incubation of the assay for 1 h at 37 °C, 
lipids were extracted, subjected to 2D-TLC analysis and 14C-phospholipids were visualized by 
autoradiography. A, Lipid composition of crude cellular extract of P. aeruginosa wild type. B, Lipid 
composition of crude cellular extract of P. aeruginosa ∆PA0920 deletion mutant. C, Lipid composition of 
crude cellular extract of P. aeruginosa wild type, pre-treated with RNase A (100 µg ml-1) for 25 min.     
A-PG is indicated by an arrow. 
 
The analysis of the lipid composition of P. aeruginosa wild type clearly indicates the 
formation of a radioactively labeled lipid spot (Fig. 8, A). This spot was identical in 
position and shape to A-PG which was found in A-PGS overproducing E. coli (Lorenzo, 
2006; Klein, 2007; Piekarski, 2007). The P. aeruginosa ∆PA0920 deletion mutant lacks 
the spot for A-PG (Fig. 8, B). Pre-treatment of P. aeruginosa wild type crude cellular 
extract with RNase A abolished detectable A-PG synthesis (Fig. 8, C), indicating the 
involvement of a tRNA substrate. The tRNA involvement of A-PG and L-PG formation 
was recently described for S. aureus MprF, B. subtilis MprF and C. perfringens MprF1 
and MprF2 (Staubitz et al., 2004; Roy and Ibba, 2008a; Roy and Ibba, 2009). 
From these results it was concluded that ORF PA0920 codes for a functional gene 
which is responsible for A-PG synthesis in P. aeruginosa. 
 
 
3.2.2 A-PG Synthesis in P. aeruginosa under Acidic Growth Conditions 
 
In S. aureus and E. faecalis lowering the pH of the cultivation medium resulted in 
increasing amounts of the PG-derivative L-PG (Houtsmuller and van Deenen, 1965; 
Gould and Lennarz, 1970). To investigate a possible pH dependent A-PG synthesis in 
P. aeruginosa, acidic and neutral media were used for cultivation. To analyze acidic 
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growth conditions a pH of 5.3 was chosen. At this pH value only a slightly diminished 
growth was observed when compared to neutral growth conditions (pH 7.3). 
For comparison of the lipid composition, P. aeruginosa wild type, ∆PA0920 and the 
chromosomal complementation of ∆PA0920 (∆PA0920compl) were cultivated in AB 
minimal medium and LB medium at neutral and acidic pH values, respectively. The 
extracted lipids were separated by 2D-TLC and visualized by molybdatophosphoric 
acid as outlined before (Fig. 9). 
 
 
Figure 9: Lipid composition of P. aeruginosa strains under neutral and acidic growth conditions. 
Cells were cultivated in neutral and acidic AB minimal medium and LB medium for 24 h at 37 °C and 
180 rpm as described in “Materials and Methods”. After cultivation, lipids were extracted, separated by 
2D-TLC and visualized by spraying with 5 % (w/v) molybdatophosphoric acid. The following strains and 
conditions were employed: Lipid composition of P. aeruginosa wild type grown in AB minimal medium 
with pH 7.3 (A) and pH 5.3 (B). P. aeruginosa ∆PA0920 deletion mutant cultivated in AB minimal 
medium with pH 7.3 (C) and pH 5.3 (D). Chromosomal complementation of P. aeruginosa ∆PA0920 
with the gene encoding A-PGS (∆PA0920compl) grown in AB minimal medium with pH 7.3 (E) and pH 
5.3 (F). P. aeruginosa wild type cultivated in LB media with a pH of 7 (G) and a pH of 5.5 (H). The pH 
value of cultivation medium remained constant over time. A-PG is indicated by arrows. PE = 
phosphatidylethanolamine, PG = phosphatidylglycerol, DPG = diphosphatidylglycerol. 
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The analysis of lipid composition by 2D-TLC using molybdatophosphoric acid staining 
revealed the occurrence of an additional lipid spot for P. aeruginosa wild type 
cultivated under acidic conditions in AB minimal medium and LB medium (Fig. 9, B, 
H). This spot was also stained positive with Molybdenum Blue and ninhydrin-reagents 
indicating an amino group containing phospholipid (data not shown). The additional 
phospholipid represented approximately 6 % (AB medium) or 1 % (LB medium) of the 
overall P. aeruginosa lipid composition as judged by integration of spot intensities (data 
not shown). Due to running behavior similar to the additional lipid synthesized after 
overproduction of A-PGS in E. coli in 2D-TLC analysis it was assumed that this lipid 
represents A-PG. Under neutral growth conditions no A-PG formation was detectable 
by staining with 5 % (w/v) molybdatophosphoric acid (Fig. 9, A, G). When                   
P. aeruginosa was cultivated in AB medium under alkaline conditions (pH 9.5), no     
A-PG synthesis was observed (data not shown). Furthermore, cultivation of                  
P. aeruginosa ∆PA0920 deletion mutant under acidic and neutral conditions in AB 
minimal medium (Fig. 9, C, D) and LB medium (data not shown) failed to induce A-PG 
synthesis. Consequently, inactivation of ORF PA0920 leads to a defect in A-PG 
synthesis. However, the complementation of P. aeruginosa ∆PA0920 deletion mutant 
with a chromosomally located ORF PA0920 with 187 bp of the upstream region and     
90 bp of the downstream region (strain ∆PA0920compl) restored formation of A-PG in 
acidic AB medium (Fig. 9, F). Again, no A-PG synthesis was detected after cultivation 
of the complementation strain in neutral AB medium (Fig. 9, E), indicating the same 
pH-dependent regulation in the chromosomal complementation strain. Interestingly, this 
strain showed a slightly increased A-PG formation when compared to the wild type 
strain under acidic growth conditions. 
These results showed a pH-dependent A-PG synthesis in P. aeruginosa. 
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3.2.3 A-PG Formation Successively Increase with Acidic Growth Conditions 
 
The A-PG formation of P. aeruginosa wild type and ∆PA0920compl was compared at 
different pH values. Therefore, the pH value of AB minimal medium was successively 
lowered in 0.5 pH steps from 7.3 to 5.3. After cultivation, extracted lipids were 
separated using 2D-TLC and visualized as outlined before (Fig. 10). 
 
Figure 10: Lipid composition of P. aeruginosa wild type and ∆PA0920compl under pH adjusted 
growth conditions. 
Cells were cultivated in AB minimal media for 24 h at 37 °C and 180 rpm as described in “Materials and 
Methods”. After cultivation, lipids were extracted, separated by 2D-TLC and visualized by spraying with 
5 % (w/v) molybdatophosphoric acid. Lipid composition of P. aeruginosa wild type (A – E) and of 
chromosomal complementation of P. aeruginosa ∆PA0920 (strain ∆PA0920compl) (F – J) cultivated in 
AB minimal medium are shown. The following pH values were employed: A and F, 7.3. B and G, 6.8.    
C and H, 6.3. D and I, 5.8. E and J, 5.3. The pH value of cultivation medium remained constant over 
time. A-PG is indicated by arrows. PE = phosphatidylethanolamine, PG = phosphatidylglycerol, DPG = 
diphosphatidylglycerol. 
 
The lipid pattern of P. aeruginosa wild type and ∆PA0920compl showed a successive 
increase of the A-PG content when the pH value of the cultivation medium was lowered 
(Fig. 10, A - E, F - J). The relative amounts of A-PG formed in the employed media 
after 24 h of cultivation were determined by integration of spot intensities after analysis 
via 2D-TLC and molybdatophosphoric acid staining (Table 6). 
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Table 6: Relative amounts of A-PG in P. aeruginosa wild type and ∆PA0920compl after cultivation 
in different pH adjusted medium. 
The relative amounts of A-PG related to the total amount of phospholipids formed in growth medium 
with different pH values after 24 h of cultivation were determined by integration of spot intensities after 
analysis via 2D-TLC and molybdatophosphoric acid staining. 
 
pH of AB 
minimal medium 
relative amount of A-PG in          
P. aeruginosa wild type [%] 
relative amount of A-PG in             
∆PA0920compl [%] 
7.3 0.5 0.5 
6.8 1 1 
6.3 1 1 
5.8 5 8 
5.3 6 10 
 
When P. aeruginosa wild type and ∆PA0920compl were cultivated in AB minimal 
medium with pH values of 7.3, 6.8 and 6.3 comparable amounts of A-PG (0.5, 1 and     
1 %) related to the total amount of phospholipids were detected. In contrast, cultivation 
in AB minimal medium at pH 5.8 and 5.3 revealed an A-PG amount of 5 and 6 % for   
P. aeruginosa wild type and 8 and 10 % for P. aeruginosa ∆PA0920compl, 
respectively. These results might indicate slight differences for the regulation of the    
A-PG synthesis due to the genomic context of the A-PGS gene. 
 
 
3.2.4 Biophysical Analysis of A-PG 
 
To verify the nature of the phospholipid formed under acidic growth conditions in 
P. aeruginosa, electrospray ionization mass spectrometry (ESI-MS), gas 
chromatography coupled with mass spectrometry (GC/MS) and nuclear magnetic 
resonance (NMR) analyses were performed (Fig. 11). 
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Figure 11: ESI-MS and GC/MS analysis of the phospholipid formed under acidic growth 
conditions. 
P. aeruginosa wild type was cultivated under acidic conditions (pH 5.3) in AB minimal medium. Lipids 
were extracted and separated by 2D-TLC. From an unstained plate lipids were scraped, resolved and 
subjected to ESI-MS analysis and GC/MS analysis. A, Survey scan of the ESI-MS analysis. The signal at 
834.6 Da corresponds to the protonated mass and the signal at 856.6 Da to the sodium salt of A-PG with 
C16:0 and C19:0 cis 9,10 cyclopropane fatty acid residues. B, Daughter ion spectrum of the molecular ion 
at 856.6 Da. Detected ions are compatible with the proposed structure as shown in the inserted 
fragmentation scheme. C, GC/MS spectrum of D- and L-alanine derivative derived from hydrolysis and 
derivatization with isopropanol and pentafluoro propionyl. D, reference GC/MS spectrum of a racemic 
mixture of D- and L-alanine derivative. Gro = glycerol residue, FA = fatty acid residue. 
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Positive ion electrospray mass spectrometry (Fig. 11, A) of the lipid with molecular ions 
at m/z 834.6 [M+H]+ and 856.6 [M+Na]+ indicated the presence of a nitrogen-
containing compound as deduced from the obtained uneven molecular mass. Fragments 
compatible with a glycerol residue bearing two fatty acid residues, which is linked by a 
phosphodiester bridge to a second glycerol moiety carrying an alanine residue, were 
detected upon collision-induced dissociation (Fig. 11, B). 
The nature of the fatty acid residues was determined by MS/MS of the negatively 
charged molecular ion at m/z 832.6 [M-H]- (data not shown). It yielded intense 
fragments at m/z 255.2 and 295.3. The identity of these fatty acid residues was 
confirmed by GC/MS analysis of the corresponding methyl esters. Authentic reference 
substances were used as a standard. The major fatty acids released from the intact lipid 
were C16:0 and C19:0 cis 9,10 cyclopropane methyl esters. These two fatty acid 
residues are the most abundant in P. aeruginosa (Hancock and Meadow, 1969). The 
residue linked to the second glycerol moiety was then unequivocally identified as 
alanine by GC/MS analysis after hydrolysis and derivatization with isopropanol and 
pentafluoro propionyl. Interestingly, this analysis revealed the occurrence of 
approximately 90 % of L-alanine and 10 % of D-alanine (Fig. 11, C, D). However, this 
result is in conflict with the proposed tRNA-dependent mechanism of A-PG synthesis. 
It was hypothesized that a partial racemization takes place during A-PG synthesis. 
Interestingly, the occurrence of D-alanyl-phosphatidylglycerol was only described for 
Mycoplasma laidlawii strain B at a molar ratio of 2:1 for D-alanyl-phosphatidylglycerol 
and L-alanyl-phosphatidylglycerol (Koostra and Smith, 1969). 
Subsequently, NMR spectroscopy was used to identify the linkage position of the 
alanine residue to the second glycerol moiety (data not shown). Due to the limited 
amounts of material only a one dimensional 1H spectrum was recorded. The obtained 
spectrum was compared with the 1H spectrum of a derivative without an attached 
alanine moiety in order to identify the signals for the two glycerol units. Two 
characteristic broad multiplet resonances compatible with centrally acylated glycerol 
residues at 5.22 and 5.27 p.p.m. were detected. A well-resolved double doublet at        
3.55 p.p.m. with couplings of 11.5 and 6 Hz corresponded to one proton of a non-
acylated CH2-OH group adjacent to an asymmetric centre (data not shown). 
Consequently, alanine must be linked to the central carbon of the second glycerol 
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moiety. This assignment is in good agreement with the central linkage position for 
various amino acids to compounds of the DPG class (Fischer and Leopold, 1999; 
Thedieck et al., 2006). These results suggest an identical binding position for amino 
acids to asymmetric phosphatidylglycerol compounds as usually found for the 
symmetric counterparts, which has never been unequivocally determined prior to this 
work. 
 
 
3.3 Transcriptional Analysis of ORF PA0920 Encoding A-PGS 
 
3.3.1 The A-PGS Gene Promoter is Induced under Acidic Conditions 
 
To elucidate the regulatory mechanism of A-PG formation, the regulation of the A-PGS 
gene promoter was studied under various growth conditions with the chromosomal 
transcriptional promoter–lacZ reporter gene fusion PAO1-PPA0920-lacZ. This strain 
contains a 469 bp fragment of the upstream region of the A-PGS gene. The             
PAO1-PPA0920-lacZ was cultivated under different pH conditions in AB minimal 
medium and LB medium, respectively. At different growth phases β-galactosidase 
activities were determined (Fig. 12). 
 
  A           B 
 
Figure 12: Control of the A-PGS gene promoter by the pH value of the growth medium. 
Cells were cultivated in AB minimal medium or LB medium for 24 h at 37 °C and 200 rpm as described 
in “Materials and Methods”. The results of PPA0920–lacZ reporter gene fusion experiments in 
P. aeruginosa wild type (strain PAO1-PPA0920-lacZ) during cultivation in different pH-adjusted media are 
shown. A, Cultivation in AB minimal medium. The following conditions were employed: pH 7.3, white 
bars. pH 6.8, light grey bars. pH 6.3, grey bars. 5.8, striped bars. pH 5.3, black bars. B, Cultivation in 
LB medium. The following conditions were employed: pH 7, white bars. pH 5.5, black bars. The            
β-galactosidase activities were determined at indicated time points. All experiments were repeated three 
times. Standard deviations are indicated. 
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The promoter activity in cells grown in AB medium at pH 7.3 (Fig. 12, A white bars) 
remained constant at approximately 250 MU. However, lowering of pH values to 6.8 
and 6.3 resulted in an increase of β-galactosidase activity up to 718 ± 58 MU (Fig. 12, A 
light grey bars) and 755 ± 46 MU (Fig. 12, A grey bars), respectively, and further to 
1053 ± 78 MU (Fig. 12, A striped bars) and 1110 ± 52 MU (Fig. 12, A black bars) for 
cultivation of the reporter strain at pH 5.8 and 5.3 for 24 h, respectively. 
A comparable activation of the A-PGS gene promoter was also detected in LB medium 
with a pH value of 5.5 (Fig. 12, B). The promoter activity in cells grown in LB medium 
at pH 7 only slightly increased up to 441 ± 44 MU (6 h) (Fig. 12, B white bars). 
Cultivation in acidic LB medium (pH 5.5) resulted in a β-galactosidase activity up to 
770 ± 120 MU after 10 h of cultivation (Fig. 12, B black bars). However, at the 
beginning of the stationary growth phase (10 h), only a slight 2-fold increase of the 
observed promoter activity was measured for cultivation in LB medium, whereas a       
5-fold increase was determined for cultivation in AB medium under acidic conditions. 
These results provide evidence for a pH-controlled promoter located in the region       
469 bp upstream of ORF PA0920. Since the observed promoter activities were also 
dependent on the employed culture medium, one might expect that additional stimuli 
are mediated. 
 
 
3.3.2 General Stress Response Regulator RpoS and Stringent Response 
Regulators SpoT and RelA are ot Involved in Promoter Induction of ORF 
PA0920 
 
The alternative sigma factor RpoS functions as a regulator of the general stress 
response. P. aeruginosa rpoS mutants show an increased susceptibility to carbon 
starvation, heat shock, increased osmolarity, low pH and hydrogen peroxide (Schuster 
et al., 2004). The relA and spoT genes are regulatory components of the stringent 
response (Mittenhuber, 2001). Chromosomal transcriptional promoter–lacZ reporter 
gene fusions for PA0920 in the rpoS deficient mutant strain PAO-MW20 (Whiteley et 
al., 2000) and in the spoT/relA deficient mutant strain NB170 (Boes et al., 2008) were 
constructed (PAO-SK03 and PAO-SK04) and the β-galactosidase activities of these 
strains were determined (Fig. 13). 
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Figure 13: Control of the A-PGS gene promoter by the pH value of the growth medium in 
P. aeruginosa rpoS mutant PAO-MW20 and in spoT/relA deficient mutant strain B170. 
Cells were cultivated in AB minimal media for 24 h at 37 °C and 200 rpm as described in “Materials and 
Methods”. The results of PPA0920-lacZ reporter gene fusion experiments in P. aeruginosa PAO-MW20 
(strain PAO-SK03) (A) and in NB170 (strain PAO-SK04) (B) during cultivation in different pH-adjusted 
AB minimal medium are shown. The following conditions were employed: pH 7.3, white bars. pH 6.3, 
grey bars. pH 5.3, black bars. The β-galactosidase activities were determined at indicated time points. All 
experiments were repeated three times. Standard deviations are indicated. 
 
The A-PGS promoter induction for the rpoS deficient mutant PAO-MW20 (strain   
PAO-SK03) and the spoT/relA deficient mutant NB170 (strain PAO-SK04) was 
comparable to the induction pattern obtained for PAO1-PPA0920-lacZ under various pH 
conditions (Fig. 13). Neither the general stress response regulator RpoS (Fig. 13, A) nor 
the stringent response regulators SpoT and RelA (Fig. 13, B) mediated pH-induced 
transcription of PPA0920. 
Furthermore, to underline these observations the lipid composition of rpoS and 
spoT/relA mutant under acidic and neutral growth conditions were elucidated (Fig. 14). 
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Figure 14: Lipid composition of rpoS deficient mutant strain PAO-MW20 and spoT/relA deficient 
mutant strain B170 under neutral and acidic growth conditions. 
Cells were cultivated in AB minimal medium for 24 h at 37 °C and 180 rpm as described in “Materials 
and Methods”. After cultivation, lipids were extracted, separated by 2D-TLC and visualized by spraying 
with 5 % (w/v) molybdatophosphoric acid. A, Lipid composition of rpoS deficient mutant strain        
PAO-MW20 at pH 5.3 and pH 7.3 (inlet). B, Lipid composition of spoT/relA deficient mutant strain 
NB170 at pH 5.3 and pH 7.3 (inlet). A-PG is indicated by arrows. PE = phosphatidylethanolamine. PG = 
phosphatidylglycerol. DPG = diphosphatidylglycerol. 
 
When rpoS and spoT/relA mutants were cultivated under neutral growth conditions (pH 
7.3) no A-PG formation was detected (Fig. 14, A, B inlets), whereas cultivation in acidic 
growth medium clearly resulted in the formation of A-PG (Fig. 14, A, B). Furthermore, 
this 2D-TLC analysis revealed that both investigated P. aeruginosa mutant strains 
produce equal amounts of A-PG under acidic growth conditions as observed for the 
P. aeruginosa wild type (compare Fig. 9). 
Therefore, an influence on the A-PGS promoter activity and on A-PG formation based 
on regulators RpoS and SpoT/RelA was ruled out. 
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3.4 Phenotypical Characterization of P. aeruginosa ∆PA0920 
Deletion Mutant 
 
A standard phenotypical characterization as well as the high-troughput Biolog® 
phenotype microarray system was used to get further insights into the biological role of 
A-PGS catalysis. 
 
 
3.4.1 Standard Phenotypical Characterization 
 
Standard phenotype assays were employed to investigate, if the P. aeruginosa ∆PA0920 
deletion mutant is impaired in biofilm formation, in motility or in the excretion of 
extracellular proteins (DNase, elastase, haemolysin, phospholipase A and C, and 
proteases). However, all these analyses revealed no differences in comparison to          
P. aeruginosa wild type (data not shown). 
Moreover, identical growth curves for the P. aeruginosa ∆PA0920 deletion mutant and 
the P. aeruginosa wild type strain were obtained under acidic and neutral pH conditions 
(data not shown), indicating no direct relevance of A-PG for the growth behavior. 
It was proposed before, that the synthesis of A-PG in P. aeruginosa might be a 
prerequisite for stress adaptation as a response to changing environmental conditions, 
for example under the investigated acidic conditions. Analogous acid-dependent 
synthesis of L-PG was observed for S. aureus and E. faecalis, but the precise functional 
role of this lipid modification was not elucidated to date (Houtsmuller and van Deenen, 
1965; Gould and Lennarz, 1970). 
However, such acid tolerance mechanisms were observed in the Gram-negative 
bacterium Sinorhizobium medicae. A mutant which lacks the mprF homolog gene lpiA 
(low-pH inducible gene A) was compromised in its ability to survive acidic conditions. 
Interestingly, the amount of aminoacylated PG in S. medicae wild type grown under 
acidic growth conditions was below the detection limit of the employed assay (Reeve et 
al., 2006). This might indicate that even a small amount of aa-PG can dramatically 
influence and modify the composition and biophysical parameters of the membrane. In 
future experiments a possible influence of A-PG containing membranes in acid 
tolerance mechanisms of P. aeruginosa has to be investigated. 
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3.4.2 High-Troughput Biolog
®
 Phenotype Microarray System 
 
To further analyze the sophisticated phenotype of the A-PG deficient P. aeruginosa 
∆PA0920 deletion mutant a total of 1152 different culture conditions were tested in a 
phenotype microarray (Biolog, Hayward, CA). The employed test system is based on 
the reduction of a tetrazolium dye to a purple formazan in the presence of NADH in the 
cell. The formation of the purple formazan can be photometrically detected. The 
analysis revealed a set of 38 conditions, in which the P. aeruginosa wild type strain and 
the P. aeruginosa ∆PA0920 deletion mutant showed phenotypical differences. In a 
second set of experiments the individual conditions of the commercial phenotype array 
were independently reproduced by mixing the components in 96-well microplates 
thereby varying the individual concentrations of the media constituents. The 
corresponding phenotypic changes of P. aeruginosa strains wild type, ∆PA0920 and 
∆PA0920compl were determined by measuring absorption of the reduced dye at 600 nm 
at defined time points. The P. aeruginosa ∆PA0920 deletion mutant showed phenotypic 
response due to CrCl3, protamine sulphate, sodium lactate and cefsulodin in the growth 
medium. 
 
 
3.4.2.1  Toxic Effects of Cr
3+
 Addition 
P. aeruginosa wild type and ∆PA0920compl in comparison to ∆PA0920 deletion 
mutant showed clear differences in the metabolic activity when CrCl3 was added. 
Cultivation in the presence of 3.5 mM CrCl3 resulted in an A600 of 0.17 for 
P. aeruginosa wild type and ∆PA0920compl, whereas the ∆PA0920 deletion mutant 
revealed a significantly lower absorption of 0.05 (Fig. 15). 
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Figure 15: Response of P. aeruginosa wild type, ∆PA0920 deletion mutant and ∆PA0920compl to 
3.5 mM of CrCl3. 
The tetrazolium dye reduction-dependent color development of cultures treated with CrCl3 is shown.        
P. aeruginosa wild type (squares), ∆PA0920 deletion mutant (triangles), and the complemented 
∆PA0920 deletion mutant (strain ∆PA0920compl) (crosses) were mixed with 3.5 mM of CrCl3 in a total 
volume of 240 µl IF medium (Biolog) and incubated in 96-well plates. At different time points, the A600 
was measured using a FusionTM plate reader (Perkin Elmer). For each condition, one representative 
experiment out of two independent experiments is shown. 
 
Cr3+ is a heavy metal ion generating toxic effects by its ability to bind to phosphate 
residues of DNA and RNA (Kortenkamp and O'Brien, 1991; Bridgewater et al., 1994). 
Furthermore, additional toxic effects due to the ability of Cr3+ to bind to carboxyl and 
sulphydryl groups in proteins have been reported (Levis and Bianchi, 1982). 
The E. coli membrane system was shown to be a very efficient barrier towards Cr3+ 
when compared with other toxic Cr(IV) species (Yao et al., 2008). However, cationic 
Cr(III) derivatives bind tightly to B. subtilis and E. coli cell walls (Flemming et al., 
1990). Therefore, one might conclude that the membrane of the A-PG deficient 
∆PA0920 deletion mutant is more susceptible to Cr3+ or that the binding capacity of the 
membrane for Cr3+ is changed compared to the P. aeruginosa wild type. 
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3.4.2.2  A-PGS-Related Resistance to the Cationic Peptide Protamine 
Addition of protamine sulphate resulted into different metabolic activities for               
P. aeruginosa wild type and the complementation strain ∆PA0920compl in comparison 
to ∆PA0920 deletion mutant. Cultivation in the presence of 5.6 mM protamine sulphate 
led to A600 values of 0.29 for the P. aeruginosa wild type strain and of 0.36 for 
∆PA0920compl. In contrast, the ∆PA0920 deletion mutant only showed an A600 of 0.02 
after 72 h (Fig. 16). 
 
 
 
Figure 16: Response of P. aeruginosa wild type, ∆PA0920 deletion mutant and ∆PA0920compl to 
5.6 mM of protamine sulphate. 
The tetrazolium dye reduction-dependent color development of cultures treated with protamine sulphate is 
shown. P. aeruginosa wild type (squares), ∆PA0920 deletion mutant (triangles), and the complemented 
∆PA0920 deletion mutant (strain ∆PA0920compl) (crosses) were mixed with 5.6 mM of protamine 
sulphate in a total volume of 240 µl IF medium (Biolog) and incubated in 96-well plates. At different 
time points, the A600 was measured using a Fusion
TM plate reader (Perkin Elmer). For each condition, one 
representative experiment out of two independent experiments is shown. 
 
Protamine is a highly cationic peptide showing antimicrobial activity against a whole 
range of Gram-positive and Gram-negative bacteria (Johansen et al., 1997). Its activity 
is believed to be dependent on the electrostatic attraction between the positively charged 
molecule and the negatively charged cell envelope, thereby resulting in disruption of the 
cell membrane and cell wall. Appropriate concentrations cause an inhibition of cell 
growth and subsequently lead to cell death due to the leakage of intracellular 
components including H+, ATP and intracellular enzymes by pore formation (Johansen 
et al., 1997; Toke, 2005). A comparable resistance to CAMPs in response to the 
lysinylation of PG or DPG has been described for S. aureus and for L. monocytogenes 
(Peschel et al., 2001; Thedieck et al., 2006). However, these related lipid alterations 
  Results and Discussion 
 
75 
 
resulted in an overall net cationic charge of the modified phospholipid molecule due to 
the lysine addition. Efficient repulsion of CAMPs due to membrane-localized L-PG was 
concluded (Peschel et al., 2001; Staubitz et al., 2004). 
Recently, determination of transposon insertion sites in protamine-hypersusceptible 
mutants of B. anthracis revealed that in all mutants the ORF BA1486 was affected 
which encodes an orthologous MprF protein (Samant et al., 2009). 
The modification of PG with alanine in P. aeruginosa produces the zwitter ionic lipid 
A-PG carrying no overall net charge compared to modification with lysine which results 
into a positive net charge. Nevertheless, clear resistance to the cationic peptide 
protamine is mediated arguing against a simple “repulsion mechanism” for 
P. aeruginosa. Since, A-PG formation in P. aeruginosa is also involved in CAMP 
resistance, it is presumed that two different enzymes have evolved allowing for a more 
specific adaptation to the particular environment. However, to date it is not clear 
whether lysinylation of PG, alanylation of PG but also the modification with other 
amino acids have a comparable effect on the physiology of the organism. 
One might conclude that A-PG formation results in a diminished binding capacity for 
CAMPs, thus hampering the initial step of antimicrobial action. Besides this, the 
subsequent interaction of protamine with the overall bilayer is of importance. A-PG 
incorporation might alter the overall membrane permeability of P. aeruginosa thereby 
preventing the disruption of the membrane structure due to the incorporation of cationic 
peptide molecules. 
 
 
3.4.2.3  A-PGS-Mediated Resistance to the Osmolyte Sodium Lactate 
P. aeruginosa wild type and ∆PA0920compl in comparison to ∆PA0920 deletion 
mutant showed clear differences in the metabolic activity when sodium lactate was 
added. The presence of 625 mM sodium lactate resulted in a final A600 of 0.09 for the   
P. aeruginosa wild type strain, 0.15 for the ∆PA0920compl strain and 0.02 for the 
∆PA0920 deletion mutant after 72 h (Fig. 17). 
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Figure 17: Response of P. aeruginosa wild type, ∆PA0920 deletion mutant and ∆PA0920compl to 
625 mM of sodium lactate. 
The tetrazolium dye reduction-dependent color development of cultures treated with sodium lactate is 
shown. P. aeruginosa wild type (squares), ∆PA0920 deletion mutant (triangles), and the complemented 
∆PA0920 deletion mutant (strain ∆PA0920compl) (crosses) were mixed with 625 mM of sodium lactate 
in a total volume of 240 µl IF medium (Biolog) and incubated in 96-well plates. At different time points, 
the A600 was measured using a Fusion
TM plate reader (Perkin Elmer). For each condition, one 
representative experiment out of two independent experiments is shown. 
 
The capacity of microorganisms to respond to fluctuations in their osmotic 
environments is a fundamental physiological process that determines their abilities to 
survive in a variety of habitats. Therefore, it has been shown that the control of the 
fluidity and the permeability of the cellular membranes are essential to maintain cell 
homeostasis (Vanden Boom and Cronan, 1989). Highly concentrated osmolytes are 
frequently used as antimicrobial agents; for example, sodium lactate is employed as 
food supplement. 
The alteration of the membrane permeability could be responsible for the specific 
phenotype observed for the P. aeruginosa mutant lacking A-PG. Furthermore, possible 
secondary effects might be involved in the susceptibility of the A-PG deficient mutant. 
As a result of high lactate concentrations outside the cell, lactic acid and protons might 
accumulate in the bacterial cell which in turn might result in cell damage (Rubin et al., 
1982; McWilliam Leitch and Stewart, 2002). A-PG incorporation in the bacterial 
membrane might inhibit the accumulation of lethal concentrations of lactate and protons 
in the cell. 
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3.2.4.4  A-PGS-Mediated Resistance to the β-Lactam Antibiotic Cefsulodin 
Addition of cefsulodin resulted into different metabolic activities for P. aeruginosa wild 
type and ∆PA0920compl in comparison to ∆PA0920. The cultivation in the presence of 
20 µM of cefsulodin led to an A600 of 0.25 for the P. aeruginosa wild type and 0.4 for 
the ∆PA0920compl strain, whereas the deletion mutant only gained an A600 of 0.06 after 
72 hours (Fig. 18). 
 
 
 
Figure 18: Response of P. aeruginosa wild type, ∆PA0920 deletion mutant and ∆PA0920compl to   
20 µM of cefsulodin. 
The tetrazolium dye reduction-dependent color development of cultures treated with cefsulodin is shown. 
P. aeruginosa wild type (squares), ∆PA0920 deletion mutant (triangles), and the complemented 
∆PA0920 deletion mutant (strain ∆PA0920compl) (crosses) were mixed with 20 µM of cefsulodin in a 
total volume of 240 µl IF medium (Biolog) and incubated in 96-well plates. At different time points, the 
A600 was measured using a Fusion
TM plate reader (Perkin Elmer). For each condition, one representative 
experiment out of two independent experiments is shown. 
 
Cefsulodin is a semi-synthetic cephalosporin impeding the cross-linking of 
peptidoglycan and therefore showing antipseudomonal activity (Tsuchiya et al., 1978). 
The β-lactams are believed to permeate through hydrophilic pores in the outer 
membrane (Irvin et al., 1981). Generally, P. aeruginosa has a high intrinsic resistance 
to β-lactam antibiotics due to its low outer membrane permeability and due to the 
presence of β-lactamases and multi-drug-efflux pumps (Lambert, 2002; Nikaido, 2003). 
In transposon mutagenesis studies of S. aureus an mprF mutant was found to be 
sensitive against the β-lactam oxacillin. Further analysis of this mutant revealed that the 
resistance to four different β-lactams was decreased (Komatsuzawa et al., 2001). 
Possibly alteration of the P. aeruginosa membrane systems might have an effect on the 
uptake of cefsulodin. Since β-lactam antibiotics do not interact directly with the lipid 
bilayer as they target the biosynthesis of peptidoglycan in the periplasm (Wilke et al., 
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2005), the mode of action remains elusive. It is known, that lipid composition and the 
presence of certain phospholipids in the bacterial membrane might have an influence on 
folding and activity of membrane proteins, for example, the lactose permease LacY of 
E. coli requires phosphatidylethanolamine to obtain its native topology (Bogdanov et 
al., 2008). According to this one might speculate that the presence of A-PG might 
modulate the activity of porins or other membrane proteins, which results into the 
observed resistance phenotypes. Interestingly, no phenotypic differences were observed 
for other β-lactam antibiotics tested in the Biolog® phenotype microarray system. 
 
 
3.2.4.5  A-PGS-dependent Homeostasis 
Biological membranes play a central role in response to environmental stress. 
Maintenance of cell homeostasis is dependent on effective transmembrane processes, 
such as nutrient transport or solute gradients for energetic purposes. Current 
investigations clearly indicate that the distribution of phospholipids in the bacterial 
membrane is non-uniform (Matsumoto et al., 2006). Therefore, small alterations of the 
lipid composition might have significant influence on the local lipid concentration. 
Cultivation of wild type P. aeruginosa in IF-10 medium and AB medium, pH 7.3 
supplemented with 3.5 mM of CrCl3, 5.6 mM of protamine sulphate, 625 mM of 
sodium lactate, and 20 µM of cefsulodin, respectively, did not result in a significantly 
increased A-PG content (data not shown). These results indicate that an overall A-PG 
content of approximately 0.5 % has an important influence on the resistance of 
P. aeruginosa. Similarly, for S. medicae it was recently shown that aminoacylated PG 
below the detection limit of the employed assay is essential for the underlying 
mechanism of acid tolerance (Reeve et al., 2006). 
From these results it becomes clear that in P. aeruginosa A-PGS-dependent lipid 
modification is a central process for the adaptation to acidic conditions. However, a 
total of four ‘other’ phenotypes for the P. aeruginosa ∆PA0920 deletion mutant indicate 
that synthesis of A-PG is also required under various other environmental conditions. 
One might expect that A-PG is able to render the binding ability for cationic molecules 
on the surface of the lipid bilayer. Concurrently, A-PG might also have significant 
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influence on the permeability and fluidity of the lipid bilayer as well as on the activity 
of membrane proteins. 
All enzymes responsible for the modification of PG share a high degree of sequence 
identity, indicating the presence of a common ancestor. The different amino acid 
specificities might be a result of adaptation processes towards different environmental 
conditions. Therefore, the analysis of the biochemical and biophysical features of the 
different aminoacylated PGs is of importance for the understanding of bacterial 
resistance mechanisms. 
 
 
3.5 Biochemical Characterization of the Catalytic Domain of the     
A-PGS from Pseudomonas aeruginosa 
 
3.5.1 Cloning, Production and Purification of Truncated aa-PGS Variants 
 
From theoretical analysis the following protein architecture of A-PGS from                  
P. aeruginosa was proposed: an N-terminal transmembrane domain consisting of              
14 transmembrane helices (amino acid residues 1 - 542), and a more hydrophilic          
C-terminal domain (543 - 881) (Fig. 7). The N-terminal domains from various 
organisms are highly variable in size (from 228 amino acid residues for C. perfringens 
MprF1 (Roy and Ibba, 2008b) to 542 amino acid residues for P. aeruginosa A-PGS) 
and share only an amino acid sequence identity of approximately 15 %. In contrast to 
this the C-terminal domains of aa-PGS can be found highly conserved with an amino 
acid sequence identity of approximately 30 %. Based on these theoretical findings it 
was concluded, that the C-terminal domain might be essential for aa-PG synthesis. 
For the future analysis aa-PGS enzymes from various organisms were investigated. 
Therefore, the corresponding gene sequences of ORF PA0920, mprF, lmo1695 and 
lin1803 from P. aeruginosa, S. aureus, L. monocytogenes and L. innocua, respectively, 
encoding the proposed hydrophilic C-terminal domains were cloned into standard 
E. coli expression vectors (pGEX-6P-1). The resulting constructs pGEX-6P-
1/PA0920∆AS1-542, pGEX-6P-1/mprF∆AS1-514, pGEX-6P-1/lmo1695∆AS1-510 and 
pGEX-6P-1/lin1803∆AS1-511, respectively, allow for the purification of truncated 
variants A-PGS543-881, MprF515-840, Lmo1695511-865, and Lin1803512-865 via a glutathione 
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S-transferase (GST) tag. Production of the corresponding proteins was performed in 
E. coli BL21 (λDE3) cells under aerobic conditions. Protein production induced by 
addition of 50 µM IPTG resulted in the production of significant amounts of the 
individual proteins from all four organisms. The purification of the GST-tagged 
enzymes via affinity chromatography with a glutathione sepharose matrix was 
performed according to manufacturer’s instructions. Proteins were eluted with buffer 
containing 10 mM of glutathione. The purification of the truncated protein variants from 
P. aeruginosa, S. aureus, L. monocytogenes and L. innocua is summarized in Figure 19. 
Alternatively, the GST-tag of A-PGS543-881 from P. aeruginosa was proteolytically 
cleaved using the PreScission Protease. 
 
 
 
Figure 19: SDS-PAGE analysis of purified recombinantly truncated aa-PGSs variants from 
different microorganisms. 
Proteins were recombinantly produced in E. coli BL21 (λDE3), chromatographically purified. Protein 
fractions were analyzed on a 12 % SDS-PAGE, and visualized via Coomassie Brilliant Blue staining. 
Lane M, molecular mass marker, relative molecular masses (*1’000) are indicated. Lane 1, purified    
GST-A-PGS543-881 from P. aeruginosa. Lane 2; purified A-PGS543-881 from P. aeruginosa after 
proteolytical cleavage of the GST-tag using the PreScission Protease. Lane 3, purified GST-MprF515-840 
from S. aureus. Lane 4, purified GST-Lmo1695511-865 from L. monocytogenes. Lane 5, purified           
GST-Lin1803512-865 from L. innocua. 
 
Affinity chromatography via glutathione sepharose resulted in highly enriched fusion 
proteins. All proteins showed a slightly decreased relative molecular mass when 
compared to the calculated molecular mass for GST-A-PGS543-881 from P. aeruginosa 
(lane 1, GST-A-PGS543-881 = 65’132 Da). MprF515-840 from S. aureus (lane 3,           
GST-MprF515-840 = 65’371 Da), Lmo1695511-865 from L. monocytogenes (lane 4,       
GST-Lmo1695511-865 = 67’489 Da), and Lin1803512-865 from L. innocua (lane 5,      
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GST-Lin1803512-865 = 67’450 Da). After a proteolytical cleavage the observed relative 
molecular mass for A-PGS543-881 from P. aeruginosa was in good agreement with the 
calculated molecular mass for the truncated protein (lane 2, A-PGS543-881 = 38’719 Da). 
 
 
3.5.2 Analytical Gel Permeation Chromatography of A-PGS543-881 
 
To determine the oligomeric state of A-PGS543-881 from P. aeruginosa, an analytical gel 
permeation chromatography was performed. The following elution diagram (Fig. 20) 
was obtained for A-PGS543-881 from P. aeruginosa. 
 
 
 
Figure 20: Analytical gel permeation chromatography analysis of purified A-PGS543-881 from           
P. aeruginosa. 
Purified A-PGS543-881 after proteolytical cleavage off the GST-tag at a concentration of ~ 9 mg ml
-1 was 
loaded onto a Superdex 75 HR 10/30 column (GE Healthcare) and eluted with 50 mM Tris-HCl, pH 8.0, 
250 mM NaCl and 2 mM DTT at a flow rate of 0.5 ml min
-1. The absorbance at 280 nm and 260 nm was 
monitored. Elution volumes of marker proteins (* 1’000) are marked with arrows. A-PGS543-881 elution 
peak is highlighted with an asterisk. 
 
The analytical gel permeation chromatography after proteolytical cleavage revealed a 
relative molecular mass of 34’000 for A-PGS543-881 from P. aeruginosa (calculated 
molecular mass = 38’719 Da) indicating a monomeric soluble A-PGS543-881 protein. In 
SDS-PAGE analysis of elution fractions at an elution volume of 8.61 and 10.29 ml no    
A-PGS543-881 protein was detectable.  
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3.5.3 Analysis of Potential Cofactors 
 
To identify possible cofactors of A-PGS543-881, UV/Vis absorption spectroscopy as well 
as fluorescence measurements were performed. However, no evidence for a 
chromogenic cofactor was obtained. 
 
 
3.6 Activity of Recombinantly Produced aa-PGS Variants 
 
3.6.1 In vivo Activity of aa-PGS Variants 
 
The truncated aa-PGS variants of P. aeruginosa, L. monocytogenes, L. innocua and 
S. aureus were tested for in vivo activity. For this purpose, E. coli BL21 (λDE3) cells 
heterologously producing truncated aa-PGS variants as GST fusion were harvested 3 h 
after induction of protein production and the total lipids of the E. coli host were 
extracted and subsequently separated by 2D-TLC (Fig. 21). This procedure allows for 
the identification of the de novo biosynthesis of aa-PG in E. coli under in vivo 
conditions due to the absence of any aa-PGS related genes in the host. 
 
 
 
Figure 21: Lipid composition of E. coli BL21 (λDE3) overproducing truncated aa-PGS variants 
from P. aeruginosa, S. aureus, L. monocytogenes and L. innocua, respectively. 
E. coli BL21 (λDE3) harboring the respective plasmid was cultivated at 37 °C and 200 rpm to an OD578 of 
0.5. Recombinant gene expression was induced by addition of 50 µM IPTG. Cells were further incubated 
for 3 h and harvested. Extracted lipids were separated by 2D-TLC and visualized by spraying with           
5 % (w/v) molybdatophosphoric acid. A, in vivo activity of GST-A-PGS543-881 from P. aeruginosa. B, in 
vivo activity of GST-MprF515-840 from S. aureus. C, in vivo activity of GST-Lmo1695511-865 from 
L. monocytogenes. D, in vivo activity of GST-Lin1803512-865 from L. innocua. E, in vivo activity of     
BL21 (λDE3) carrying empty vector pGEX-6P-1 as negative control. A-PG is indicated by an arrow, 
theoretical position of L-PG is marked with an ellipse. PE = phosphatidylethanolamine, PG = 
phosphatidylglycerol, DPG = diphosphatidylglycerol. 
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The employed in vivo A-PGS activity of A-PGS543-881 variant from P. aeruginosa 
resulted in the accumulation of approximately 10 % A-PG when compared to the total 
lipid content (Fig. 21, A). This value is higher than the observed 5 % for the 
overproduction of wild type A-PGS in E. coli TOP10 (Fig. 6) (Klein, 2007), which can 
be ascribed to the increased overproduction level for the truncated protein variant. The 
E. coli genome lacks genes encoding an aa-PGS. Consequently, control experiments 
with E. coli BL21 (λDE3) carrying empty vector pGEX-6P-1 as negative control 
showed no aa-PG synthesis (Fig. 21, E). 
Overproduction of truncated variants MprF515-840 from S. aureus (Fig. 21, B), 
Lmo1695511-865 from L. monocytogenes (Fig. 21, C) and Lin1803512-865 from L. innocua 
(Fig. 21, D) failed to result in detectable L-PGS activity. However, in a comparable in 
vivo experiment for the S. aureus MprF protein it was recently shown that under in vivo 
conditions 6 of the transmembrane helices are required for maintaining a functional 
enzyme (Ernst et al., 2009). When all transmembrane helices of MprF1 from 
C. perfringens or from MprF of B. subtilis were deleted residual enzymatic activity was 
obtained under in vitro conditions. Besides this, no detectable lipid modification was 
observed with the employed in vivo assay (Roy and Ibba, 2009). 
This initial experiment is indicative for the efficient conversion of the E. coli specific 
PG substrate by the GST-A-PGS543-881 fusion protein under in vivo conditions. 
Furthermore, these results point out that the newly established A-PGS543-881 protein 
variant from P. aeruginosa is an appropriate enzyme to investigate the enzymatic 
mechanism of A-PGS or A-PGS related systems. 
 
 
3.6.2 In vitro Activity of aa-PGS Variants 
 
In the in vitro aa-PGS activity assay using E. coli extracts the substrate molecules PG 
and Ala-tRNAAla or Lys-tRNALys were provided by an E. coli crude cellular extract. 
Due to the fact that truncated variants of B. subtilis MprF showed L-PG formation 
solely under in vitro conditions, the in vitro activity of truncated enzyme variants of       
S. aureus, L. monocytogenes and L. innocua was also investigated. 
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Therefore, 500 µl of crude cellular extract of E. coli overproducing the alanyl-tRNA 
synthetase and lysyl-tRNA synthetase, respectively, were supplemented with an      
ATP-regenerating system, 2 mM ATP and 20 µM of 14C labeled L-alanine or 14C 
labeled L-lysine. The reaction was initiated by the addition of 20 µM of each individual 
purified truncated aa-PGS variant. Subsequently polar lipids were extracted and 
characterized by 2D-TLC and autoradiography (Fig. 22). 
 
 
Figure 22: Autoradiography analysis of 2D-TLC plates of in vitro A-PGS activity assays using       
E. coli extracts with purified truncated GST-A-PGS543-881 variant of P. aeruginosa. 
In vitro assays using E. coli extracts with radioactively labeled [1-14C]-L-alanine and 20 µM of purified                      
GST-A-PGS543-881 were performed as described in “Materials and Methods”. After incubation of the assay 
for 1 h at 37 °C, lipids were extracted, subjected to 2D-TLC analysis and 14C-phospholipids were 
visualized by autoradiography. A, Activity of purified GST-A-PGS543-881 from P. aeruginosa. B, Negative 
control without enzyme. C, Negative control, pre-treatment of crude cellular extract with 100 µg ml-1 
RNase A for 25 min. A-PG is indicated by arrows. 
 
In Figure 22 the result of a typical in vitro assay using E. coli extracts for the truncated 
protein variant GST-A-PGS543-881 is shown. Control experiments in the absence of    
GST-A-PGS543-881 (Fig. 22, B) or with RNase A pre-treatment (Fig. 22, C) did not result 
in the formation of any detectable amounts of A-PG indicating a tRNA-dependent 
reaction mechanism. However, incubation with 20 µM of GST-A-PGS543-881 yielded 
high amounts of A-PG (Fig. 22, A). Interestingly, the standard in vitro assay using       
E. coli extracts revealed two radioactively labeled spots (Fig. 22, A arrows). Since both 
of these spots are the result of A-PGS activity, one can speculate about the formation of 
the both isomers 3’ and 2’ A-PG. The analysis of 3’ A-PG isomer using standard        
2D-TLC procedure is hampered since this lipid spot is usually overlapped by 
phosphatidylethanolamine. 
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From these results, it was concluded, that the C-terminal domain of A-PGS                
(A-PGS543-881) from P. aeruginosa harbors the active site. In contrast, the truncated     
aa-PGS variants of S. aureus, L. monocytogenes and L. innocua failed to synthesize     
L-PG under the employed conditions of the in vitro assay using E. coli extracts (data not 
shown). These results might indicate that solely the C-terminal domain of these three 
enzymes is not sufficient for L-PG synthesis. It was concluded that for catalytic activity 
additional amino acids located in the N-terminal transmembrane region are required. 
Based on these results A-PGS from P. aeruginosa was employed for all future 
experiments to elucidate key amino acids and the substrate requirements of the tRNA-
dependent catalysis. 
 
 
3.6.3 Quantitative Determination Method of the specific A-PGS Activity by 
Scintillation Counting 
 
The detection of radioactively labeled phospholipids using autoradiography of 2D-TLC 
allows only for a qualitative analysis of A-PG synthesis. For the quantification of the 
enzymatic activity of A-PGS543-881 [1-
14C]-L-alanine incorporation into the lipid fraction 
was analyzed by scintillation counting after lipid extraction. Therefore, in vitro assays 
using E. coli extracts with different concentrations of the purified truncated              
GST-A-PGS543-881 variant of P. aeruginosa were performed. At different time points 
samples were subjected to lipid extraction and radioactively labeled phospholipids 
determined by scintillation counting (Fig. 23). Alternatively, solubilized full length     
A-PGS was used for determination of specific activity of the wild type enzyme. 
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Figure 23: Liquid scintillation analysis of in vitro activity of purified GST-A-PGS543-881 from 
P. aeruginosa. 
In vitro assays using E. coli extracts with radioactively labeled [1-14C]-L-alanine supplemented with 
different enzyme concentrations were performed as described in “Materials and Methods”. The assay was 
incubated at 37 °C, at indicated time points samples of 100 µl volume were subjected to lipid extraction 
and liquid scintillation analysis. The following concentrations of purified P. aeruginosa GST-A-PGS543-
881 were employed: 0 µM (black line), 2 µM (grey line), 5 µM (dashed black line), 10 µM (dashed grey 
line), and 20 µM (dotted black line). 
 
A linear increase of product formation using different concentrations of                    
GST-A-PGS543-881 from P. aeruginosa was observed (Fig. 23). In the presence of 2 - 
10 µM of GST-A-PGS543-881, this type of experiment resulted in a linear increase of     
A-PG formation over a time scale of 10 min (Fig. 23), whereas in assays in which the 
enzyme was omitted (black line) no product formation was observed. The observed activity 
for the P. aeruginosa GST-A-PGS543-881 enzyme in the employed assay yielded a specific 
activity of 27 pmol · mg-1 · min-1 which is comparable to the measured value of             
23 pmol · mg-1 · min-1 for the solubilized full length A-PGS protein. Interestingly, full 
length A-PGS and the truncated A-PGS543-881 variant have similar product formation 
efficiencies indicating no critical involvement of the N-terminal domain in the catalytic 
mechanism. 
The observed specific activity is comparable to values obtained for other membrane 
proteins of the phospholipid biosynthesis pathway. For example, for the 
phosphatidylglycerolphosphate synthase from cardiac mitochondria an activity of 
15 ± 2 pmol · mg-1 · min-1 was observed (Cao et al., 1995). 
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3.7 Substrate Specificity and Recognition of P. aeruginosa A-PGS - 
Rationale of the Approach 
 
For modification of PG two substrate molecules - the aminoacylated tRNA and PG - 
have to be precisely recognized by the enzyme. 
Besides protein biosynthesis the A-PGS from P. aeruginosa and A-PGS homolog 
proteins are one of the rare examples of using aminoacylated tRNA as substrate next to 
peptidoglycan crosslinking, synthesis of antibiotics and tetrapyrrole biosynthesis 
(Matsuhashi et al., 1965; Yamato et al., 1986; Smith et al., 1992). Therefore,            
Ala-tRNAAla has a dual function in the metabolism of P. aeruginosa. It is recognized by 
two enzymes: alanyl-tRNA synthetase (AlaRS) and A-PGS. To ensure accurate protein 
biosynthesis and also for the synthesis of A-PG, tRNA substrate recognition is of prime 
importance. Aminoacyl-tRNA synthetases distinguish their cognate tRNA by specific 
tRNA identity elements. The tRNA identity is affected by positive and negative 
elements that respectively activate specific aminoacylation and prevent false 
aminoacylation. The positive elements include isolated nucleotides in single-stranded 
regions, base pairs in helices, and can also be structural motifs. However, the anticodon 
bases and the discriminator base N73 are the most occurring tRNA identity elements for 
aminoacyl-tRNA synthetases (Crothers et al., 1972; Schulman, 1991; McClain, 1993). 
The substrate specificity for the amino acid part of A-PGS was determined using an in 
vivo approach in the natural host P. aeruginosa. The tRNA identity and the recognition 
elements for the PG substrate were investigated using in vitro activity assays. The 
standard A-PGS in vitro assay mixture contained purified PG and recombinantly 
purified AlaRS in the presence of a commercially available mixture of tRNAs from 
E. coli. Alternatively, the tRNA mixture was replaced with purified tRNAAla1 or 
tRNAAla2 from P. aeruginosa which were produced by in vitro transcription (Sampson 
and Uhlenbeck, 1988). Alternatively, tRNA microhelices were employed. Additionally, 
the PG constituent of the assay was substituted with PG derivatives. The lipid content 
was extracted and 14C labeled compounds were analyzed by autoradiography after     
2D-TLC. To quantify the A-PG formation in experiments with in vitro transcribed 
tRNAs or in the presence of microhelices, the polar lipids were analyzed by scintillation 
counting after lipid extraction from the assay mixture. 
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3.7.1 A-PGS from P. aeruginosa Shows a Substrate Specificity for tRA-bound 
Alanine 
 
In very early investigations the presence of L-PG in P. aeruginosa strain NCTC 6750 
was described (Kenward et al., 1979). In the present study A-PG formation for 
P. aeruginosa PAO1 was found (chapter 3.2.4). In order to unambiguously characterize 
the specificity of P. aeruginosa A-PGS, crude cellular extracts from the P. aeruginosa 
PAO1-derivative ADD1976 overproducing A-PGS were incubated with radioactively 
labeled alanine, lysine, and also with alanine in combination with lysine, respectively. 
De novo biosynthesis of aminoacyl-PG was monitored using 2D-TLC and 
autoradiography (Fig. 24). 
 
 
Figure 24: In vivo formation of aminoacylated PG by P. aeruginosa crude cellular extracts. 
A 2D-TLC analysis of 14C-phospholipids is shown. Crude cellular extract from P. aeruginosa ADD1976 
harboring pUCP20T-T7-PA0920-His6 was incubated with different radioactively labeled amino acids. 
The resulting lipids were extracted, subjected to 2D-TLC and autoradiography analysis. The following 
amino acids were added: A, 2.8 mM [U-14C]-L-alanine. B, 2.8 mM [U-14C]-L-lysine. C, 2.8 mM            
[U-14C]-L-alanine and 2.8 mM [U-14C]-L-lysine. The black arrows indicate the position of A-PG. The 
ellipses indicate the theoretical position of L-PG. Not converted radioactively labeled alanine is 
highlighted by black arrow heads. 
 
Solely the addition of radioactively labeled alanine led to A-PG formation (Fig. 24, A 
black arrow). Addition of radioactively labeled lysine did not yield detectable L-PG 
amounts (Fig. 24, B ellipse). The addition of both, isotopically labeled alanine and 
lysine led to formation of significant amounts of A-PG whereas no L-PG synthesis was 
detectable (Fig. 24, C).  
These experiments clearly indicate that A-PGS catalysis is highly specific for the 
biosynthesis of A-PG. 
Recently, the E. faecium aa-PGS revealed a relaxed specificity for lysine, arginine and 
alanine under in vitro conditions. The orthologous B. subtilis protein showed a 
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specificity for lysine, in parallel with a relaxed specificity allowing for A-PG synthesis 
(Roy and Ibba, 2009). Interestingly, also a single strict specificity was determined for   
A. tumefaciens aa-PGS for lysine and for C. perfringens MprF1 for alanine (Roy and 
Ibba, 2009). 
 
 
3.7.2 The tRA identity of P. aeruginosa A-PGS 
 
tRNA identity elements allow for the discrimination of tRNAs by aminoacyl-tRNA 
synthetases. The modification of PG catalyzed by the A-PGS was shown to be       
tRNA-dependent (chapter 3.2.1 and 3.6.2). Thus, the Ala-tRNAAla has to be precisely 
identified by the A-PGS. To analyze the tRNA identity of P. aeruginosa A-PGS an in 
vitro activity assay was performed. For this approach tRNAAla with posttranscriptional 
base modifications and unmodified tRNAAla were investigated. Furthermore, several 
microhelices mimicking the minimal part of the tRNAAla and tRNAHis acceptor stem 
were used. tRNAs and tRNA microhelices were aminoacylated by their cognate 
aminoacyl-tRNA synthetase and tested as substrate for A-PG synthesis. 
Therefore, tRNAAla from P. aeruginosa was, inter alia, synthesized by in vitro 
transcription using purified T7 RNA polymerase. Furthermore, AlaRS from                 
P. aeruginosa and E. coli and the histidyl-tRNA synthetase (HisRS) from E. coli were 
purified. 
 
 
3.7.2.1  Synthesis and Purification of two P. aeruginosa tRA
Ala
 Isoacceptors 
The two isoacceptor tRNAAla genes (PA4280.3, PA3133.2) from P. aeruginosa were 
cloned into the pUC18 and pUC119 vector system under control of the T7 promoter. In 
vitro transcription of these constructs after digestion with BstNI yields unmodified 
tRNA transcripts with a 3’-CCA end (Sampson and Uhlenbeck, 1988). Therefore, T7 
RNA polymerase was overproduced in E. coli BL21 (DE3)-RIL CodonPlusTM cells and 
purified via N-terminal His6-tag. After in vitro transcription tRNA transcripts were 
purified via MonoQ chromatography according to Jahn et al. (1991) or alternatively via 
12 % polyacrylamide gel electrophoresis in the presence of 8 M urea according to Pande 
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et al. (1991). Figure 25 summarizes the purification of the recombinantly produced     
T7 RNA polymerase and the anion exchange chromatography of tRNAAla1 from 
P. aeruginosa. (Pande et al., 1991) (Jahn et al., 1991). 
 
 
Figure 25: SDS-PAGE analysis of purified T7 RA polymerase (A) and purification of tRA
Ala1
 by 
anion exchange chromatography (B). 
A, The T7 RNA polymerase was recombinantly produced in E. coli BL21 (DE3)-RIL CodonPlusTM with 
an N-terminal His6-tag, chromatographically purified, separated by 12 % SDS-PAGE, and visualized via 
Coomassie Brilliant Blue staining. Lane M, molecular mass marker, relative molecular masses (* 1’000) 
are indicated; lane 1, purified T7 RNA polymerase. 
B, Elution diagram of tRNAAla1 purification by anion exchange chromatography: in vitro transcribed 
tRNAAla1 was loaded onto a MonoQ 5/50 GL column and eluted with a linear 20 ml gradient of sodium 
chloride from 0 to 750 mM at a flow rate of 0.5 ml min-1 by monitoring absorbance (280 nm and 260 nm) 
and conductivity. The elution peak corresponding to tRNAAla1 is marked with an asterisk (*). The 
template-containing elution peak is highlighted by a number sign (#). Peaks “N” label nucleoside 
triphosphates. 
(Jahn et al., 1991) 
Affinity chromatography via nickel-chelating sepharose resulted in highly enriched     
T7 RNA polymerase. The observed relative molecular mass for the T7 RNA 
polymerase was in good agreement with the calculated molecular mass of 98’000 (Fig. 
25, A). 
In vitro transcription of the two isoacceptor tRNAAla genes from P. aeruginosa was 
performed using purified T7 RNA polymerase. Efficient in vitro transcription was 
indicated by the visible precipitation of PPi. The subsequent purification of tRNA
Ala1 via 
anion exchange chromatography using a 20 ml gradient (0 - 750 mM NaCl) is shown in 
Figure 25 B. The respective nature of each individual peak was derived from MonoQ 
purification according to Jahn et al. (1991). Excess nucleoside triphosphates were 
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removed at a conductivity of 15 – 45 mS cm-1 (peaks labeled N). tRNAAla1 eluted at a 
conductivity of 54 – 62 mS cm-1 (peak labeled *) followed by the DNA template (peak 
labeled #). The template DNA was precipitated and re-used for a new round of in vitro 
transcription by T7 RNA polymerase. 
tRNA containing fractions of MonoQ purification were ethanol precipitated and 
analyzed by polyacrylamide gel electrophoresis (Fig. 26). 
 
 
Figure 26: PAGE analysis of purified tRA
Ala
 transcripts. 
Polyacrylamide gel analysis of purified in vitro transcribed tRNAAla1 and tRNAAla2. tRNA was separated 
using a 10 % polyacrylamide gel, and visualized via toluidine blue staining. Lane 1, in vitro transcribed 
tRNAAla1 from P. aeruginosa; lane 2, in vitro transcribed tRNAAla2 from P. aeruginosa; lane 3, tRNA 
Mix isolated from E. coli (Sigma Aldrich). 
 
Purified in vitro transcribed tRNAAla1 (PA4280.3) and tRNAAla2 (PA3133.2) from        
P. aeruginosa (Fig. 26, C lane 1, 2) showed identical electrophoretic behavior 
compared to a tRNA Mix from E. coli (lane 3).  
 
 
3.7.2.2  Purification of AlaRS and HisRS and Aminoacylation of tRAs  
Purified tRNAs and tRNA microhelices were aminoacylated by their cognate 
aminoacyl-tRNA synthetase. Therefore, the AlaRS and HisRS from E. coli were 
produced using the E. coli ASKA library clones JW2667 and JW2498 (Kitagawa et al., 
2005), respectively. P. aeruginosa AlaRS was recombinantly produced using E. coli 
Results and Discussion   
  
92 
 
Rosetta (DE3) pLysS. Both AlaRS enzymes and HisRS were purified via His6-tag 
affinity chromatography (Fig. 27). 
 
 
Figure 27: SDS-PAGE analysis of purified AlaRS and HisRS. 
AlaRS and HisRS were recombinantly produced in E. coli with an N-terminal His6-tag, 
chromatographically purified, separated by 12 % SDS-PAGE, and visualized via Coomassie Brilliant 
Blue staining. Lane M, molecular mass marker, relative molecular masses (* 1’000) are indicated; lane 1, 
purified AlaRS from E. coli; lane 2, purified AlaRS from P. aeruginosa; lane 3, purified HisRS from 
E. coli. 
 
Affinity chromatography via nickel-chelating sepharose resulted in highly enriched to 
apparent pure AlaRS from E. coli (calculated molecular mass = 96’032 Da), AlaRS 
from P. aeruginosa (96’865 Da) and HisRS from E. coli (47’029 Da) (Fig. 27, A       
lane 1-3). 
Aminoacylation activity of purified AlaRS from E. coli and P. aeruginosa and HisRS 
from E. coli was analyzed using radioactively labeled alanine or histidine. Based on the 
incorporation of radioactively labeled amino acids the radioactively labeled 
aminoacylated tRNA of an efficient aminoacylation reaction is precipitated by 
trichloroacetic acid and subsequently analyzed by scintillation counting (Fig. 28). 
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Figure 28: Aminoacylation of tRA
Ala1
 (A) and microhelix F (B) by AlaRS and HisRS, respectively, 
from E. coli. 
A, AlaRS aminoacylation reaction was performed at RT according to Swairjo et al. (2004) using 4.75 µM 
of [2,3-3H]-L-alanine, 10 µM of in vitro transcribed tRNAAla1 from P. aeruginosa and 1 µM of purified 
AlaRS from E. coli. 
B, HisRS aminoacylation reaction was carried out at 37 °C according to Connolly et al. (2004) containing 
21.7 µM of [U-14C]-L-histidine, 10 µM of microhelix F (carrying tRNAHis identity elements allowing for 
aminoacylation with histidine) and 1 µM of purified HisRS from E. coli. 
At different time points samples were spotted onto Whatman filters (Whatman, Munich, Germany) and 
the tRNA was precipitated by incubation of the filters in 5 % (w/v) trichloroacetic acid for 10 min. 
Subsequently filters were subjected to 4 ml scintillation liquid and counts per minute were detected using 
a TriCarb 2900 TR scintillation counter. 
 
Figure 28 exemplarily shows the aminoacylation of tRNAAla1 from P. aeruginosa by the 
E. coli AlaRS  and microhelix F by the HisRS from E. coli, respectively. Microhelix F 
carries tRNAHis identity elements allowing for aminoacylation with histidine. For both 
enzymes an increase of precipitated radioactivity was observed, indicating efficient 
aminoacylation activities (Fig. 28, A and B). 
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3.7.2.3  A-PGS Catalysis is ot Dependent on Posttranscriptional 
Modifications of tRA 
tRNA molecules are posttranscriptionally modified in vivo. tRNAAla from E. coli 
contains the five base modifications 4-thiouridine, dihydrouracil, 7-methylguanosine,   
5-methyluridine and pseudouridine (Fig. 29) (Ledoux et al., 2009).  
 
 
 
Figure 29: Comparison of tRA
Ala
 from E. coli carrying posttranscriptional modifications and in 
vitro transcribed unmodified tRA
Ala
 from P. aeruginosa. 
Residues in smaller type are not conserved in the both isoacceptor tRNAAla from E. coli and 
P. aeruginosa, respectively. Differences between tRNAAla from E. coli and P. aeruginosa are highlighted 
in grey. Posttranscriptional base modifications of E. coli tRNAAla are highlighted in green: s4U =             
4-thiouridine, D = dihydrouracil, Gm7 = 7-methylguanosine, T = 5-methyluridine, Ψ = pseudouridine. 
 
In order to investigate if posttranscriptional base modifications are required for A-PGS 
catalysis a coupled in vitro AlaRS/A-PGS activity assay was performed. Therefore, the 
assay mixture contained purified PG and recombinantly purified AlaRS in the presence 
of a commercially available mixture of posttranscriptional modified tRNAs from          
E. coli, or alternatively in the presence of purified unmodified tRNAAla1 or tRNAAla2 
from P. aeruginosa which were produced by in vitro transcription (Sampson and 
Uhlenbeck, 1988) (Fig. 30). The lipids were extracted and 14C labeled compounds were 
analyzed by autoradiography after 2D-TLC (Fig. 30). 
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Figure 30: In vitro formation of A-PG with posttranscriptional modified and unmodified tRA
Ala
. 
In vitro assays with radioactively labeled [1-14C]-L-alanine were performed as described in “Materials 
and Methods”. After incubation of the assay for 1 h at 37 °C, lipids were extracted and subjected to      
2D-TLC analysis. 14C-phospholipids were visualized by autoradiography. A, A-PG synthesis with E. coli 
posttranscriptional modified tRNA Mix as substrate. B, A-PG synthesis using in vitro transcribed 
tRNAAla1 as substrate. C, A-PG synthesis using in vitro transcribed tRNAAla2 as substrate. D, omitting 
GST-A-PGS543-881 from the assay. E, After pre-treatment of the assay mixture with 100 µg ml
-1 RNase A 
for 25 min. A-PG is indicated by arrows. 
 
In Figure 30, A the result of a typical in vitro A-PGS standard assay using a tRNA 
mixture with posttranscriptional base modifications from E. coli as substrate is shown. 
Clear A-PG synthesis was observed. This was also the case for experiments containing 
in vitro transcribed P. aeruginosa tRNAAla1 and tRNAAla2 which do not carry any 
posttranscriptional base modifications (Fig. 30, B, C). Control experiments in the 
absence of GST-A-PGS543-881 or after RNase A pre-treatment did not result in any 
detectable A-PG synthesis (Fig. 30, D, E). 
These experiments clearly indicate that the sequence variations of tRNAAla from E. coli 
and P. aeruginosa (Fig. 29) do not abolish A-PG synthesis. Furthermore, it was 
concluded that the A-PGS tRNA substrate recognition is not dependent on 
posttranscriptional base modifications. 
 
 
3.7.2.4  Substrate Specificity for the Acceptor Stem of Ala-tRA
Ala
 
In in vivo and in vitro analyses of the A-PG formation by the A-PGS from                    
P. aeruginosa it was clearly shown that the catalysis is highly specific for the 
transesterification of the alanyl-moiety from Ala-tRNAAla. Important experiments with 
relevance for the understanding of the substrate specificity of A-PGS have been already 
performed more than 40 years ago, when Gould and co-workers tested several modified 
Ala-tRNA derivatives as substrate for A-PGS from the Gram-positive bacterium            
C. perfringens (Gould et al., 1968). All substrate analogs carrying modified amino acid 
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moieties (N-acetylalanyl-tRNAAla, lactyl-tRNAAla and phenylalanyl-tRNAAla) did not 
sustain any A-PGS activity which clearly indicates that this part of the aminoacylated 
tRNA substrate is recognized with a high degree of specificity. Furthermore, it was 
shown, that the tRNAAla part of the molecule is also relevant for substrate recognition, 
since Ala-tRNACys was not tolerated as an A-PGS substrate (Gould et al., 1968). In the 
present study several microhelices (Fig. 31) were used to mimic the minimal part of the 
tRNAAla acceptor stem to elucidate the main determinants of the P. aeruginosa A-PGS 
catalysis. Specific P. aeruginosa tRNAAla1 was synthesized by in vitro transcription and 
aminoacylated with radioactively labeled alanine. Purified aminoacylated tRNAAla1 or 
microhelices were subjected to the A-PGS in vitro assay. Subsequently, radioactively 
labeled phospholipids were extracted and analyzed by liquid scintillation analysis. The 
relative activity of A-PGS543-881 for in vitro transcribed tRNA
Ala1 (Fig. 31) was set as 
100 % and all other values were related to that. 
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Figure 31: Analysis of A-PGS substrate recognition by using derivatives of tRA
Ala
. 
Comparison of the tRNA sequences of the employed microhelices with the wild type tRNAAla1 sequence 
from P. aeruginosa. Bases that are essential determinants for E. coli AlaRS and for E. coli HisRS are 
highlighted with grey boxes and with a striped box, respectively. All bases that are modified when 
compared to microhelix A are highlighted in bold font. Numbering of microhelices is based on full-length 
E. coli tRNAAla. The relative activity of A-PGS543-881 for in vitro transcribed tRNA
Ala1 was set as 100 %, 
obtained relative activities were related to that. *: Microhelix C - Efficient aminoacylation despite the 
mutated ´discriminator base` A73G has been shown earlier (Hou and Schimmel, 1988). #: Microhelix C 
and D were only inefficiently aminoacylated and therefore analyzed in a coupled AlaRS/A-PGS assay. 
Both microhelices served as active substrate in A-PG synthesis. 
 
When microhelix A (Nagan et al., 1999) was used as tRNA substrate analog a relative 
activity of 90 % was observed. This result clearly indicates that no D-loop, anticodon-
loop, variable loop or TΨC-loop of the tRNA is required for A-PGS substrate 
recognition. The acceptor stem of this microhelix carries only five of the terminal base 
pairings (G1-C72, G2-C71, G3-U70, G4-C69, C5-G68) which can be found in the 
natural substrate. Accordingly all potential identity elements of this minimal substrate 
must be located on this part of the molecule. Therefore, microhelix B was analogously 
analyzed to characterize the potential role of base pair C5-G68. The enclosed mutation 
C5A-G68U resulted in a residual activity of only 40 %, which clearly indicates that this 
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position is highly relevant for A-PGS catalysis. Microhelix E also resulted in 90 % 
activity as observed for reference microhelix A, which clearly indicates that the         
U2-A71 base pair is not an important determinant for the A-PGS. 
Bases G3, U70 and A73 are tRNAAla identity elements of the AlaRS (Nagan et al., 
1999), these positions are essential for the efficient aminoacylation by AlaRS. 
Microhelix C or microhelix D carrying additional mutations at position G1-C72 (among 
other mutated positions) were only inefficiently aminoacylated in the employed assay. 
Therefore, a potential role as tRNA identity elements for A-PGS catalysis was analyzed 
in a coupled AlaRS/A-PGS assay. For both microhelices A-PG synthesis was observed. 
This type of analysis clearly indicated that mutation of position G1-C72 does not 
impede A-PG formation. These two experiments clearly rule out these two positions as 
tRNA identity elements for A-PGS catalysis. 
Very early investigations with chemically modified ´alanyl-moieties` are indicative for a 
highly specific recognition of the alanyl part of the substrate (Gould et al., 1968). To 
substantiate this idea for the A-PGS from P. aeruginosa microhelix F was 
aminoacylated with histidine. Comparison of microhelix F with microhelix E (which is 
an efficient substrate for A-PG synthesis) indicates only three variations of individual 
bases (G-1, C70, C73). This artificial substrate molecule did not result in any detectable 
A-PGS activity, suggesting that the alanyl-moiety is an important determinant for       
A-PGS substrate recognition. However, for this experiment an influence from the three 
base variations of microhelix F cannot be clearly ruled out. 
From the results of the present study it was proposed that substrate recognition of the   
A-PGS enzyme only includes the acceptor stem of the tRNA substrate molecule. It was 
speculated that five of the terminal base pairings and especially the C5-G68 base pair 
are required to direct the alanyl-moiety of Ala-tRNAAla into the active site of the A-PGS 
enzyme. tRNA identity elements for recognition of tRNAAla by the AlaRS from E. coli 
compromise the discriminator base A73, the base pairings G2:C71, G3:U70 and 
G4:C69 of the acceptor stem in combination with base G20 of the D-loop. The 
anticodon loop is not needed for recognition (Hou and Schimmel, 1988; Francklyn and 
Schimmel, 1989; Tamura et al., 1991). Figure 32 summarizes tRNAAla identity elements 
for AlaRS and A-PGS.  
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Figure 32: Comparison of the tRA
Ala
 identity elements for E. coli AlaRS and P. aeruginosa              
A-PGS. 
tRNA Identity elements for recognition by AlaRS and A-PGS are highlighted in grey. A-PGS 
additionally recognizes the alanyl-moiety. Residues in smaller type are not conserved in the both 
isoacceptor tRNAAla from E. coli and P. aeruginosa, respectively. Posttranscriptional base modifications 
of E. coli tRNAAla are highlighted in green: s4U = 4-thiouridine, D = dihydrouracil, Gm7 =                        
7-methylguanosine, T = 5-methyluridine, Ψ = pseudouridine. 
 
Comparison of tRNA identity elements for both enzymes, the AlaRS and A-PGS, shows 
that major elements are located in the acceptor stem of the tRNA. 
The glutamyl-tRNA reductase from E. coli catalyzes the initial step of tetrapyrrole 
biosynthesis by the NADPH-dependent reduction of tRNA-bound glutamate to 
glutamate-1-semialdehyde (Smith et al., 1992). For this enzyme it was shown by 
analysis of 51 tRNAGlu variants, that the unique tertiary core structure of tRNAGlu plays 
an important role in substrate recognition. Besides this, neither the acceptor stem nor the 
anticodon stem are major tRNA identity elements for glutamyl-tRNA reductase 
(Randau et al., 2004) in contrast to the glutamyl-tRNA synthetase (Sekine et al., 1996). 
Furthermore, mischarged Gln-tRNAGlu was shown to serve as glutamyl-tRNA reductase 
substrate indicating a relaxed specificity for the amino acid residue (Lüer et al., 2007). 
This might indicate that tRNA-dependent enzymes using the same tRNA as substrate 
recognize in some extent different structures and bases of tRNA. 
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3.7.3 Specificity of PG Substrate Recognition 
 
Phospholipids from E. coli are preferentially esterified with palmitic acid, hexadec-9-
enoic acid and octadec-11-enoic acid, whereas phospholipids from P. aeruginosa are 
predominantly condensed with palmitic acid and methylene octadecanoic acid (Hancock 
and Meadow, 1969; Cronan and Rock, 1996). The employed in vivo activity assay 
might indicate that minor modifications of the fatty acid side chains of PG are tolerated 
by the A-PGS system. However, there are several investigations for phospholipid 
biosynthetic enzymes showing a high degree of fatty acid specificity (MacDonald et al., 
1988; Henneberry et al., 2002). Besides the possibility to transplant active enzyme from 
several organisms into E. coli, there is no detailed experimental information about the 
specificity of aa-PGS towards the fatty acid residues on phosphatidylglycerol. 
Furthermore, only one publication deals with the head group specificity of L-PGS from 
S. aureus (Lennarz et al., 1967). 
To determine the specificity of A-PGS substrate recognition several derivatives of PG 
(Table 7) were analyzed in the in vitro activity assay. The most abundant fatty acids of 
the employed standard PG from egg yolk lecithin (Sigma-Aldrich) are oleic acid (18:1; 
(9Z)-octadec-9-enoic acid), linoleic acid (18:2; cis, cis-9,12-octadecadienoic acid) and 
palmitic acid (16:0; hexadecanoic acid) (Fredriksson et al., 2006) (compare Table 7). In 
parallel control reactions in the absence of the phospholipid were employed. 
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Table 7: Analysis of A-PGS substrate recognition by using derivatives 
of phosphatidylglycerol. 
Structures of the employed analogs of PG are indicated. R represents the 
polar head group of the phospholipid, FA1 – FA4 represents the individual 
fatty acid residues. For diphosphatidylglycerol (cardiolipin from bovine 
heart) (compound 5) the most abundant fatty acid residue is linoleic acid 
(Schlame and Otten, 1991). The relative activities of the individual 
compounds in the in vitro assay are indicated, standard deviations are 
± 10 %. 
  
 
 
To analyze the influence of the overall structure of the individual fatty acid, a PG 
molecule carrying two saturated C16 fatty acids, each modified by fourfold methylation 
(compound 1) was used. With this substrate no reduction of the specific activity was 
observed, which might indicate, that the integrity of the overall structure of the 
hydrophobic side chain (methylation or presence of double bonds) is not relevant for   
A-PGS substrate recognition. When a PG derivative containing two C6 fatty acids 
(instead of the usual C16 or C18 compounds) (compound 2) was investigated a residual 
activity of 20 % was determined which again demonstrates that the overall lipid fatty 
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acid residues are not recognized by the enzyme in detail. This conclusion was 
corroborated by using a PG derivative carrying solely one C18 fatty acid (compound 3). 
This truncated substrate molecule still resulted in a residual activity of 20 %. During A-
PG catalysis the 2’ hydroxy group or alternatively the 3’ hydroxy group of the 
glycerophosphate moiety of PG nucleophilically attacks the carboxylate function of 
Ala-tRNAAla. To study the functional role of the polar head group of the phospholipid 
for A-PGS substrate recognition a truncated substrate carrying an ethylene glycol 
phosphate (compound 4) and a larger substrate carrying a diphosphatidylglycerol 
(additional with carrying four fatty acid residues) (compound 5) instead of the glycerol 
phosphate were also analyzed. These both substrate analogs did not result in any 
detectable A-PGS activity. 
From these experiments it was concluded that the fatty acid residue of PG is not an 
important determinant for A-PGS substrate recognition, whereas the polar head group 
of A-PG is specific recognized. 
 
 
3.8 Towards an Enzymatic Mechanism of A-PGS 
 
 
The analysis of the enzymatic mechanism of A-PGS (or of orthologous enzymes) is of 
central importance for all subsequent efforts for the identification of efficient inhibitor 
molecules. For this purpose, the established in vitro activity assays in combination with 
classical chemical modification experiments and with an extended mutagenesis study 
was employed. Generally, there is the possibility of two different biosynthetic strategies 
for the formation of A-PG: A direct transesterification of the alanyl-moiety of Ala-
tRNAAla onto the 2´ or 3´ hydroxyl group of phosphatidylglycerol or alternatively a 
covalent catalysis via an enzyme localized alanyl ester intermediate. A direct 
transesterification mechanism might be metal ion assisted whereas formation of a 
covalent reaction intermediate requires the presence of a highly conserved nucleophilic 
residue (seryl, aspartyl, glutamyl, histidyl or cysteinyl). 
A-PGS homolog proteins contain a highly conserved hydrophilic C-terminal domain 
sharing an overall of ~ 30 % sequence identity, and a less conserved N-terminal 
transmembrane domain (chapter 3.1). Furthermore, the truncated A-PGS543-881 variant 
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from P. aeruginosa is sufficient for A-PG catalysis (chapter 3.6.1, 3.6.2), indicating that 
most probably the active site is located in this hydrophilic C-terminal domain. 
It was suggested, that the essential amino acid residues for the recognition of the tRNA 
and the phospholipid substrate are conserved in all A-PGS homolog proteins. Therefore, 
highly conserved amino acid residues were exchanged by site directed mutagenesis, 
followed by a kinetic analysis of purified recombinant mutant A-PGS543-881 proteins. In a 
second approach, purified recombinant wild type A-PGS543-881 protein was modified by the 
reaction of different inhibitory compounds with specificity for specific amino acid residues 
or treated with chelating agents. Subsequently, these modified proteins were tested for 
activity. 
 
 
3.8.1 A-PGS Catalysis is ot Dependent on a Highly Conserved ucleophilic 
Residue 
 
Presence of an activated nucleophilic side chain is an important feature of enzymes 
performing covalent catalysis (Scheiner and Lipscomb, 1975; Moser et al., 1999; 
Perozich et al., 1999; Iqbal et al., 2009). In many cases compounds like 
phenylmethylsulfonyl fluoride (PMSF), diisopropyl fluorophosphate (DIPFP) 
(inhibiting serine residues) or iodacetamide (cysteine residues) allow for the direct 
chemical modification of such active site nucleophiles resulting in the covalent 
inactivation of the enzyme. When the A-PGS543-881 from P. aeruginosa was treated with 
these three chemical modification reagents at concentrations up to 10 mM 
(iodacetamide) or up to 1 mM (PMSF and DIPFP) no significant loss of A-PGS activity 
was observed (Table 8). 
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Table 8: Enzymatic activity of A-PGS543-881 after chemical modification under in vitro conditions. 
A-PGS543-881 was purified in the absence of reducing agents and subsequently modified with 
phenylmethylsulfonyl fluoride, diisopropyl fluorophosphate and iodacetamide, respectively. After an 
extensive dialysis step proteins were subjected to the standard in vitro assay using E. coli extracts as 
described in “Materials and Methods”. The relative enzymatic activity of the corresponding unmodified 
A-PGS543-881 was set as 100 %, and all other values were related to this value. Assays were performed in 
duplicate; standard deviations are ± 10 %. 
 
modifying agent concentration [mM] relative enzymatic activity [%] 
phenylmethylsulfonyl fluoride 0.1 100 
     (PMSF) 1 100 
diisopropyl fluorophosphate 0.1 100 
     (DIPFP) 1 100 
iodacetamide 1 100 
 10 90 
 
To substantiate these initial observations highly conserved amino acid residues with 
potential relevance for the catalytic mechanism of A-PGS were identified in an amino 
acid sequence alignment composed of A-PGS and L-PGS proteins from various 
organisms (Fig. 33). 
 
Lm              HLWLVGFVGVFIAVVSLVIIYIYLSTTKEKLGSPFEAVKVREHLAKWG-GNEVSHTMFLR 546 
Li              HLWLVGFVGVFIAVVSLVIIYIYLSTTKEKLGSPFEAVKVREHLAKWG-GNEVSHTMFLR 546 
Cp2             KFGFIAFALVTVIYVAIYFLNIRRKIPVKTFDQCSEYIEK--IIEEYK-GDSLTHLVFLK 539 
Sa              VLRYYFWLTILIIAIIIGMIAWLFDYQFSKVRISSKIEDCEEIINQYG-GNYLSHLIYSG 545 
Sx              ILRYYFWITILLVAIIVGVIVWWFEYRYRSSNSRDNIATCESIIDKYN-GNYLSHLMYSG 545 
Bc              VKRSALAAAFFVPTFLLIGSLIANRYRNEFPGQPANDKRLQNFLDEHG-GNVLSHLGFLG 563 
Ba              VKRSALAAAFFVPTFLLIGSLIANRYRNEFPGQPANDKRLQNFLDEHG-GNVLSHLGFLG 563 
Bs              ITHATIMAIIIVPLFFLIFTVVYHK-RTKPIGEKADPERLAAFLNEKG-GNALSHLGFLG 556 
Cp1             YLRIALFTYISFIIFVIIWYLTMPKIEDDERYMDADLEKVSKFFKEIDYGTIFSHLVYLK 265 
Pa              ALRAALGSCLLLLALALGWLLRAAPPAIREPN-AEELQRAARIIRHSD--QPDGGLALTG 578 
                         . .  . :                  .       : .               
 
Lm              DKLLFWAAEGEVLFSYRIIADKMVIMGEPTGNMDKMEAAIEEVMMNADRFGYRPVFYEVR 606 
Li              DKLLFWAANGEVLFSYRIIADKMVIMGEPTGNMEKMEDAIEEVMTNADRFGYRPVFYEVR 606 
Cp2             DKYIYLNEDKDLFIQYEVYGDKLFVLGNPVGNNENLFREIEKFCEYADNYGYTPVFYQVN 599 
Sa              DKQFFTNENKTAFLMYRYKASSLVVLGDPLGDENAFDELLEAFYNYAEYLGYDVIFYQVT 605 
Sx              DKKFFINDNKDAFVMYRYHNNTYIILGDPIGNSESFYSLLEAFYKEAEYLGYDIIFYQVT 605 
Bc              DKQFFFSSDGKALLLFSITGKRLVVLGDPIGDPSSYRTVLQEFLAEADRFGYICVFYQIE 623 
Ba              DKQFFFSSDGKALLLFSITGKRLVVLGDPIGDPSSYRTVLQEFLAEADRFGYICVFYQIE 623 
Bs              DKRFYFSSDGNALLLFGKIARRLVVLGDPSGQRESFPLVLEEFLNEAHQKGFSVLFYQIE 616 
Cp1             DKKVFWANEGESLIMYSKYKDKIIVLGDPIATKENLYSCIEEFQAFTNLYGYDVVFYEIE 325 
Pa              DKALLFHESDDAFLMYARRGRSMIALYDPIGPAMQRAELIWQFRDLCDLHHARPVFYQVR 638 
                ** .    .   :. :       . : :* .        :  .    .      :**::  
                       D579 -> D579A, D579N 
 
Lm              GTMIPYLHDHGFDFIKLGEEGFVDVQNFTMS--GKKKKGERALMNKLEREGYTFEIIEPP 664 
Li              GTMIPYLHDHGFDFIKLGEEGFVDVQNFTMS--GKKKKGERALMNKLDREGYTFEIIQPP 664 
Cp2             EEMISYLHSNGYDFMKIGEEAKVDVKEFKVV--GNKMKSLKTSRSKVTKEGYTFHMVEPP 657 
Sa              DQHMPLYHNFGNQFFKLGEEAIIDLTQFSTS--GKKRRGFRATLNKFDELNISFEIIEPP 663 
Sx              DKYMSLYHSFGNQFFKLGEEAVINLTSFTTS--GKKKRGLRATLNKLDDLGYSFEVLEPP 663 
Bc              SKWMSLYHDFGYNFFKLGEEAVVDLNTFTIT--GKKRAGMRATFNRFEREGYTFSIHQPP 681 
Ba              SKWMSLYHDFGYNFFKLGEEAVVDLNTFTIT--GKKRAGMRATFNRFEREGYTFSIHQPP 681 
Bs              REDMALYHDFGYNFFKLGEEAYVDLNTFTLT--GKKKAGLRAINNRFEREEYTFHVDHPP 674 
Cp1             EKNFSTYHDAGYYFFKLGEEARIDLEEFNLI--GSKKSAFRNTLRRVEREGYNFSIIEPP 383 
Pa              AENLPFYMDIGLTALKLGEEARVDLLRFDLENKGKEMKDLRYTWNRGQRDGLALEFHEP- 697 
                   :.   . *   :*:***. :::  *     *.:    :    :       : . .*  
                                  E657 -> E657D, E657Q 
                 E658 -> E658D, E658Q 
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Lm              FNHDTWTTLRAVSDEWLDGR--EEKGFSLGFFDTYYLEQAPIAIAKNGE-GTIVGFASMM 721 
Li              FNNEMWKTLRAVSDEWLDGR--EEKGFSLGFFDTYYLEQADIALAKNAD-GTVVGFASMM 721 
Cp2             FSREFLDYLKEISDEWLDGR--KEKGFSVGFFDEDYLNKAPIAILRDRE-GEIKAFANIM 714 
Sa              FSTEFINELQHVSDLWLDNR--QEMHFSVGEFNEEYLSKAPIGVMRNEE-NEVIAFCSLM 720 
Sx              FSQQMITDLKAISDDWLADK--NEMHFSVGSFDEHYISQAPIGVLKDNE-QSVIAFCTLM 720 
Bc              FSDELFEELRKVSDAWLGGK--KEKSFSLGYFDREYISRAPIATLSDAD-GKIIAFTTFM 738 
Ba              FSNELFEELRKVSDAWLGGK--KEKSFSLGYFDHEYISRAPIATLSDAD-GKIIAFTTFM 738 
Bs              FSDAFLEELKQISDEWLGSK--KEKGFSLGFFDPSYLQKAPIAYMKNAE-GEIVAFANVM 731 
Cp1             FNNEVVSQLKEISDKWLGDR--KEKGFSLGWFSEDYIQRSPIAILKNEEENKIMGFVTIM 441 
Pa              -GQAPLDELKAISDAWLGGKQVREKGFSLGRFTPAYLNFFRIAIVRHQG--KPVAFANLL 754 
                 .      *: :** ** .:  .*  **:* *   *:.   *.   .       .* ..: 
           S709 -> S709A, S709N 
    D710 -> D710A, D710N 
       E720 -> E720Q 
                                  S724 -> S724A, S724N 
 
Lm              PSYTDE-MTSIDLMRYSKEAPSGIMDFLFINLFEKAKEDGFQTFNAGMAPLANVGESKYA 780 
Li              PSYTDE-MTSIDLMRYSKEAPSGIMDFLFINLFEKAKEDGFQTFNAGMAPLANVGESKYA 780 
Cp2             YMYDDE-SFSVDLMRFSKNTPRGVMDFMFINLIEYGKEKGYEIFNMGMAPLANVGLSKYA 773 
Sa              PTYFND-AISVDLIRWLPELDLPLMDGLYLHMLLWSKEQGYTKFNMGMATLSNVGQLHYS 779 
Sx              PTYYNG-VISVDLIRWKQDIELPLMDSLYLNMLLWSKDNNYEHFNMGMATLSNVGQIPYS 779 
Bc              PVYQDG-SLSVDLMRYYPDAPSGIMDAIFIHLFQWAKENEYHSFNIGMAPLSNVGLSTQS 797 
Ba              PVYQDG-SLSVDLMRYYPDAPSGIMDAIFIHLFQWAKENEYHSFNIGMAPLSNVGLSTQS 797 
Bs              PMYQEG-EISVDLMRYRGDAPNGIMDALFIRMFLWAKEEGCTSFNMGMAPLANVGTAFTS 790 
Cp1             DANDGGETVAIDLMRIDKDAPNASMDYLMLNLFLTFKEKGYKYFSLGEAPLSNVGFNTHS 501 
Pa              ETDSRE-LASLDLMRVHPDAPKLTMEFLMLGLILHYKAQGHARFSLGMVPLAGLQPRRGA 813 
                         ::**:*   :     *: : : ::   * .    *. * ..*:.:     : 
´               S763 -> S763A, S763N 
 
Lm              FLGERLAGLVYRYSQGFYGFKGLRNFKSKYVTEWEQKFVAFRKRSSIAFTMLQLMILVGK 840 
Li              FLGERLAGLVYRYSQGFYGFKGLRNFKSKYVTEWEQKFVAFRKRSSIAFTMLQLMILVGK 840 
Cp2             FWNEKLALQFYENGQALYSFKGLRRFKEKFSHNWEYKYIAYRRNTSILITVIQAAIVCSR 833 
Sa              YLRERLAGRVFEHFNGLYRFQGLRRYKSKYNPNWEPRFLVYRKDNSLWESLSKVMRVIRH 839 
Sx              FYGERIAGRVFEHFNGLYRFQGLRRYKEKFNPKWEPRFLVYRKHQSLWVSMLKVMRVIRK 839 
Bc              FWSERVAAAIFNNVRYTYSFSGLRHFKEKYKPAWSGKYLAFRKNHSLPITMLSVTKLIGK 857 
Ba              FWSERVAAAIFNNVRYTYSFSGLRHFKEKYKPAWSGKYLAFRKNHSLPITMLSVTKLIGK 857 
Bs              FWSERFAAVIFNNVRYMYSFSGLRAFKEKYKPEWRGKYLAYRKNRSLSVTMFLVTRLIGK 850 
Cp1             HLQEKLARLVYNSGNIFYSFDGLRRYKSKFSPIWQPRYLAYPKFMSLPEVFINLCLLIAN 561 
Pa              PLTQRLGALVFRRGEQFYNFQGLRRFKDKFQPDWEPRYLAVPAGLDPLVALADTAALIAG 873 
                   ::..  .:.  .  * *.*** :*.*:   *  :::.     .    .     :    
 
Lm              KRPLANSQVVLDFPLEEETKKPDSE 865 
Li              KRPLANNQVVLDFPLNEEIEKPDSE 865 
Cp2             NRNVDESIVVRNLKSLIK------- 851 
Sa              K------------------------ 840 
Sx              NN----------------------- 841 
Bc              RKNS--------------------- 861 
Ba              RKNS--------------------- 861 
Bs              SKKDSV------------------- 856 
Cp1             SKERVEKK----------------- 569 
Pa              GLTGLVKR----------------- 881    
 
Figure 33: Sequence alignment of the C-terminal domain of A-PGS homolog proteins. 
Homologous A-PGS proteins from L. monocytogenes (Lm), L. innocua (Li), C. perfringens MprF2 (Cp2), 
S. aureus (Sa), S. xylosus (Sx), Bacillus cereus (Bc), B. anthracis (Ba), B. subtilis (Bs), C. perfringens 
MprF1 (Cp1) and P. aeruginosa (Pa) were assembled with Clustal W2 (Larkin et al., 2007). Identical 
residues are indicated by an asterisk, conserved substitutions by a colon, and semiconserved substitutions 
by a period. The first amino acid of the C-terminal hydrophilic A-PGS543-881 variant is highlighted in 
black. The proposed C-terminal helix is underlined. Amino acid positions that have been mutagenized are 
highlighted in grey, point mutations that have been analyzed in the present study are indicated. The 
complete sequence alignment can be found in the appendix. 
 
An overall of 8 amino acid residues which potentially might function as an active site 
nucleophile (D579, D710, E657, E658, E720, S709, S724, S763; P. aeruginosa 
numbering) were found 100 % conserved in all available A-PGS or L-PGS sequences of 
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the database. However, the employed sequence alignment did not reveal a highly 
conserved cysteinyl or histidyl residue. Therefore, involvement of a possible thiol ester 
intermediate was ruled out. To provide good insight into the functional role of the 
identified residues, each of these amino acid positions was mutagenized into a residue 
with a comparable size (conservative exchange) or alternatively into a residue with 
differing size or charge characteristics. The initial characterization of all mutant 
enzymes was performed in an E. coli in vivo activity assay analogously as described in a 
recent publication (Ernst et al., 2009). This type of analysis only revealed mutant 
proteins showing activities similar to the wild type enzyme (E657Q, E658D, E658Q, 
E720Q, D710A, D710N, S709A, S709N, S763A, and S763N), mutants with decreased 
activities (D579A, D579N, E657D, and S724A) and with no detectable A-PGS activity 
(S724N) (Table 9). However a precise quantification of the relative A-PGS activity was 
hampered due to the accumulation of comparable amounts of A-PG in the bacterial 
membrane of E. coli despite greatly varying enzymatic activities (time course 3 h). 
Though, the newly established in vitro assay using E. coli extracts allowed for the 
accurate determination of the specific activity of mutant proteins under initial-rate 
conditions. Therefore, lipid samples of the in vitro assay using E. coli extracts taken at 
various time points were analyzed by scintillation counting. All activities indicated in 
Table 9 are averaged on the basis of three independent experiments. 
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Table 9: Overview of the relative activity of A-PGS543-881 mutant proteins. 
Standard in vivo assays and in vitro assays using E. coli extracts were performed as described in 
“Materials and Methods”. The specific activity observed for wild type A-PGS543-881 was set as 100 % and 
all other values of mutant proteins were related to this value. A-PG formation in the in vivo assay was 
classified as: +++, activity comparable to wild type enzyme; +, decreased activity when compared to wild 
type enzyme; -, no detectable A-PGS activity. 
 
mutation in vivo activity relative enzymatic activity ± 
standard deviation [%] 
Wild type A-PGS543-881 + + + 100 ± 0 
D579A +  3 ± 1 
D579N + 5 ± 2 
E657D + 4 ± 1 
E657Q + + + 21 ± 4 
E658D + + + 28 ± 7 
E658Q + + + 19 ± 3 
S709A + + + 5 ± 1 
S709N + + + 17 ± 3 
D710A + + + 26 ± 3 
D710N + + + 30 ± 3 
E720Q + + + 10 ± 2 
S724A + 7 ± 2 
S724N - 0 ± 0 
S763A + + + 23 ± 5 
S763N + + + 11 ± 1 
 
Numerous mutagenesis studies for enzymes employing a transient covalent bond of the 
substrate with residues in the active site resulted in a complete loss of enzymatic 
activity when the active site nucleophile residue was mutagenized (Carter and Wells, 
1988; Corey and Craik, 1992; Moser et al., 1999). However, mutagenesis of residues 
serine 709 and 763 into asparagine residues resulted in residual A-PGS activities of      
17 ± 3 % and 11 ± 1 % when compared to the wild type enzyme. Also when those two 
residues were altered into alanine, residual activities of 5 ± 1 % and 23 ± 5 % were 
observed which rules out a potential role as an active site nucleophile. In contrast to 
this, mutant protein S724N did not sustain any A-PG formation. But the analysis of the 
more conservative mutant S724A clearly indicated a residual activity of 7 ± 2 %. This 
observation is not compatible with the involvement of a S724 nucleophile in the active 
site of A-PGS. 
The significantly reduced activities of the employed mutant proteins might indicate that 
residues S709, S724 and S763 play an important role in A-PGS substrate recognition. 
Steric effects (S724A, S724N, S763A, and S763N) and/or the reduced ability for the 
formation of salt bridges might be responsible for the resulting activities. 
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Mutation experiments for residues aspartate 579 and 710 revealed an important role of 
these residues for A-PGS catalysis as indicated by residual activities of 3 ± 1 % and 
5 ± 2 % (D579A, D579N) or 26 ± 3 % and 30 ± 3 % (D710A, D710N). Furthermore 
mutation of residues glutamate 657, 658 and 720 resulted in systematically decreased 
A-PGS activities of 4 ± 1 % or 21 ± 4 % (E657D, E657Q), 28 ± 7 % or 19 ± 3 % 
(E658D, E658Q) and of 10 ± 2 % (E720Q). Obtained values for this set of mutant 
enzymes argue for the involvement of these glutamate and aspartate residues in A-PGS 
catalysis. Steric effects or the absence of polar interactions upon substrate binding might 
be responsible for the reduced activities. 
Taking into account the results of the chemical modification experiments and the results 
of the mutagenesis study it was concluded that the P. aeruginosa A-PGS does not 
employ a covalent catalysis. Therefore, a direct transesterification mechanism is 
concluded. 
 
 
3.8.2 A-PGS Catalysis is ot Dependent on Metal Ions 
 
To further elucidate the principles of A-PGS catalysis involvement of metal ions was 
analyzed. For this purpose the potential inhibitory effect of the chelating agents 
ethylenediaminetetraacetic acid and 1,10-phenanthroline were analyzed (Table 10). 
 
Table 10: Enzymatic activity of A-PGS543-881 after treatment with chelating agents under in vitro 
conditions. 
A-PGS543-881 was purified in the absence of reducing agents and subjected to the standard in vitro assay 
using E. coli extracts or in vitro activity assay as described in “Materials and Methods”. 
Ethylenediaminetetraacetic acid and 1,10-phenanthroline, respectively, were added directly to the assays. 
The relative enzymatic activity of the corresponding unmodified A-PGS543-881 was set as 100 %, and all 
other values were related to this value. Assays were performed in duplicate, standard deviations are          
± 10 %. n.t. = not tested. 
 
modifying / chelating agent concentration 
[mM] 
relative activity 
determined under in 
vitro conditions using    
E. coli extracts [%] 
relative  
 in vitro activity [%] 
ethylenediaminetetraacetic  3 100 100 
     acid (EDTA) 10 100 100 
 20 n.t. 100 
1,10-phenanthroline 1 100 n.t. 
 3 n.t. 100 
 5 n.t. 75 
 10 45 35 
 20 n.t. 20 
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When the in vitro activity assay was performed in the presence of up to 20 mM EDTA 
or up to 5 mM 1,10-phenanthroline no significant inactivation was observed. However, 
in the presence of 10 mM and 20 mM 1,10-phenanthroline a residual activity of 
approximately 35 % and 20 %, respectively, was determined. Since these experiments 
could not clearly rule out the involvement of a “tightly bound” metal ion the purified 
protein GST-A-PGS543-881 was concentrated (10.5 mg ml
-1 - 161 µM) and subjected to 
inductively coupled plasma - mass spectrometry (ICP-MS) experiments (Table 11). 
 
Table 11: Determination of metal ion content by ICP-MS analysis. 
Purified GST-A-PGS543-881 protein was concentrated and subjected to inductively coupled plasma - mass 
spectrometry (ICP-MS) experiments. In parallel the sole GST protein (4 mg ml-1 - 154 µM) was analyzed 
to determine the background level of the employed purification strategy. Experiments were performed in 
duplicates. 
 
metal ion 
 
concentration of metal ion in 
GST-A-PGS543-881 [µM] 
concentration of metal ion 
in GST [µM] 
Cu2+ 0.3 0.2 
Fe2+ 4.3 1.6 
Mg2+ 18.8 1.2 
Mn2+ 0.4 0.02 
Ni2+ 0.2 0.2 
Zn2+ 0.9 0.2 
 
This type of analysis did not reveal any ferrous, manganese, nickel, copper, or zinc ions 
above the background level of the employed buffer system (Table 11). The purified 
protein fraction only revealed substoichiometric amounts of magnesium (19 µM). In the 
context of the dramatically higher chelator concentrations of the employed inhibition 
experiments (10 mM - 20 mM) metal-dependent A-PGS catalysis was ruled out. 
 
 
3.8.3 Chemical Modification of Lysine and Arginine Residues 
 
Chemical modification experiments in the presence of citraconic anhydride 
(modification of lysine residues) and p-hydroxyphenylglyoxal (modification of arginine 
residues) at concentrations of up to 10 mM were performed to identify lysine and 
arginine residues which are involved in the catalytic mechanism of A-PG synthesis 
(Table 12). 
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Table 12: Enzymatic activity of A-PGS543-881 after treatment with chelating agents under in vitro 
and in vitro (using Ala-tRA
Ala
) conditions. 
A-PGS543-881 was purified in the absence of reducing agents and subsequently modified with citraconic 
anhydride and p-hydroxyphenylglyoxal, respectively, subjected to the standard in vitro assay using E. coli 
extracts or in vitro assay as described in “Materials and Methods”. After an extensive dialysis step 
proteins were subjected to the standard in vitro A-PGS543-881assays. The relative enzymatic activity of the 
corresponding unmodified A-PGS543-881 was set as 100 %, and all other values were related to this value. 
Assays were performed in duplicate, standard deviations are ± 10 %. n.t. = not tested. 
 
modifying agent concentration 
[mM] 
relative activity 
determined under in vitro 
conditions using E. coli 
extract [%] 
relative  
 in vitro activity [%] 
citraconic anhydride 2 100 n.t. 
 10 100 n.t. 
p-hydroxyphenylglyoxal 0.5 90 n.t. 
 1 90 100 
 5 60 n.t. 
 10 60 100 
 
Although, amino acid exchanges of K547, K621, R734A, and K806 of S. aureus MprF 
lead to completely abrogate L-PG synthesis under in vivo conditions (Ernst et al., 2009) 
the results of chemical modification experiments of P. aeruginosa A-PGS do not 
indicate the critical involvement of lysine and arginine residues in A-PGS catalysis. 
 
 
3.9 The Postulated C-terminal Helix of A-PGS is Essential for A-PG 
Synthesis 
 
Bioinformatical analysis revealed a transmembrane segment located at the C-terminus 
of the A-PGS protein (Fig. 7). This putative transmembrane helix was elucidated for the 
involvement in A-PG catalysis. Based on theoretical analyses of the aa-PGS from 
B. subtilis and C. perfringens an additional C-terminal transmembrane helix was 
proposed (Roy and Ibba, 2009). Computational analysis of the overall domain 
architecture of P. aeruginosa A-PGS also revealed a potential transmembrane helix 
(amino acid residues 860 to 879) located at the C-terminus of the membrane protein 
(Fig. 7). To elucidate the functional role of this putative transmembrane segment of     
A-PGS two C-terminally truncated variant proteins were analyzed for activity:            
A-PGS1-855N and A-PGS543-855N. For investigation of in vivo activity, A-PGS1-855N and 
A-PGS543-855N were recombinantly overproduced in E. coli TOP10 and BL21 (λDE3), 
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respectively. The extracted lipids were separated by 2D-TLC and visualized as outlined 
before (Fig. 34). 
 
 
Figure 34: Lipid composition of E. coli cells overproducing different A-PGS variants. 
E. coli BL21 (λDE3) or TOP10 harboring the respective plasmid were cultivated at 37 °C and 200 rpm to 
an OD578 of 0.5. Recombinant gene expression in BL21 (λDE3) and TOP10 was induced by addition of 
50 µM IPTG and 0.02 (w/v) % L-arabinose, respectively. Cells were further incubated for 3 h or 4 h and 
harvested. The lipids were extracted, separated by 2D-TLC and visualized by spraying with 5 % 
molybdatophosphoric acid. Lipid composition of: A, A-PGS543-855N overproducing BL21 (λDE3).             
B, A-PGS543-881 overproducing BL21 (λDE3). C, A-PGS1-855N overproducing TOP10. D, A-PGS 
overproducing TOP10. A-PG is indicated by an arrow. PE = phosphatidylethanolamine, PG = 
phosphatidylglycerol, DPG = diphosphatidylglycerol. 
 
In the employed in vivo activity assay the A-PGS1-855N mutant did not sustain any 
detectable A-PGS activity (Fig. 34, C). This was also the case when the purified mutant 
protein A-PGS543-855N was analyzed in the in vitro assay using E. coli extracts (data not 
shown). However, under in vivo conditions A-PG formation for the A-PGS543-855N 
mutant was observed (Fig. 34, A). The amount of A-PG was significantly decreased in 
comparison to A-PGS543-881 variant (Fig. 34, B) indicating a critical involvement of the 
C-terminal transmembrane domain into catalysis. 
From these results it was concluded that amino acid residues 856 - 881 play a crucial 
role for the activity of P. aeruginosa A-PGS. Due to the hydrophobic nature of this 
protein segment a potential involvement in the recognition of the lipid substrate might 
be speculated. 
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3.10 Cellular Localization of A-PGS and A-PG in P. aeruginosa 
 
3.10.1 Biochemical Approach for the Subcellular Localization of A-PGS 
 
Bioinformatic analysis identified A-PGS as a transmembrane protein containing 14 
transmembrane helices located in the cytoplasmic membrane. To experimentally 
elucidate cellular localization of A-PGS, membrane fractions were prepared from 
E. coli strain TOP10 carrying pBAD-His-A/PA0920. To determine the precise 
localization of A-PGS in E. coli, a separation of the cytoplasmic and outer membrane 
fraction was performed using a well-established procedure (Yamato et al., 1975). The 
concluded localization of A-PGS in the cytoplasmic membrane was further elucidated 
using a second independent approach. This experiment made use of the ability to 
selectively solubilize membrane proteins of the cytoplasmic membrane using sarcosyl 
as a detergent (Eitel and Dersch, 2002) (Fig. 35). 
 
 
Figure 35: SDS-PAGE analysis of membrane fraction preparation and separation of cytoplasmic 
and outer membrane.    (Yamato et al., 1975; Eitel and Dersch, 2002). 
E. coli TOP10 harboring pBAD-His-A/PA0920 was cultivated as described in “Materials and Methods”. 
The membrane fraction was purified by discontinuous sucrose gradient centrifugation. The cytoplasmic 
and outer membrane was separated by two independent approaches according to Yamato et al. (1975) and 
Eitel & Dersch (2002). Proteins were separated by 9 % SDS-PAGE, and visualized via Coomassie 
Brilliant Blue staining. Lane M, molecular size marker, relative molecular masses as indicated (*1’000). 
Lane 1, cytosolic fraction after cell disruption. Lane 2, insoluble fraction after cell disruption. Lane 3, 
membrane fraction obtained by discontinuous sucrose gradient centrifugation. Lane 4, Triton X-100-
solubilized membrane proteins. Lane 5, purified A-PGS after affinity chromatography using chelating 
sepharose. Lane 6, cytoplasmic membrane fraction prepared as described in Yamato et al. (1975). Lane 7, 
outer membrane fraction prepared as described in Yamato et al. (1975). Lane 8, sarcosyl-solubilized 
cytoplasmic membrane proteins according to Eitel & Dersch (2002). Lane 9, outer membrane proteins 
after sarcosyl solubilization method according to Eitel & Dersch (2002). The position of A-PGS is 
indicated by an arrow. It is important to mention that A-PGS samples had to be incubated at 40 °C 
instead of the 95 °C with standard SDS-PAGE loading buffer to prevent the membrane protein from 
aggregation. 
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After cell disruption and centrifugation, A-PGS was detected in the insoluble and the 
membrane fraction (Fig. 35, lane 2, 3) but was completely absent from the cytosolic 
fraction (Fig. 35, lane 1). For purification of A-PGS the obtained membrane fraction 
was solubilized using Triton X-100 (Fig. 35, lane 4). Approximately 80 % of the overall 
A-PGS protein was found solubilized. Furthermore, in the solubilized fraction A-PGS 
appeared as the prominent protein band. To further purify A-PGS, a standard protocol 
for the purification of His6-tagged proteins in the presence of 9 mM Triton X-100 was 
employed. A-PGS was successfully eluted in the presence of 500 mM imidazole (Fig. 
35, lane 5). 
The separation of the cytoplasmic and outer membrane fraction according to Yamato et 
al. (1975) revealed A-PGS as one of the most dominant proteins of the cytoplasmic 
membrane fraction (Fig. 35, lane 6), whereas A-PGS was almost completely absent in 
the outer membrane (Fig. 35, lane 7). Also, the selective solubilization of cytoplasmic 
membrane proteins using sarcosyl (Eitel and Dersch, 2002) determined the A-PGS 
protein as the most dominant protein of the solubilized cytoplasmic membrane fraction 
(Fig. 35, lane 8). Only trace amounts of A-PGS were detected in the outer membrane 
fraction (Fig. 35, lane 9). 
Based on these results it was concluded that A-PGS is a cytoplasmic transmembrane 
protein. 
Interestingly, the theoretical relative molecular mass of ~ 98’000 Da differs 
significantly from the experimental determined molecular mass of His6-A-PGS (Fig. 35) 
and A-PGS-myc-His6 (data not shown). It was supposed that this phenomenon results 
from the extended hydrophobic segments of the membrane protein as described for 
other membrane proteins (Kramer et al., 2000). 
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3.10.2 Cellular Localization of A-PG 
 
The biophysical separation of the cytoplasmic and the outer membrane was also used to 
analyze the localization of the reaction product of the A-PGS catalysis. Phospholipids of 
both membrane fractions were extracted and separated by 2D-TLC (Fig. 36). 
 
 
Figure 36: 2D-TLC analysis of cytoplasmic and outer membrane phospholipids. 
Cytoplasmic and outer membrane fractions were prepared from E. coli strain TOP10 carrying pBAD-His-
A/PA0920 according to Yamato et al. (1975). The lipids from these fractions were extracted, separated by 
2D-TLC and visualized by spraying with 5 % molybdatophosphoric acid. A, Lipid composition of the 
cytoplasmic membrane fraction. B, Lipid composition of the outer membrane fraction. A-PG is indicated 
by arrows. PE = phosphatidylethanolamine, PG = phosphatidylglycerol, DPG = diphosphatidylglycerol. 
 
The cytoplasmic and the outer membrane fraction of A-PGS overproducing E. coli cells 
contained almost identical amounts of A-PG (Fig. 36, A, B). 
From these results it was concluded that the A-PGS-dependent biosynthesis is located in 
the cytoplasmic membrane whereas the resulting phospholipid A-PG is a constituent of 
the cytoplasmic and the outer bacterial membrane. The mechanism by which A-PG is 
transported from the proposed place of A-PG synthesis - the inner leaflet of the 
cytoplasmic membrane – to the outer leaflet of cytoplasmic membrane and into the 
outer membrane remains to be determined. Bacterial phospholipid translocation by 
flippases is only poorly understood. However, only recently a putative flippase activity 
for the N-terminal transmembrane domain of S. aureus MprF was proposed (Ernst et 
al., 2009). In future experiments a possible flippase activity of the N-terminal domain of 
A-PGS from P. aeruginosa has to be investigated. 
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3.10.3 Microscopic Localization of the P. aeruginosa A-PGS 
 
To investigate the location of P. aeruginosa A-PGS and especially its postulated          
C-terminal transmembrane helix (compare chapter 3.1) the subcellular localization of 
A-PGS and the C-terminus of A-PGS by immunogold labeling of ultrathin plastic-
embedded cell sections was determined. For this purpose a myc epitope C-terminally 
fused to wild type A-PGS was immune electron microscopically detected, with a myc-
specific antibody (Fig. 37). 
 
 
Figure 37: Localization analysis of A-PGS and its C-terminus by immunogold labeling. 
E. coli TOP10 pBADmyc-His-A/PA0920 was cultivated as described in “Materials and Methods”. The 
subcellular localization of a myc epitope C-terminally fused to the A-PGS was immune electron 
microscopically detected. Immunogold labeling was performed in the presence of a myc-specific 
antibody. Gold particles, indicative for the localization of the myc epitope, almost exclusively decorate 
the cytosolic part of the cytoplasmic membrane. 
 
In Figure 37 gold particles, indicative for the localization of the myc epitope, almost 
exclusively decorate the cytosolic part of the inner membrane. This new methodology 
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revealed a homogeneous distribution of A-PGS in the cytoplasmic bacterial membrane. 
Besides this, the experiment confirms the results of previous biochemical analysis 
which indicated the localization of A-PGS in the cytoplasmic bacterial membrane 
(chapter 3.10.1). Furthermore, the localization of the myc epitope revealed a 
cytoplasmic orientation of the C-terminus of A-PGS. However, this observed 
cytoplasmic orientation is in disagreement with the computational prediction (Fig. 7). 
Based on these labeling experiments it was concluded that the postulated C-terminal 
helix is not a transmembrane helix that penetrates the bacterial membrane. This part of 
the molecule might be a hydrophobic protein segment which is part of the soluble 
catalytic domain. These results were also confirmed by localization analysis of 
constructs A-PGS543-855N and A-PGS543-881. After the separation of the membrane 
fraction from the cytosolic fraction both protein variants were exclusively detected in 
the soluble protein fraction (data not shown). Besides this, gel permeation experiments 
(chapter 3.5.2) revealed a monomeric, monomodal protein fragment A-PGS543-881 which 
is inconsistent with a highly hydrophobic transmembrane segment. 
The C-terminal localization and the requirement of residues 856 - 881 for A-PGS 
activity might indicate that this C-terminal part of the molecule is directly involved in 
substrate recognition and/or catalysis. Furthermore, P. aeruginosa A-PGS does not 
possess a C-terminal transmembrane helix. 
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4 SUMMARY 
 
Aminoacyl-phosphatidylglycerol synthases (aa-PGS) catalyze the tRNA-dependent 
modification of the phospholipid phosphatidylglycerol (PG) with alanine, lysine and 
arginine, respectively, resulting in a significant change of membrane biochemistry. 
However, the exact biological roles and catalytic mechanisms of these enzymes were 
poorly understood. Due to the contribution to antibiotic resistance and host adaptation 
this enzyme of the opportunistic pathogen P. aeruginosa is of special interest. 
In this study, the alanyl-phosphatidylglycerol (A-PG) formation in Gram-negative 
P. aeruginosa PAO1 was investigated. Analysis of the membrane composition of the 
bacterium grown under acidic conditions (pH 5.3) revealed up to 6 % of A-PG of the 
total amount of phospholipids compared to almost no A-PG at neutral pH. In agreement, 
the corresponding PA0920 gene encoding alanyl-phosphatidylglycerol synthase          
(A-PGS) was found significantly upregulated under acidic conditions. Formation of     
A-PG was found responsible for the resistance of P. aeruginosa to the antibiotic 
cefsulodin, the heavy metal ion Cr3+, the osmolyte sodium lactate, and the cationic 
peptide protamine sulphate. Clearly, alanylation of the membrane serves multiple 
adaptation reactions to environmental stresses. 
In a second part of this study a recombinant minimal P. aeruginosa A-PGS catalytic 
fragment was produced and employed as a versatile tool for the elucidation of the 
enzymatic mechanism in vitro. This robust test system clearly reflected the in vivo 
properties of A-PGS catalysis. Based on a site-directed mutagenesis study with            
15 mutant A-PGS proteins in combination with chemical enzyme modification 
experiments a direct transesterification mechanism for A-PGS catalysis was proposed. 
Determinants of the substrates were elucidated. The polar head group of PG is 
specifically recognized, whereas the fatty acid residue of PG is not an important 
determinant for A-PGS substrate recognition. The tRNA substrate recognition of the    
A-PGS enzyme does not include posttranscriptional base modifications. Besides this, 
only the acceptor stem of the overall structure of the tRNA is recognized. Based on      
A-PGS activity assays with 6 different tRNA microhelices it was speculated that five of 
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the terminal base pairings and especially the C5-G68 base pair are required to direct the 
alanyl-moiety of Ala-tRNAAla into the active site of the enzyme.  
Electron microscopy in combination with immunogold-labeling revealed a 
homogeneous distribution of P. aeruginosa A-PGS in the cytoplasmic bacterial 
membrane. Finally, the cytoplasmic location of the C-terminus of the membrane protein 
which is relevant for A-PGS activity was determined. 
Obtained results provided first significant insights into the enzymatic mechanism of     
A-PG formation which provide a solid basis for development of A-PGS inhibitory 
molecules in the future. 
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5 OUTLOOK 
 
As outlined above, a detailed biochemical characterization of A-PGS from                   
P. aeruginosa was performed in this study. The following questions have to be 
addressed in future experiments: 
 
• determination of the three-dimensional structure of A-PGS 
• identification of amino acid determinants for the specificity of          
aa-PGS enzymes 
• complementation of the P. aeruginosa ∆PA0920 deletion mutant 
strain with L-PGS to characterize the functional role of A-PG versus 
L-PG formation 
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7 APPEDIX 
 
Sequence alignment of orthologous A-PGS proteins 
Homologous aa-PGS proteins from Listeria monocytogenes (Lm), Listeria innocua (Li), Clostridium 
perfringens MprF2 (Cp2), Staphylococcus aureus (Sa), Staphylococcus xylosus (Sx), Bacillus cereus 
(Bc), Bacillus anthracis (Ba), Bacillus subtilis (Bs), Clostridium perfringens MprF1 (Cp1) and 
Pseudomonas aeruginosa (Pa). Identical residues are indicated by an asterisk, conserved substitutions by 
a colon, and semiconserved substitutions by a period. The first amino acid of the soluble A-PGS543-881 
variant is highlighted in black. The proposed C-terminal helix is underlined. Amino acid positions that 
have been mutagenized are highlighted in grey, point mutations that have been analyzed in the present 
study are indicated. 
 
CLUSTAL 2.0.12 multiple sequence alignment 
 
Lm              -----------------MKEKLMQAYAWFQKNSTVVKIVFITFVMAFVIFEIINIATGID 43 
Li              -----------------MKEKLMQAYAWFQRNSMIVKIVFITFVMGFVIFEIVNIATGID 43 
Cp2             ---------------------VKLNIKISDKLKLFFKIAFVSLVILFIVREFTSVFKNFN 39 
Sa              -----------------------MNQEVKNKIFSILKITFATALFIFVAITLYRELSGIN 37 
Sx              -----------------------MTKELRSKLFTILKIAFALTLFTIVAITLYKELSHIN 37 
Bc              ------------------------MSFSWKRFLQIGKIIFPFVVLTIVFFQAKKELAGIS 36 
Ba              ------------------------MSFSWKRFLQIGKIIFPFVVLTIVFFQAKKELAGIS 36 
Bs              -------------------------MLIKKNALSILKIVFPIAVLLFVIYQSKKELTNLS 35 
Cp1             ------------------------------------------------------------ 
Pa              MRTDAPVPEHPAPPSSPASPQRIRLIDRITAYRQPIGLVFTLLLFGLALVACYHLLREID 60 
                                                                             
 
Lm              YPSLKENLTSQSPEQIFIMFIVGLIAVTPMLLYDYVIVKLLPGKFSPSHVIASGWITNTF 103 
Li              YPSLKANITSQSPEQIFIMFIVGLIAVTPMLLYDYVIVKLLPGKFSPIHVVASGWITNTF 103 
Cp2             SEYFFMYRNKLDFLNLLIIAALGVISYIPLSFYDFILKRKVRIRLKNRKLYKYSWIASSI 99 
Sa              FKDTLVEFSKINRMSLVLLFIGGGASLVILSMYDVILSRALKMDISLGKVLRVSYIINAL 97 
Sx              LKDAIKSFSKINRFWLVALFLSGGASIIVLSIYDVILAKTLKLKIGLAKTIRIGYIVNAL 97 
Bc              FLEAINTIKNIPTGGVFLAITLGAFAVSTMFFYDYVMLRYLKADIPVQKIFRISWIANTL 96 
Ba              FLEAINTIKNIPTGGVFLAITLGAFAVSTMFFYDYVMLRYLKADIPVQKIFRISWIANTL 96 
Bs              FKRTLMVINGLERTDLFMLVLIGLLAVAAMSLYDYVLKYSLRLSITNGKVFRVSWIANSF 95 
Cp1             ------------------------------------------------------------ 
Pa              PGALHDAIADVPRPALLGALSATALGFVILLGYEWSASRFAGVTLPMRSLATGGFSAFAI 120 
                                                                             
 
Lm              TNIGGFGGVLGASLRASFYGKNAS-HKEILLAISKIALFLVSGLSIYCLVSLA-TLLIPG 161 
Li              TNIGGFGGVLGASLRASFYGKNAS-HKEILLAISKIALFLVSGLSIYCLVSLT-TLLIPG 161 
Cp2             ASLLGFGGATSLAFKQYFYGDYVDDKKKLLKEIGKIVALNLTGLSIVCCTYMG-IRISSW 158 
Sa              NAIVGFGGFIGAGVRAMVYKNYTHDKKKLVHFISLILISMLTGLSLLSLLIVFHVFDASL 157 
Sx              NAVVGFGGFIGASVRFLFYKNTTDDKKALFHTISIVLISMLTGLSLLSILVVIHVFDISH 157 
Bc              NGFIGFGGLVGAGVRTMLYRPYIKENGKLIKSIAWMTTAFINGLAILSFLGLIGILDTSF 156 
Ba              NGFIGFGGLVGAGVRTMLYRPYIKENGKLIKSIAWMTTAFINGLAILSFLGLIGILDTSF 156 
Bs              NNVLGFGGLAGVGLRMMFYKEHTKDHKALVKGIAWLTSSMLLGLSVFSIFVAARVLPVDE 155 
Cp1             ------------------------------------------------------------ 
Pa              GNAVGLSLLSGGSVRYRLYSRHGIGAAEIARMTLFASLSLGCALPVLAALAALCDLDDAA 180 
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Lm              FADHFVNYWPWLLAGGLYFPILFTITKWKSKS---------------LFVDLPIKRELTL 206 
Li              FADHFVNYWPWLLAGGLYFPILFTITKWKSKS---------------LFVDLPIKRELTL 206 
Cp2             NNLGIIKYAIGIIA--LYAPGFILYSAYKYSK---------------TKDKLEFFSTLGI 201 
Sa              ILDKITWVRWVLYVVSFFLPLFIIYSMVRPPD------------------KNNRFVGLYC 199 
Sx              IFTPYPWVKWLMYVVALFLPIFVVFTIIKPVQ------------------KTHRLLGVYC 199 
Bc              ILHEKPWLWPVLIFFALFVPIYIGFSKLKNRKP--------KQTEGQDEREEEKNPTVLY 208 
Ba              ILHEKPWLWPVLIFFALFVPIYIGFSKLKNRKT--------KQAEGQDEGEEEKNPTVLY 208 
Bs              VIHEKPWLWAVVIGFALILPLSLAVSKIKDRK-----------AGDEENADKVKNPIFAY 204 
Cp1             ------------------------------------------------------------ 
Pa              SALHLPRALVAVIAIAVLSLAVGLVAFLARHRLPGERPSPDSLLVRLGRRSLRLPGLRLS 240 
                                                                             
 
Lm              IIASLLEWGFAFGCFAIIGTLMGEPVDIFKVFPLFVIASVIGIASMVPGGVGTFDVVMIL 266 
Li              IVASLLEWGFAFGCFAIIGVLMGEPVDIFKVFPLFVIASVIGIASMVPGGVGTFDVVMIL 266 
Cp2             IFISFLEWLTTIILIYETLRITGASISVLNFLPIYIESAVVGMISMIPGGIGTFDLTFMT 261 
Sa              TLVSCVEWLAAAVVLYFCGVIVDAHVSFMSFIAIFIIAALSGLVSFIPGGFGAFDLVVLL 259 
Sx              TIVSGVEWFVAALVLYMSMAIVGVQIPFATFMGIFILAALSGLISFIPGGFGTFDLVVLL 259 
Bc              SLVSLVEWVSAGIVMYVILILFGIDIEFQKFLGVYVIAALAGVVSLVPGGLGSFDLVFLT 268 
Ba              SLVSLVEWVSAGIVMYVILILFGIDIEFQKFLGVYVIAALAGVVSLVPGGLGSFDLVFLT 268 
Bs              IGASVVEWLMAGTVIYFALFAMGIHADIRYVFGVFVIAAIGGMISLVPGGFGSFDLLFLL 264 
Cp1             ------------------------------------------------------------ 
Pa              LLQLLITALDVAAAATVLYLLLPETPPFAAFLLVYLLALAAGVLSHVPGGVGVFEAVLLA 300 
                                                                             
 
Lm              GLSQLGVSQELALAWMLFYRIFYYIIPFVVGLLFFVQKAGKKVNDFLEG----------- 315 
Li              GLSQLGVSQELALAWMLFYRIFYYIIPFIVGLLFFVQKAGKRLNDFLEG----------- 315 
Cp2             GLEALGIPIEQTLLVIILYRISYYIVPALIGVLLFVHDFGGKINKKFNG----------- 310 
Sa              GFKTLGVPEEKVLLMLLLYRFAYYFVPVIIALILSSFEFGTSAKKYIEGSKYFIPAKDVT 319 
Sx              GLKALNVNEEAIVLGLSLYRFAYYLFPVLIALILSTFEFRSTAKRYWEDSRILVPVKDMT 319 
Bc              GLGQYGIDTGVLLPAMLLYRLVYYILPFCLGLIFAAFEMTGVAIKKFEDKPFIAPALETT 328 
Ba              GLGQYGIDTGVLLPAMLLYRLVYYILPFCLGLIFAAFEMTGVAIKKFEDKPFIAPALETT 328 
Bs              GMEQLGYHQEAIVTSIVLYRLAYSFIPFILGLFFAAGDLTENTMKRLETNPRIAPAIETT 324 
Cp1             --------------MWDSLKKSYRHLKNILGFVTDKRNYENIKKLLKN------------ 34 
Pa              AFAG-QLGAAPLAAALLLYRLIYVVLPLLLACLLLLFLEARRLWVTRQA----------- 348 
                                   :  *  .   :. .              :             
 
Lm              -----LPLLFLQKVAHRFLVIFVYGSGLLLILSSAVPNAIYHVPFLYKIMPFNFLFTSQI 370 
Li              -----LPLLFLQKVAHRFLVFFVYGSGLLLILSSAVPNAIYHVPFLYKIMPFNFLFTSQI 370 
Cp2             -----LPYEIVSKVAYKIVVSLVFISGAIIVLSNIAPQYLLKIKLLKEILGKQVLGLSIG 365 
Sa              SFLMSYQKDIIAKIPSLSLAILVFFTSMIFFVN-----NLTIVYDALYDGNHLTYYILLA 374 
Sx              SLLGSYQKDIIARIPSFAIALLLLFTSLVFFLN-----NLTIIYDGLYDPNHYIYYIIVS 374 
Bc              GVIWTLQRDFLGKLGSWASAALTVFAGLMVILSTILPTSINRAHALHILAPKHLIQFSFS 388 
Ba              GVIWTLQRDFLGKLGSWASAALTVFAGLMVILSTILPTSINRAHALHILAPKHLIQFSFS 388 
Bs              NVLLVVQRAVLVRILQGSLSLIVFVAGLIVLASVSLP--IDRLTVIPHIPRPALLLFN-G 381 
Cp1             -------YKILSDISNIIVSVLVFLSGILLIISGIYPSIFYKIKFLDNIYSLSFLRFSHR 87 
Pa              -------IRVASGFAAPILAILVFLSGVVLLFSGATPAIDTRLEHLGFLIPHRLIDASHL 401 
                         .   .       :   :. :.. .                            
 
Lm              TIVAFGFLLLGLARGIECKTKKAYIITVIVLGCAIFNTLARVFSMKQAIFLGIVLLCLFL 430 
Li              TIVAFGFLLLGLARGIECKTKKAYIITVIVLGCAIFNTLARVFSMKQAIFLGIVLLCLFL 430 
Cp2             MSVVLGFLIMLAALMLKYRAKSIYKASMVLFILGIILSLTKGINPYELVFLIIVAYLLYL 425 
Sa              IHTSACLLLLLNVVGIYKQSRRAIIFAMISILLITVATFFTYASYILITWLAIIFVLLIV 434 
Sx              IHTCACLLLLLNVIGVYKLSKRAILFSIISVLFIFIATAYTYASFILLSWLTVIFILLLV 434 
Bc              LSLTFGILLLILSRGIYYGTKRSYYMTIVSLIGAAIFNTLKGIDIEETFILLIVLAVLYM 448 
Ba              LSLTFGILLLILSRGIYYGTKRSYYMTIISLIGAAVFNTLKGIDIEETFILLIVLAVLYM 448 
Bs              LSLSSALILLILPIELYKRTKRSYTMAITALVGGFVFSFLKGLNISAIFVLPMIIVLLVL 441 
Cp1             ASILIGLMLIMTSKEVFFKVKRAYYVTLTLLIVGGAFAFIKDLDYKEGIFILGVIILLIL 147 
Pa              VASLIGVLCLLLAQGLRRRLSAAWALTLVLLLVGALLSLLKGFDWEEASLLSLTAALLAM 461 
                      .: :     :          ::  .            .      :      * : 
 
Lm              ARNEFYREK--LVYTWSKVIIDSIIFIVCLAGYI-VIGIYNSPNIKHSKEIPDYLRIASE 487 
Li              ARNEFYREK--LVYTWSKVIIDSIIFIVCLAGYI-VIGIYNSPNIKHSKEIPDYLRIASE 487 
Cp2             SKRMFYRDS--FVVSCKNTLIDSGILIASFSIYF-FILITFGTHLKYVGIVRKMPYKMAY 482 
Sa              AFRRARRLK--RPVRMRNIVAMLLFSLFILYVN------HIFIAGTLYALDIYTIEMHTS 486 
Sx              FYRRARVIK--RPFRYSKLLLSVITGAIILYIN------HLVIKSTFYSLEIYHIEMLTS 486 
Bc              LRKRFVREK--MEVSLSDIVKVFIFLLITLYLYK-NLG-ILFAGAKEAFKPDFVVRNITQ 504 
Ba              LRKRFVREK--MEVSLSDIVKVFIFLLITLYLYK-NLG-ILFAGAKEAFKPDFVVRNITQ 504 
Bs              LKKQFVREQ--ASYTLGQLIFAVALFTVALFNYN-LIAGFIWDRMKKVLRHEYFVHSTSH 498 
Cp1             SKKSFYRKS--IPIKVTKLSGILIVLSIVMIIFASFIHKFNIHFSKNYKYYIDFFHSTKG 205 
Pa              FRRSFYRPSRLMEVPFSPLYVGASICVVGASVWLLLFANQDVHYSNQLWWQFALDADAPR 521 
                  .     .                                    .               
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Lm              HLWLVGFVGVFIAVVSLVIIYIYLSTTKEKLGSPFEAVKVREHLAKWG-GNEVSHTMFLR 546 
Li              HLWLVGFVGVFIAVVSLVIIYIYLSTTKEKLGSPFEAVKVREHLAKWG-GNEVSHTMFLR 546 
Cp2             KFGFIAFALVTVIYVAIYFLNIRRKIPVKTFDQCSEYIEK--IIEEYK-GDSLTHLVFLK 539 
Sa              VLRYYFWLTILIIAIIIGMIAWLFDYQFSKVRISSKIEDCEEIINQYG-GNYLSHLIYSG 545 
Sx              ILRYYFWITILLVAIIVGVIVWWFEYRYRSSNSRDNIATCESIIDKYN-GNYLSHLMYSG 545 
Bc              VKRSALAAAFFVPTFLLIGSLIANRYRNEFPGQPANDKRLQNFLDEHG-GNVLSHLGFLG 563 
Ba              VKRSALAAAFFVPTFLLIGSLIANRYRNEFPGQPANDKRLQNFLDEHG-GNVLSHLGFLG 563 
Bs              ITHATIMAIIIVPLFFLIFTVVYHK-RTKPIGEKADPERLAAFLNEKG-GNALSHLGFLG 556 
Cp1             YLRIALFTYISFIIFVIIWYLTMPKIEDDERYMDADLEKVSKFFKEIDYGTIFSHLVYLK 265 
Pa              ALRAALGSCLLLLALALGWLLRAAPPAIREPN-AEELQRAARIIRHSD--QPDGGLALTG 578 
                         . .  . :                  .       : .               
 
Lm              DKLLFWAAEGEVLFSYRIIADKMVIMGEPTGNMDKMEAAIEEVMMNADRFGYRPVFYEVR 606 
Li              DKLLFWAANGEVLFSYRIIADKMVIMGEPTGNMEKMEDAIEEVMTNADRFGYRPVFYEVR 606 
Cp2             DKYIYLNEDKDLFIQYEVYGDKLFVLGNPVGNNENLFREIEKFCEYADNYGYTPVFYQVN 599 
Sa              DKQFFTNENKTAFLMYRYKASSLVVLGDPLGDENAFDELLEAFYNYAEYLGYDVIFYQVT 605 
Sx              DKKFFINDNKDAFVMYRYHNNTYIILGDPIGNSESFYSLLEAFYKEAEYLGYDIIFYQVT 605 
Bc              DKQFFFSSDGKALLLFSITGKRLVVLGDPIGDPSSYRTVLQEFLAEADRFGYICVFYQIE 623 
Ba              DKQFFFSSDGKALLLFSITGKRLVVLGDPIGDPSSYRTVLQEFLAEADRFGYICVFYQIE 623 
Bs              DKRFYFSSDGNALLLFGKIARRLVVLGDPSGQRESFPLVLEEFLNEAHQKGFSVLFYQIE 616 
Cp1             DKKVFWANEGESLIMYSKYKDKIIVLGDPIATKENLYSCIEEFQAFTNLYGYDVVFYEIE 325 
Pa              DKALLFHESDDAFLMYARRGRSMIALYDPIGPAMQRAELIWQFRDLCDLHHARPVFYQVR 638 
                ** .    .   :. :       . : :* .        :  .    .      :**::  
                      D579 -> D579A, D579N 
 
Lm              GTMIPYLHDHGFDFIKLGEEGFVDVQNFTMS--GKKKKGERALMNKLEREGYTFEIIEPP 664 
Li              GTMIPYLHDHGFDFIKLGEEGFVDVQNFTMS--GKKKKGERALMNKLDREGYTFEIIQPP 664 
Cp2             EEMISYLHSNGYDFMKIGEEAKVDVKEFKVV--GNKMKSLKTSRSKVTKEGYTFHMVEPP 657 
Sa              DQHMPLYHNFGNQFFKLGEEAIIDLTQFSTS--GKKRRGFRATLNKFDELNISFEIIEPP 663 
Sx              DKYMSLYHSFGNQFFKLGEEAVINLTSFTTS--GKKKRGLRATLNKLDDLGYSFEVLEPP 663 
Bc              SKWMSLYHDFGYNFFKLGEEAVVDLNTFTIT--GKKRAGMRATFNRFEREGYTFSIHQPP 681 
Ba              SKWMSLYHDFGYNFFKLGEEAVVDLNTFTIT--GKKRAGMRATFNRFEREGYTFSIHQPP 681 
Bs              REDMALYHDFGYNFFKLGEEAYVDLNTFTLT--GKKKAGLRAINNRFEREEYTFHVDHPP 674 
Cp1             EKNFSTYHDAGYYFFKLGEEARIDLEEFNLI--GSKKSAFRNTLRRVEREGYNFSIIEPP 383 
Pa              AENLPFYMDIGLTALKLGEEARVDLLRFDLENKGKEMKDLRYTWNRGQRDGLALEFHEP- 697 
                   :.   . *   :*:***. :::  *     *.:    :    :       : . .*  
                                  E657 -> E657D, E657Q 
                 E658 -> E658D, E658Q 
 
Lm              FNHDTWTTLRAVSDEWLDGR--EEKGFSLGFFDTYYLEQAPIAIAKNGE-GTIVGFASMM 721 
Li              FNNEMWKTLRAVSDEWLDGR--EEKGFSLGFFDTYYLEQADIALAKNAD-GTVVGFASMM 721 
Cp2             FSREFLDYLKEISDEWLDGR--KEKGFSVGFFDEDYLNKAPIAILRDRE-GEIKAFANIM 714 
Sa              FSTEFINELQHVSDLWLDNR--QEMHFSVGEFNEEYLSKAPIGVMRNEE-NEVIAFCSLM 720 
Sx              FSQQMITDLKAISDDWLADK--NEMHFSVGSFDEHYISQAPIGVLKDNE-QSVIAFCTLM 720 
Bc              FSDELFEELRKVSDAWLGGK--KEKSFSLGYFDREYISRAPIATLSDAD-GKIIAFTTFM 738 
Ba              FSNELFEELRKVSDAWLGGK--KEKSFSLGYFDHEYISRAPIATLSDAD-GKIIAFTTFM 738 
Bs              FSDAFLEELKQISDEWLGSK--KEKGFSLGFFDPSYLQKAPIAYMKNAE-GEIVAFANVM 731 
Cp1             FNNEVVSQLKEISDKWLGDR--KEKGFSLGWFSEDYIQRSPIAILKNEEENKIMGFVTIM 441 
Pa              -GQAPLDELKAISDAWLGGKQVREKGFSLGRFTPAYLNFFRIAIVRHQG--KPVAFANLL 754 
                 .      *: :** ** .:  .*  **:* *   *:.   *.   .       .* ..: 
           S709 -> S709A, S709N 
    D710 -> D710A, D710N 
      E720 -> E720Q 
                                  S724 -> S724A, S724N 
 
Lm              PSYTDE-MTSIDLMRYSKEAPSGIMDFLFINLFEKAKEDGFQTFNAGMAPLANVGESKYA 780 
Li              PSYTDE-MTSIDLMRYSKEAPSGIMDFLFINLFEKAKEDGFQTFNAGMAPLANVGESKYA 780 
Cp2             YMYDDE-SFSVDLMRFSKNTPRGVMDFMFINLIEYGKEKGYEIFNMGMAPLANVGLSKYA 773 
Sa              PTYFND-AISVDLIRWLPELDLPLMDGLYLHMLLWSKEQGYTKFNMGMATLSNVGQLHYS 779 
Sx              PTYYNG-VISVDLIRWKQDIELPLMDSLYLNMLLWSKDNNYEHFNMGMATLSNVGQIPYS 779 
Bc              PVYQDG-SLSVDLMRYYPDAPSGIMDAIFIHLFQWAKENEYHSFNIGMAPLSNVGLSTQS 797 
Ba              PVYQDG-SLSVDLMRYYPDAPSGIMDAIFIHLFQWAKENEYHSFNIGMAPLSNVGLSTQS 797 
Bs              PMYQEG-EISVDLMRYRGDAPNGIMDALFIRMFLWAKEEGCTSFNMGMAPLANVGTAFTS 790 
Cp1             DANDGGETVAIDLMRIDKDAPNASMDYLMLNLFLTFKEKGYKYFSLGEAPLSNVGFNTHS 501 
Pa              ETDSRE-LASLDLMRVHPDAPKLTMEFLMLGLILHYKAQGHARFSLGMVPLAGLQPRRGA 813 
                         ::**:*   :     *: : : ::   * .    *. * ..*:.:     : 
´               S763 -> S763A, S763N 
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Lm              FLGERLAGLVYRYSQGFYGFKGLRNFKSKYVTEWEQKFVAFRKRSSIAFTMLQLMILVGK 840 
Li              FLGERLAGLVYRYSQGFYGFKGLRNFKSKYVTEWEQKFVAFRKRSSIAFTMLQLMILVGK 840 
Cp2             FWNEKLALQFYENGQALYSFKGLRRFKEKFSHNWEYKYIAYRRNTSILITVIQAAIVCSR 833 
Sa              YLRERLAGRVFEHFNGLYRFQGLRRYKSKYNPNWEPRFLVYRKDNSLWESLSKVMRVIRH 839 
Sx              FYGERIAGRVFEHFNGLYRFQGLRRYKEKFNPKWEPRFLVYRKHQSLWVSMLKVMRVIRK 839 
Bc              FWSERVAAAIFNNVRYTYSFSGLRHFKEKYKPAWSGKYLAFRKNHSLPITMLSVTKLIGK 857 
Ba              FWSERVAAAIFNNVRYTYSFSGLRHFKEKYKPAWSGKYLAFRKNHSLPITMLSVTKLIGK 857 
Bs              FWSERFAAVIFNNVRYMYSFSGLRAFKEKYKPEWRGKYLAYRKNRSLSVTMFLVTRLIGK 850 
Cp1             HLQEKLARLVYNSGNIFYSFDGLRRYKSKFSPIWQPRYLAYPKFMSLPEVFINLCLLIAN 561 
Pa              PLTQRLGALVFRRGEQFYNFQGLRRFKDKFQPDWEPRYLAVPAGLDPLVALADTAALIAG 873 
                   ::..  .:.  .  * *.*** :*.*:   *  :::.     .    .     :    
 
Lm              KRPLANSQVVLDFPLEEETKKPDSE 865 
Li              KRPLANNQVVLDFPLNEEIEKPDSE 865 
Cp2             NRNVDESIVVRNLKSLIK------- 851 
Sa              K------------------------ 840 
Sx              NN----------------------- 841 
Bc              RKNS--------------------- 861 
Ba              RKNS--------------------- 861 
Bs              SKKDSV------------------- 856 
Cp1             SKERVEKK----------------- 569 
Pa              GLTGLVKR----------------- 881    
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